Source,Text,Link,Verb,Original_Form,Context
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,refer,refers,'secondary glioblastoma' refers to a minority of glioblastomas that evolve
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,evolve,evolve,minority of glioblastomas that evolve from previously diagnosed who grade ii or
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,include,changes in glioblastoma include mutations in genes regulating receptor tyrosine kinase (
Abstract,"""Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26948367,include,includes,"treatment of glioblastoma includes surgery, radiotherapy, and alkylating chemotherapy."
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,infiltrate,infiltrating,"tumors are glioblastomas, and 30% are diffusely infiltrating lower-"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,improve,improved,"patients with glioblastoma, the combination of temozolomide with radiotherapy improved survival"
Abstract,"""Glioblastoma and Other Primary Brain Malignancies in Adults: A Review.""",https://pubmed.ncbi.nlm.nih.gov/36809318,follow,followed,therapy for glioblastoma is surgery followed by radiation and the alkylating chemotherapeutic
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,think,thought,glioblastomas are intrinsic brain tumors thought to originate from neuroglial
Abstract,"""Molecular targeted therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31541850,exhibit,exhibit,", uncommon glioblastoma subsets may exhibit specific vulnerabilities amenable to targeted interventions"
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,exhibit,exhibit,"glioblastomas exhibit vast inter- and intra-tumoral heterogeneity,"
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,recapitulate,recapitulate,-derived glioblastoma organoids (gbos) that recapitulate the histological features
Abstract,"""A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/31883794,deploy,deployed,features of glioblastomas and can be rapidly deployed to investigate patient-
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,base,based,newly diagnosed glioblastoma is based on radiotherapy combined with temozolomide.
Abstract,"""Glioblastoma and other malignant gliomas: a clinical review.""",https://pubmed.ncbi.nlm.nih.gov/24193082,remain,remains,"relevance: glioblastoma remains a difficult cancer to treat, although therapeutic"
Abstract,"""Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions.""",https://pubmed.ncbi.nlm.nih.gov/32328653,discuss,discussed,idhwt) glioblastomas will be discussed.
Title,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,emerge,emerging,developments in glioblastoma therapy: oncolytic viruses and emerging future strategies.
Abstract,"""Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies.""",https://pubmed.ncbi.nlm.nih.gov/36851761,describe,describe,virotherapy for glioblastomas and describe several ovs and their combination with other
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,recur,recur,", primary glioblastomas invariably recur as aggressive, therapy-resistant relapses"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,emerge,emerging,of recurrent glioblastoma is just slowly emerging.
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,ask,ask,on recurrent glioblastoma and ask whether and how therapies change intra-
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,determine,determine,"in recurrent glioblastoma will determine, whether, one day, glioblastoma"
Abstract,"""A comprehensive profile of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27041580,contain,contained,"day, glioblastoma can be contained in a state of chronic disease"
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,rank,ranks,glioblastoma ranks among the most lethal of all human cancers
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,display,display,"glioblastomas display striking cellular heterogeneity, with stem-like"
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,induce,induce,glioblastomas induce a systemic immunosuppression with mixed responses to oncoimmunologic
Abstract,"""Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.""",https://pubmed.ncbi.nlm.nih.gov/31160393,offer,offers,"collectively, glioblastoma offers a reliable cancer to study cancer stem cells"
Abstract,"""Current status and recent advances in reirradiation of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33602305,recur,recur,"gliomas (glioblastomas, gbm) will recur locally within 2 years"
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,develop,develop,majority of glioblastomas (~90%) develop rapidly de novo in
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,differ,differ,"and secondary glioblastomas are largely indistinguishable, but they differ in their"
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,associate,associated,in primary glioblastomas and which are associated with a hypermethylation phenotype.
Abstract,"""The definition of primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23209033,originate,originate,and secondary glioblastomas are distinct tumor entities that originate from different precursor
Abstract,"""Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36853018,remain,remains,"chemotherapy, glioblastoma remains refractory to treatment and recurrence is inevitable."
Abstract,"""Single-cell RNA sequencing reveals tumor heterogeneity, microenvironment, and drug-resistance mechanisms of recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36853018,remain,remains,of recurrent glioblastoma remains unclear.
Title,"""Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.""",https://pubmed.ncbi.nlm.nih.gov/34011400,reveal,reveals,macrophages in glioblastoma reveals marco as a mesenchymal pro-tumor marker
Abstract,"""Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.""",https://pubmed.ncbi.nlm.nih.gov/34011400,suggest,suggest,progression in glioblastomas and suggest potential therapeutic targets to prevent their recruitment
Abstract,"""Medicinal Plants for Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/34939551,demonstrate,demonstrates,"glioblastoma, an aggressive brain cancer, demonstrates the least"
Abstract,"""Medicinal Plants for Glioblastoma Treatment.""",https://pubmed.ncbi.nlm.nih.gov/34939551,use,used,valuable for glioblastoma prevention and its incidence by effectively being used as
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,provide,providing,"cells within glioblastomas, providing previously unattainable insights into the genetic and"
Abstract,"""Understanding glioblastoma at the single-cell level: Recent advances and future challenges.""",https://pubmed.ncbi.nlm.nih.gov/38814900,expect,expected,"heterogeneity of glioblastomas are expected, which will help guide the development"
Abstract,"""The cause of death in patients with glioblastoma is multifactorial: clinical factors and autopsy findings in 117 cases of supratentorial glioblastoma in adults.""",https://pubmed.ncbi.nlm.nih.gov/1654403,review,reviewed,with supratentorial glioblastoma multiforme (gm) we reviewed 117 consecutive cases
Title,"""Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/35303420,match,matched,of primary glioblastomas and matched explants and cell lines show variable retention
Abstract,"""Single-cell landscapes of primary glioblastomas and matched explants and cell lines show variable retention of inter- and intratumor heterogeneity.""",https://pubmed.ncbi.nlm.nih.gov/35303420,characterize,characterized,glioblastomas (gbms) are aggressive brain tumors characterized by
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,treat,treated,all intracranial glioblastomas treated in 2 different neurosurgical departments during the last
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,include,included,proven intraventricular glioblastomas were included in the study.
Abstract,"""Intraventricular Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26773981,affect,affect,: intraventricular glioblastoma is extremely rare and can affect younger individuals including
Abstract,"""Neoplastic Myelopathies.""",https://pubmed.ncbi.nlm.nih.gov/29613896,recognize,recognized,"grade iv glioblastomas, and newly recognized pediatric diffuse midline gliomas with"
Title,"""Risk factors for glioblastoma are shared by other brain tumor types.""",https://pubmed.ncbi.nlm.nih.gov/38520250,share,shared,factors for glioblastoma are shared by other brain tumor types.
Abstract,"""Risk factors for glioblastoma are shared by other brain tumor types.""",https://pubmed.ncbi.nlm.nih.gov/38520250,ionize,ionizing,"factors for glioblastoma (gbm), i.e., ionizing radiation,"
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,emerge,emerged,pivotal in glioblastoma treatment resistance and dna methylation emerged as an important
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,subject,subjected,"from 47 glioblastoma patients were subjected to dna methylation profiling, including"
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,"general, glioblastomas with a subclass transition showed upregulated metabolic processes."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,display,displayed,newly diagnosed glioblastomas with mesenchymal transition displayed increased stem cell-like
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,show,showed,of recurrent glioblastomas with mesenchymal transition showed increased immune components but decreased
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,impact,impacting,"% of glioblastomas, not impacting patient survival."
Abstract,"""Temporal change of DNA methylation subclasses between matched newly diagnosed and recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38244080,target,targeted,for recurrent glioblastoma targeted therapies.
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,represent,represents,review: glioblastoma represents one of the major challenges in neurooncology and
Abstract,"""Management of Elderly Patients with Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28324304,remain,remains,patients with glioblastoma remains poor.
Abstract,"""Surgical site infections after glioblastoma surgery: boon or bane?""",https://pubmed.ncbi.nlm.nih.gov/38279060,clarify,clarified,course of glioblastoma patients has not been fully clarified since available data
Abstract,"""Surgical site infections after glioblastoma surgery: boon or bane?""",https://pubmed.ncbi.nlm.nih.gov/38279060,scan,scanned,surgery for glioblastoma between 2010 and 2020 in our institution were scanned
Abstract,"""Surgical site infections after glioblastoma surgery: boon or bane?""",https://pubmed.ncbi.nlm.nih.gov/38279060,identify,identified,infections after glioblastoma resection were identified and compared to an age-
Title,"""Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.""",https://pubmed.ncbi.nlm.nih.gov/37814403,revisit,revisited,of brain glioblastoma outside cns: pathogenesis revisited.
Abstract,"""Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.""",https://pubmed.ncbi.nlm.nih.gov/37814403,exist,exists,"metastasis of glioblastoma pathogenesis, no effective treatment exists to date."
Abstract,"""Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.""",https://pubmed.ncbi.nlm.nih.gov/37814403,worsen,worsen,for metastatic glioblastoma as their side effects may worsen the patient prognosis
Abstract,"""Extracranial metastasis of brain glioblastoma outside CNS: Pathogenesis revisited.""",https://pubmed.ncbi.nlm.nih.gov/37814403,require,requires,metastasis of glioblastoma requires further investigation with a wide inclusion of patients
Title,"""Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.""",https://pubmed.ncbi.nlm.nih.gov/34067762,associate,associated,mechanisms in glioblastoma and tumor-associated epilepsy.
Abstract,"""Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.""",https://pubmed.ncbi.nlm.nih.gov/34067762,associate,associated,"progression of glioblastomas is associated with a variety of neurological impairments,"
Abstract,"""Glutamatergic Mechanisms in Glioblastoma and Tumor-Associated Epilepsy.""",https://pubmed.ncbi.nlm.nih.gov/34067762,associate,associated,"both, glioblastoma and tumor-associated epilepsy are closely linked to"
Title,"""Glioblastoma and dementia may share a common cause.""",https://pubmed.ncbi.nlm.nih.gov/20181435,share,share,glioblastoma and dementia may share a common cause.
Abstract,"""Glioblastoma and dementia may share a common cause.""",https://pubmed.ncbi.nlm.nih.gov/20181435,share,share,'s and glioblastoma may share an as yet unknown peripheral tissue pathway
Abstract,"""Glioblastoma patients' survival and its relevant risk factors during the pre-COVID-19 and post-COVID-19 pandemic: real-world cohort study in the USA and China.""",https://pubmed.ncbi.nlm.nih.gov/38376848,remain,remains,"patients with glioblastomas (gbms), it remains unclear whether the"
Abstract,"""The Impacts of miRNAs in Glioblastoma Progression.""",https://pubmed.ncbi.nlm.nih.gov/27480776,find,found,studies in glioblastoma patients have found that aberrant mirna expression can be
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,occur,occurs,", recurrent glioblastoma usually occurs within several months after resection and causes"
Abstract,"""[Radiosurgery for recurrent glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/34951763,identify,identify,with recurrent glioblastoma and to identify the factors determining its effectiveness.
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,infiltrate,infiltrate,within each glioblastoma and the ability of glioma cells to diffusely infiltrate
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,tend,tend,"is that glioblastomas tend to be poorly infiltrated by t cells,"
Abstract,"""A Conceptual Framework for Inducing T Cell-Mediated Immunity Against Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35505129,direct,directed,"to induce glioblastoma-directed t cell responses, including neoantigen-"
Abstract,"""Management of glioblastoma multiforme in pregnancy.""",https://pubmed.ncbi.nlm.nih.gov/22404670,present,presenting,glioblastoma multiforme presenting during pregnancy presents unique challenges to the
Title,"""Glioblastoma multiforme: emerging treatments and stratification markers beyond new drugs.""",https://pubmed.ncbi.nlm.nih.gov/26159214,emerge,emerging,glioblastoma multiforme: emerging treatments and stratification markers beyond new
Abstract,"""Glioblastoma with Probable Intratumoral Adenocarcinoma Metastasis: A Rare Report with Review of Literature.""",https://pubmed.ncbi.nlm.nih.gov/38378180,support,supporting,"ruling out glioblastoma with true epithelial metaplasia, and supporting the diagnosis"
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,study,studied,progression in glioblastoma are being studied.
Abstract,"""Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets.""",https://pubmed.ncbi.nlm.nih.gov/32268863,discuss,discussed,therapy for glioblastoma has also been discussed.
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,constitute,constitutes,glioblastoma is the most common intracranial malignancy and constitutes about
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,explain,explain,profiles in glioblastoma may explain the difficulties encountered in the validation of
Abstract,"""Molecular heterogeneity of glioblastoma and its clinical relevance.""",https://pubmed.ncbi.nlm.nih.gov/25156108,call,call,"heterogeneity of glioblastomas, and call attention to the importance of this"
Title,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,use,using,glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,constitute,constituted,glioblastoma treatment as now constituted offers increased survival measured in
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,synthesize,synthesizing,because glioblastomas are active in synthesizing a bewildering variety of growth
Abstract,"""Glioblastoma chemotherapy adjunct via potent serotonin receptor-7 inhibition using currently marketed high-affinity antipsychotic medicines.""",https://pubmed.ncbi.nlm.nih.gov/20880389,review,reviewed,changes in glioblastoma is reviewed in this paper.
Abstract,"""Status epilepticus in patients with glioblastoma: Clinical characteristics, risk factors, and epileptological outcome.""",https://pubmed.ncbi.nlm.nih.gov/37748366,treat,treated,-novo glioblastoma treated at our institution between 01/2006 and 01/2020 and
Abstract,"""Role of circulating mitochondria in venous thrombosis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37178770,develop,develop,patients with glioblastoma multiforme (gbm) develop deep venous thrombosis or
Abstract,"""Metabolic Vulnerabilities in Brain Cancer.""",https://pubmed.ncbi.nlm.nih.gov/33781499,alter,altered,glioblastomas (gbms) exhibit altered metabolism to support a
Abstract,"""Leveraging extrachromosomal DNA to fine-tune trials of targeted therapy for glioblastoma: opportunities and challenges.""",https://pubmed.ncbi.nlm.nih.gov/36131011,facilitate,facilitated,"glioblastoma evolution is facilitated by intratumour heterogeneity, which poses"
Abstract,"""Morphologic and Molecular Aspects of Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33781498,evolve,evolved,definition of glioblastomas has continually evolved from a reliance on strict morphologic
Abstract,"""Morphologic and Molecular Aspects of Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33781498,include,includes,"workup of glioblastomas includes intraoperative evaluations with tissue-sparing techniques,"
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,associate,associated,in glioblastoma it is associated with a poor prognosis and more
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,examine,examine,cxcr4 in glioblastoma tissue to further examine the potential of these pet
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,stain,stained,glioblastoma tissue cores were stained for cxcr4.
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,undergo,underwent,with recurrent glioblastoma underwent [68ga]ga-pentixafor pet; residual resected
Abstract,"""CXCR4 expression in glioblastoma tissue and the potential for PET imaging and treatment with [(68)Ga]Ga-Pentixafor /[(177)Lu]Lu-Pentixather.""",https://pubmed.ncbi.nlm.nih.gov/33550492,analyze,analyzed,"the 191 glioblastomas, 426 cores were analyzed using immunohistochemistry."
Abstract,"""Pharmacometabolomics Informs Quantitative Radiomics for Glioblastoma Diagnostic Innovation.""",https://pubmed.ncbi.nlm.nih.gov/28816643,serve,serve,suggest that glioblastomas serve as a useful application paradigm.
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,advance,advances,"mechanisms of glioblastomas, advances in treatment that translate into substantial improvement"
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,propose,proposed,cytomegalovirus in glioblastoma pathogenesis was proposed more than a decade ago and
Abstract,"""Cytomegalovirus and glioblastoma: a review of evidence for their association and indications for testing and treatment.""",https://pubmed.ncbi.nlm.nih.gov/25289896,demonstrate,demonstrate,treatment of glioblastoma did not demonstrate a beneficial effect on tumor growth
Abstract,"""Bevacizumab for glioblastoma: current indications, surgical implications, and future directions.""",https://pubmed.ncbi.nlm.nih.gov/25581938,neutralize,neutralizing,treating recurrent glioblastomas with the antiangiogenic drug bevacizumabâ€”a neutralizing antibody
Abstract,"""Bevacizumab for glioblastoma: current indications, surgical implications, and future directions.""",https://pubmed.ncbi.nlm.nih.gov/25581938,design,designed,"bevacizumab for glioblastoma treatment to date, ongoing trials designed to address"
Abstract,"""GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35456993,promote,promotes,% of glioblastomas and promotes tumor formation and progression.
Abstract,"""GZ17-6.02 Inhibits the Growth of EGFRvIII+ Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/35456993,utilize,utilizing,subset of glioblastomas and our data warrants further preclinical studies utilizing xenograft
Title,"""Glioblastoma arising within sites of encephalomalacia from cerebrovascular insult: two cases and a review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/29422364,arise,arising,glioblastoma arising within sites of encephalomalacia from cerebrovascular insult:
Abstract,"""Glioblastoma arising within sites of encephalomalacia from cerebrovascular insult: two cases and a review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/29422364,result,resulting,"factors in glioblastoma formation, chronic inflammation resulting from non-traumatic"
Abstract,"""Glioblastoma arising within sites of encephalomalacia from cerebrovascular insult: two cases and a review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/29422364,arise,arising,instances of glioblastoma arising within areas of encephalomalacia caused by remote vascular
Abstract,"""Glioblastoma arising within sites of encephalomalacia from cerebrovascular insult: two cases and a review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/29422364,discuss,discuss,"literature associating glioblastoma with prior brain injury, and discuss potential mechanisms"
Abstract,"""Glioblastoma multiforme: a review of therapeutic targets.""",https://pubmed.ncbi.nlm.nih.gov/19409033,present,present,such as glioblastoma multiforme (gbm) present some of the greatest
Title,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,base,based,glioblastoma molecular classification tool based on mrna analysis: from
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,incorporate,incorporate,most glioblastoma studies incorporate the layer of tumor molecular subtype based
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,apply,applies,"tool for glioblastoma molecular subtyping, and each study applies a different"
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,use,using,"tool for glioblastoma classification, with high accuracy, while using a"
Abstract,"""Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.""",https://pubmed.ncbi.nlm.nih.gov/36555518,base,based,tool for glioblastoma molecular classification based on the mrna analysis of only
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,remain,remains,necrosis in glioblastomas remains unelucidated.
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,result,results,"patients with glioblastomas, because the hypoxia that results from procoagulation selects"
Abstract,"""Necrosis and glioblastoma: a friend or a foe? A review and a hypothesis.""",https://pubmed.ncbi.nlm.nih.gov/12182418,base,based,development in glioblastomas that is evidence-based is likely to provide
Abstract,"""Role of micro-RNA (miRNA) in pathogenesis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26004603,play,play,"pathogenesis of glioblastoma, as mirnas play a critical role in the"
Abstract,"""A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37427593,lack,lack,glioblastomas (gbm) are aggressive tumors that lack effective
Title,"""Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.""",https://pubmed.ncbi.nlm.nih.gov/37581329,cycle,cycling,treatment of glioblastoma with redox-cycling 'mitocans': a
Abstract,"""Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.""",https://pubmed.ncbi.nlm.nih.gov/37581329,redoxcycle,redoxcycling,treatment of glioblastoma by redoxcycling 'mitocans' such as quinone/
Abstract,"""Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.""",https://pubmed.ncbi.nlm.nih.gov/37581329,treat,treated,performed on glioblastoma mice (orthotopic model) treated with coenzyme q0
Abstract,"""Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.""",https://pubmed.ncbi.nlm.nih.gov/37581329,treat,treated,observed in glioblastoma mice treated with q0/a.discussion: q0/
Abstract,"""Tolerable treatment of glioblastoma with redox-cycling 'mitocans': a comparative study in vivo.""",https://pubmed.ncbi.nlm.nih.gov/37581329,cause,causing,", particularly glioblastoma, from normal ones by redox targeting, causing"
Abstract,"""Risk factors for glioblastoma in adults in Japan: an exploratory cohort study based on the Shizuoka Kokuho Database, the Shizuoka study.""",https://pubmed.ncbi.nlm.nih.gov/38206510,utilize,utilizing,onset of glioblastoma (gbm) utilizing a comprehensive administrative claims database
Abstract,"""Baseballs, tennis balls, livestock farm manure, the IDH1 mutation, endothelial cell proliferation and hypoxic pseudopalisading (granulomatous) necrosis: Mycobacterium avium subspecies paratuberculosis and the epidemiology, cellular metabolism and histology of diffuse gliomas, including glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31086759,note,noted,", including glioblastoma, has been noted in livestock farmers in western"
Abstract,"""Baseballs, tennis balls, livestock farm manure, the IDH1 mutation, endothelial cell proliferation and hypoxic pseudopalisading (granulomatous) necrosis: Mycobacterium avium subspecies paratuberculosis and the epidemiology, cellular metabolism and histology of diffuse gliomas, including glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31086759,handle,handle,rates of glioblastoma in tennis and baseball players who handle balls coated
Abstract,"""Baseballs, tennis balls, livestock farm manure, the IDH1 mutation, endothelial cell proliferation and hypoxic pseudopalisading (granulomatous) necrosis: Mycobacterium avium subspecies paratuberculosis and the epidemiology, cellular metabolism and histology of diffuse gliomas, including glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31086759,define,defining,consistent with glioblastoma's two defining histopathologic characteristics: endothelial cell proliferation
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,locate,located,cases of glioblastoma metastases with the development of foci located at a
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,receive,received,with brain glioblastomas who received treatment at the burdenko neurosurgical institute (
Abstract,"""Glioblastoma metastases: a literature review and a description of six clinical observations.""",https://pubmed.ncbi.nlm.nih.gov/26146042,associate,associated,metastases of glioblastomas that are closely associated with the cerebrospinal fluid circulation
Abstract,"""Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37056564,identify,identified,datasets of glioblastomas and identified 2 robust immune subtypes based on lncrna
Abstract,"""Epigenetically regulated lncRNAs dissect the intratumoural heterogeneity and facilitate immune evasion of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37056564,facilitate,facilitate,"regulation in glioblastomas, and will facilitate the development of epigenetic immunotherapy"
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,cement,cemented,regards to glioblastoma etiology has been particularly satisfying because it cemented the
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,set,set,how the glioblastoma genomic data set serves as an illustrative platform for
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,evolve,evolve,that most glioblastomas evolve along a multitude of pathways rather than a
Abstract,"""Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.""",https://pubmed.ncbi.nlm.nih.gov/22002595,relate,relate,subtypes of glioblastoma as they relate to key principles of developmental neurobiology
Abstract,"""Therapeutic control and resistance of the EGFR-driven signaling network in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25885672,represent,represents,"feature of glioblastomas (gbm), and its inhibition represents a"
Title,"""Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018.""",https://pubmed.ncbi.nlm.nih.gov/37792220,follow,following,of developing glioblastoma following non-cns primary cancer: a seer
Abstract,"""EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy.""",https://pubmed.ncbi.nlm.nih.gov/24671641,represent,represents,"% of glioblastomas, it currently represents one of the most promising"
Abstract,"""The Hospital Frailty Risk Score Independently Predicts Postoperative Outcomes in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/38211815,compare,compare,resection of glioblastoma (gbm) and compare its prognostic ability with
Abstract,"""Venous thromboembolism (VTE) and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25985958,have,have,"glioblastoma (gbm) patients, in particular, have"
Abstract,"""Venous thromboembolic events in glioblastoma patients: An epidemiological study.""",https://pubmed.ncbi.nlm.nih.gov/35545894,dehydrogenase,dehydrogenase,hundred fourteen glioblastoma patients with isocitrate dehydrogenase wild-type status were
Abstract,"""Insular glioblastoma: surgical challenges, survival outcomes and prognostic factors.""",https://pubmed.ncbi.nlm.nih.gov/33356607,analyse,analysed,insular glioblastomas (igbm) have not been analysed separately before
Abstract,"""Insular glioblastoma: surgical challenges, survival outcomes and prognostic factors.""",https://pubmed.ncbi.nlm.nih.gov/33356607,have,had,"patients had glioblastoma, while four had gliosarcoma."
Abstract,"""Ischaemic stroke in the setting of glioblastoma: A case series and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/26988080,challenge,challenging,"setting of glioblastoma, and clinically challenging due to co-existing"
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,develop,develop,and secondary glioblastomas (gbms) that develop from low-grade
Abstract,"""Isocitrate dehydrogenase status and molecular subclasses of glioma and glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25434382,represent,represent,metabolic enzyme glioblastomas (idh1) represent a distinguishing feature of low
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,undergo,undergoing,-wildtype glioblastomas which are undergoing evaluation in clinical trials.
Abstract,"""Advances in Treatment of Isocitrate Dehydrogenase (IDH)-Wildtype Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/37154886,offer,offer,-wildtype glioblastomas offer hope and the prospect of incremental improvements in
Abstract,"""Contrast Enhancement Patterns in Pediatric Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/36112052,comprise,comprise,", pediatric glioblastomas (gbms) comprise 2.9% of all central"
Title,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,radio-,radio-,mechanisms of glioblastoma resistance to radio- and chemotherapy.
Abstract,"""Role of microRNAs in mechanisms of glioblastoma resistance to radio- and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23590435,characterize,characterized,"and multiform glioblastoma are characterized by highly pronounced anaplasia, malignization,"
Abstract,"""MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme.""",https://pubmed.ncbi.nlm.nih.gov/35806153,highlight,highlighting,"changes in glioblastomas, also highlighting benefits, including those of liquid"
Abstract,"""MGMT and Whole-Genome DNA Methylation Impacts on Diagnosis, Prognosis and Therapy of Glioblastoma Multiforme.""",https://pubmed.ncbi.nlm.nih.gov/35806153,bear,bearing,especially in glioblastomas bearing mutations in the isocitrate dehydrogenase (idh)
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,develop,developed,"and curing glioblastoma, new and innovative therapeutic strategies must be developed"
Abstract,"""Emerging role of combination of all-trans retinoic acid and interferon-gamma as chemoimmunotherapy in the management of human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17676389,gap,gaps,"options for glioblastomas, gaps in our knowledge of immune recognition of"
Abstract,"""Metastatic glioblastoma: case presentations and a review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21964740,estimate,estimated,metastases from glioblastoma (gbm) are uncommon with an estimated incidence
Abstract,"""Epigenetic regulation of cancer stem cell and tumorigenesis.""",https://pubmed.ncbi.nlm.nih.gov/32723561,attract,attract,"brain, glioblastoma stem cells (gscs) attract extensive research interests"
Abstract,"""The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34152549,help,help,-wildtype glioblastoma through its unique features can help researchers find innovative
Abstract,"""The inverse paradigm and the ancestral cell of IDH-wildtype glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34152549,need,need,-wildtype glioblastoma need to be supplemented and updated to overcome therapeutic
Title,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,derive,derived,metabolism of glioblastoma derived from the depiction of (18)f-fluoromisonidazole
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,characterize,characterized,"purpose: glioblastoma is the most aggressive primary brain tumor, characterized"
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,undergo,underwent,patients with glioblastoma (n = 33) who underwent preoperative 18f
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,receive,received,"among the glioblastoma patients who received gross total resection, mrna expressions"
Abstract,"""Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of (18)F-Fluoromisonidazole and (18)F-Fluorodeoxyglucose Positron Emission Tomography.""",https://pubmed.ncbi.nlm.nih.gov/38449509,validate,validated,"survival in glioblastoma, as validated by tcga database."
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,increase,increase,", and glioblastomas increase the risk of ad."
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,relate,related,"surgery, glioblastoma was related to a significantly lower ad risk than"
Abstract,"""Risk of Death from Alzheimer's Disease Associated with Brain Tumor, Glioma, and Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37840492,associate,associated,gliomas and glioblastomas were associated with a significantly lower risk of death
Abstract,"""Ventriculoperitoneal Shunting for Glioblastoma: Risk Factors, Indications, and Efficacy.""",https://pubmed.ncbi.nlm.nih.gov/27218235,develop,develop,"background: glioblastoma patients can develop hydrocephalus, either obstructive, typically"
Abstract,"""Ventriculoperitoneal Shunting for Glioblastoma: Risk Factors, Indications, and Efficacy.""",https://pubmed.ncbi.nlm.nih.gov/27218235,associate,associated,patients with glioblastoma-associated hydrocephalus.
Abstract,"""Ventriculoperitoneal Shunting for Glioblastoma: Risk Factors, Indications, and Efficacy.""",https://pubmed.ncbi.nlm.nih.gov/27218235,diagnose,diagnosed,"of 841 glioblastoma patients diagnosed from 2004 to 2014, 64 ("
Abstract,"""Ventriculoperitoneal Shunting for Glioblastoma: Risk Factors, Indications, and Efficacy.""",https://pubmed.ncbi.nlm.nih.gov/27218235,suspect,suspected,"in most glioblastoma patients with suspected ch or oh, specifically younger"
Title,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,manage,managed,patients with glioblastoma: series of cases managed in the department of
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,admit,admitted,patients with glioblastoma admitted to the department of hematology-oncology (
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,account,accounted,glioblastoma accounted for 47.6% of treated intracranial tumours.
Abstract,"""[Epidemiological, clinical, therapeutic and evolutionary features of patients with glioblastoma: series of cases managed in the Department of Hematology-Oncology at the Mohammed VI University Hospital Center in Marrakech in 2016 and 2017].""",https://pubmed.ncbi.nlm.nih.gov/34603572,have,had,cases had glioblastomas-idh1-wild and one case had glioblastoma
Abstract,"""Probabilistic radiographic atlas of glioblastoma phenotypes.""",https://pubmed.ncbi.nlm.nih.gov/22997168,reflect,reflect,"factor in glioblastoma, which may reflect the genetic profile of tumor"
Abstract,"""Probabilistic radiographic atlas of glioblastoma phenotypes.""",https://pubmed.ncbi.nlm.nih.gov/22997168,analyze,analyzed,de novo glioblastoma were analyzed.
Abstract,"""Probabilistic radiographic atlas of glioblastoma phenotypes.""",https://pubmed.ncbi.nlm.nih.gov/22997168,grow,grow,: most glioblastomas grow into the periventricular white matter regions adjacent to
Abstract,"""Probabilistic radiographic atlas of glioblastoma phenotypes.""",https://pubmed.ncbi.nlm.nih.gov/22997168,have,having,"patients with glioblastoma, in idh1 mutant tumors, in tumors having"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,affect,affecting,"glioblastoma, the most common and heterogeneous tumor affecting brain"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,explore,explored,"features of glioblastomas that are, indeed, currently explored in preclinical"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,discuss,discussing,"landscapes of glioblastomas, in each case discussing the corresponding targeted therapies"
Abstract,"""Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance.""",https://pubmed.ncbi.nlm.nih.gov/36479695,enforce,enforcing,"investigate many glioblastoma epigenetic biomarkers in clinical practice, further enforcing the"
Abstract,"""Antiangiogenesis treatment for glioblastoma multiforme: challenges and opportunities.""",https://pubmed.ncbi.nlm.nih.gov/18492463,discuss,discusses,"research on glioblastoma angiogenesis and discusses its underlying biology, clinical trial"
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,develop,develop,"brain cancer glioblastoma multiforme, develop resistance to cell death, in"
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,show,showed,"freshly isolated glioblastomas from 49 patients showed mitochondrial hyperpolarization, which was"
Abstract,"""Metabolic modulation of glioblastoma with dichloroacetate.""",https://pubmed.ncbi.nlm.nih.gov/20463368,secure,secured,"who had glioblastoma, we prospectively secured baseline and serial tumor tissue"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,remain,remains,treatment of glioblastomas remains ineffective and essentially palliative.
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,display,display,cells called glioblastoma stem cells (gscs) display relative resistance to
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,metastasize,metastasize,"while glioblastomas rarely metastasize beyond the central nervous system, glioblastomas"
Abstract,"""Potential therapeutic implications of cancer stem cells in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20457135,invade,invade,"system, glioblastomas invade into brain structures to prevent surgical cure and"
Abstract,"""KLF6 depletion promotes NF-kappaB signaling in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28166199,predict,predicts,the analyzed glioblastomas and predicts unfavorable patient prognosis suggesting that haploinsufficiency is
Abstract,"""Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.""",https://pubmed.ncbi.nlm.nih.gov/26427041,take,taken,"22 recurrent glioblastoma taken from the chinese population, and further analyzed"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,discover,discovered,"nscs with glioblastoma, since we have discovered that recurrent glioblastomas were"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,incline,inclined,that recurrent glioblastomas were inclined to be derived from subventricular zone (
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,provide,providing,"process of glioblastoma relapse, providing the basis for dealing with newly"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,help,help,"newly diagnosed glioblastoma patients, which may help postpone the recurrence of"
Abstract,"""Neural stem cells promote glioblastoma formation in nude mice.""",https://pubmed.ncbi.nlm.nih.gov/30945128,preprocesse,preprocessing,recurrence of glioblastoma as far as possible through preprocessing the tumor-
Abstract,"""Coixendide efficacy in combination with temozolomide in glioblastoma and transcriptome analysis of the mechanism.""",https://pubmed.ncbi.nlm.nih.gov/37726303,explore,explore,treatment of glioblastoma (gbm) and explore its possible mechanism.
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,have,have,"morphologically indistinguishable glioblastomas have distinct classes of causal oncogene activation, and"
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,limit,limited,application for glioblastoma has been severely limited by an inability to determine
Abstract,"""Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy.""",https://pubmed.ncbi.nlm.nih.gov/12878856,detect,detecting,subsets of glioblastoma and detecting pathway profiles that can be used to
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,know,known,"glioblastomas, also known as glioblastoma multiforme (gbm)"
Abstract,"""An update on the epigenetics of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27585647,noncode,noncoding,"modification, glioblastoma stem cells, dna methylation, noncoding rnas expression"
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,detect,detected,in human glioblastoma stem cells and glioblastoma cells and was mainly detected
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,detect,detected,cells and glioblastoma cells and was mainly detected in the cytoplasm rather
Abstract,"""OCT4B Isoform Promotes Anchorage-Independent Growth of Glioblastoma Cells.""",https://pubmed.ncbi.nlm.nih.gov/30622231,grow,grown,formation of glioblastoma cells when grown in soft agar culture conditions.
Title,"""Congenital glioblastoma diagnosed by fetal sonography.""",https://pubmed.ncbi.nlm.nih.gov/10361971,diagnose,diagnosed,congenital glioblastoma diagnosed by fetal sonography.
Abstract,"""Congenital glioblastoma diagnosed by fetal sonography.""",https://pubmed.ncbi.nlm.nih.gov/10361971,detect,detected,of congenital glioblastoma detected at the 39th week of gestation by fetal
Abstract,"""Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study.""",https://pubmed.ncbi.nlm.nih.gov/33034890,collect,collected,cases after glioblastoma surgeries between 2009 and 2016 were collected from 14
Abstract,"""Surgical Site Infections after glioblastoma surgery: results of a multicentric retrospective study.""",https://pubmed.ncbi.nlm.nih.gov/33034890,affect,affect,"ssis after glioblastoma surgery, as they significantly affect patient survival."
Abstract,"""Mitigating temozolomide resistance in glioblastoma via DNA damage-repair inhibition.""",https://pubmed.ncbi.nlm.nih.gov/31964274,improve,improve,patients with glioblastoma and improve overall survival.
Title,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,underlie,underlie,aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,have,have,patients with glioblastoma have a high risk of developing venous thromboembolism (
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,perform,performed,of all glioblastomas was performed for diagnostic purposes and included mutational status
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,diagnose,diagnosed,"patients with glioblastoma, 25 were diagnosed with vte."
Abstract,"""Targeted DNA sequencing to identify genetic aberrations in glioblastoma that underlie venous thromboembolism; a cohort study.""",https://pubmed.ncbi.nlm.nih.gov/36435047,relate,related,deletion in glioblastoma-related vte.
Title,"""Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.""",https://pubmed.ncbi.nlm.nih.gov/28273720,associate,associated,recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and
Abstract,"""Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.""",https://pubmed.ncbi.nlm.nih.gov/28273720,examine,examined,patients with glioblastoma (25 newly-diagnosed/32 recurrent) were examined
Abstract,"""Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.""",https://pubmed.ncbi.nlm.nih.gov/28273720,show,showed,and recurrent glioblastoma showed significantly lower ( p â‰¤ 0.001) Âµcov
Abstract,"""Recurrence of glioblastoma is associated with elevated microvascular transit time heterogeneity and increased hypoxia.""",https://pubmed.ncbi.nlm.nih.gov/28273720,have,had,recurrent glioblastoma had significantly higher Âµvth ( p = 0.014)
Abstract,"""Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.""",https://pubmed.ncbi.nlm.nih.gov/21942727,tolerate,tolerate,patients with glioblastoma and whether elderly patients with glioblastoma can tolerate the
Abstract,"""Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.""",https://pubmed.ncbi.nlm.nih.gov/21942727,tolerate,tolerate,patients with glioblastoma can tolerate the same aggressive treatment as younger patients
Abstract,"""Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.""",https://pubmed.ncbi.nlm.nih.gov/21942727,undergo,underwent,diagnosed cerebral glioblastoma (2000-2006) who underwent regular follow
Abstract,"""Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.""",https://pubmed.ncbi.nlm.nih.gov/21942727,undergo,undergoing,"patients with glioblastoma, age was a prognostic factor in patients undergoing"
Abstract,"""Glioblastoma therapy in the elderly and the importance of the extent of resection regardless of age.""",https://pubmed.ncbi.nlm.nih.gov/21942727,undergo,undergoing,"patients with glioblastoma, undergoing resection to the extent feasible, followed"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,constitute,constitute,these glioblastoma subtypes constitute distinct disease entities that affect patients of
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,develop,develop,"that primary glioblastomas develop in older patients (mean age, 62"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,develop,develop,"secondary glioblastomas develop in younger patients (mean, 45 years"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,locate,located,"in secondary glioblastomas, 57% were located in hotspot codons 248"
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,distribute,distributed,"in primary glioblastomas, mutations were more widely distributed."
Abstract,"""Genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15822813,arise,arise,in these glioblastoma subtypes arise through different mechanisms.
Title,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,present,presenting,glioblastoma multiforme presenting with ischemic stroke: case report and
Abstract,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,confirm,confirmed,diagnosis of glioblastoma multiforme was confirmed.
Abstract,"""Glioblastoma multiforme presenting with ischemic stroke: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/21489628,present,presenting,"knowledge, glioblastomas presenting with ischemic stroke are rare, and such"
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,undergo,undergo,patients with glioblastoma who undergo maximal safe surgical resection.
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,invade,invade,glioblastomas that invade the corpus callosum and cross midline to
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,bgbms)-are,bgbms)-are,-butterfly glioblastomas (bgbms)-are one subgroup of tumors traditionally deemed inoperable
Abstract,"""Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29162526,increase,increased,of butterfly glioblastoma prolongs survival without increased risk of permanent neurologic deficit
Abstract,"""Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27151973,associate,associated,patients with glioblastoma are associated with worse quality of life.
Abstract,"""Incidence, Characteristics, and Implications of Seizures in Patients With Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27151973,have,had,patients with glioblastoma from 2010 through 2014 had their medical records reviewed
Title,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,represent,represent,metastasis in glioblastoma may represent the emergence of neoplastic subclones.
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,metastasize,metastasize,glioblastomas only rarely metastasize to sites outside the central nervous
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,find,found,and metastatic glioblastomas for genetic alterations commonly found in glioblastomas: tp53
Abstract,"""Systemic metastasis in glioblastoma may represent the emergence of neoplastic subclones.""",https://pubmed.ncbi.nlm.nih.gov/11138924,tend,tend,that metastatic glioblastomas tend to occur in younger adults who do not
Title,"""Molecular subtyping of glioblastoma based on immune-related genes for prognosis.""",https://pubmed.ncbi.nlm.nih.gov/32968155,base,based,subtyping of glioblastoma based on immune-related genes for prognosis.
Abstract,"""Molecular subtyping of glioblastoma based on immune-related genes for prognosis.""",https://pubmed.ncbi.nlm.nih.gov/32968155,associate,associated,glioblastoma (gbm) is associated with an increasing mortality
Title,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,associate,associated,resistance in glioblastoma and is associated with tumor risk and prognosis.
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,illuminate,illuminated,lgals3 in glioblastoma has not yet been broadly illuminated.
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,face,facing,survival of glioblastoma cells facing ionizing irradiation or temozolomide was investigated by
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,collect,collected,of 120 glioblastoma cases were collected to analyze the relationship between lgals3
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,treat,treating,biomarker influencing glioblastoma risk and prognosis and a potential target for treating
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,ionize,ionizing,lgals3 promotes glioblastoma cells' resistance to ionizing irradiation and temozolomide and
Abstract,"""LGALS3 Promotes Treatment Resistance in Glioblastoma and Is Associated with Tumor Risk and Prognosis.""",https://pubmed.ncbi.nlm.nih.gov/30341098,increase,increase,resistance in glioblastoma and increase patient survival.
Abstract,"""Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37277696,occur,occurring,glioblastoma is a grade iv pernicious neoplasm occurring in the
Abstract,"""Identification of genomic biomarkers and their pathway crosstalks for deciphering mechanistic links in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37277696,provide,providing,prognosis of glioblastoma but also in providing a molecular foothold for oncogenic
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,include,included,"mutant primary glioblastomas only, as previous series included secondary glioblastomas."
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,retrieve,retrieved,-wildtype glioblastomas and idh-mutant secondary glioblastomas retrieved from datasets
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,retrieve,retrieved,mutant secondary glioblastomas retrieved from datasets.
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,combine,combined,"seen in glioblastomas, such as egfr amplification, combined +7/-10,"
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,mismatch,mismatch,"pathogenesis in glioblastomas, chromatin modifying and mismatch repair pathways were common"
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,have,have,mutant primary glioblastomas have better prognosis than secondary glioblastomas and have major
Abstract,"""Molecular landscape of IDH-mutant primary astrocytoma Grade IV/glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33692446,have,have,than secondary glioblastomas and have major molecular differences from other commoner glioblastomas
Abstract,"""Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32469935,perform,performed,ido in glioblastoma were performed with data from publicly available datasets.
Abstract,"""Increased effect of two-fraction radiotherapy in conjunction with IDO1 inhibition in experimental glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32469935,compare,comparing,carrying intracranial glioblastomas comparing two-fraction radiotherapy+ido1-inhibition to controls
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,have,have,"aims: glioblastoma patients have a dismal prognosis, due to inevitable"
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,implicate,implicated,dominate the glioblastoma tumour microenvironment and have been implicated in tumour progression
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,contain,contain,"early recurrent glioblastomas contain focal reactive regions with occasional fibrosis, chronic"
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,compare,compared,and recurrent glioblastomas were compared between patients with early recurrences (n
Abstract,"""Characterisation of the tumour microenvironment in primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39449228,show,showed,"early recurrent glioblastomas showed enrichment for tams, expressing both pro- and"
Abstract,"""Borax regulates iron chaperone- and autophagy-mediated ferroptosis pathway in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/36988300,classify,classified,glioblastoma (gbm) is classified as a stage-
Abstract,"""Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/27416574,lead,leads,background: glioblastoma is a highly malignant brain tumour that usually leads
Abstract,"""Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/27416574,diagnose,diagnosed,of 115 glioblastoma patients who were diagnosed at king abdullah university hospital
Abstract,"""Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/27416574,have,had,"of developing glioblastoma, while individuals with group o had a lower"
Abstract,"""Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/27416574,compare,compared,of developing glioblastoma compared to individuals with group o. discussion: in
Abstract,"""Glioblastoma and ABO blood groups: further evidence of an association between the distribution of blood group antigens and brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/27416574,have,have,"of developing glioblastoma, while individuals with group o have a reduced"
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,investigate,investigated,newly diagnosed glioblastoma were investigated.
Abstract,"""Next generation sequencing in adult patients with glioblastoma in Switzerland: a multi-centre decision analysis.""",https://pubmed.ncbi.nlm.nih.gov/35486306,use,using,newly diagnosed glioblastoma using custom made or commercially available assays.
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,lack,lack,"-type glioblastoma) frequently lack contrast enhancement, which can wrongly"
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,calculate,calculated,of molecular glioblastoma were calculated.
Abstract,"""Gyriform infiltration as imaging biomarker for molecular glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35364762,help,help,of molecular glioblastomas that can help distinguishing these tumors from idh-
Abstract,"""Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/19107234,fail,failed,mg malignant glioblastoma cell lines failed to alter two-dimensional cell
Abstract,"""Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/19107234,cause,caused,but inhibited glioblastoma colony formation in soft agar and caused diminished cell
Abstract,"""Glioblastoma inhibition by cell surface immunoglobulin protein EWI-2, in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/19107234,explain,explained,inhibition of glioblastoma growth in vivo is at least partly explained by
Abstract,"""Glioblastomas at the white matter of temporo-parietal junction cause a poor postoperative independence level.""",https://pubmed.ncbi.nlm.nih.gov/37847481,decrease,decrease,cerebral hemispheric glioblastomas (gbms) often decrease the karnofsky performance status
Abstract,"""[Glioblastomas: gliomagenesis, genetics, angiogenesis, and microenvironment].""",https://pubmed.ncbi.nlm.nih.gov/20817192,derive,derive,"studies, glioblastomas derive from malignant transformation of stem cells and/or glial"
Abstract,"""CD47 Promotes Human Glioblastoma Invasion Through Activation of the PI3K/Akt Pathway.""",https://pubmed.ncbi.nlm.nih.gov/29321087,underlie,underlying,"promotes human glioblastoma invasion and, if so, the underlying mechanisms"
Title,"""Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?""",https://pubmed.ncbi.nlm.nih.gov/36593389,achieve,achieved,newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?
Abstract,"""Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?""",https://pubmed.ncbi.nlm.nih.gov/36593389,readmitte,readmitted,of 240 glioblastoma patients (8%) were readmitted to the
Abstract,"""Unplanned intensive care unit readmission after surgical treatment in patients with newly diagnosed glioblastoma - forfeiture of surgically achieved advantages?""",https://pubmed.ncbi.nlm.nih.gov/36593389,associate,associated,newly diagnosed glioblastoma is significantly associated with poor survival and thus may
Abstract,"""Unique molecular characteristics of radiation-induced glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17882018,represent,represent,-induced glioblastomas (rigs) represent a significant proportion of glioblastomas
Abstract,"""Unique molecular characteristics of radiation-induced glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17882018,see,seen,proportion of glioblastomas (gbms) seen in children and young adults
Abstract,"""Glioblastoma Multiforme with Hypodipsic Hypernatremia in a Seven-Month-Old Golden Retriever.""",https://pubmed.ncbi.nlm.nih.gov/27487344,occur,occur,"histopathologically as glioblastoma multiforme, an unusual tumor to occur in a"
Abstract,"""[Role of adrenomedullin in glioblastomas growth].""",https://pubmed.ncbi.nlm.nih.gov/15888388,analyse,analysed,"in all glioblastomas analysed, whereas a low expression was found in"
Abstract,"""GATA4 and DcR1 methylation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23320456,determine,determined,methylation and glioblastoma patient survival was not determined.
Abstract,"""GATA4 and DcR1 methylation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23320456,promoter,promoter,event in glioblastoma but they promoter methylation cannot be considered as
Title,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,accord,according,"newly diagnosed glioblastoma, idh-wildtype according to who 2021 classification"
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,assess,assess,"-diagnosed glioblastoma, idh-wildtype in order to assess the"
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,enhance,enhanced,contrast enhanced glioblastomas (26.7 months) than in contrast enhanced glioblastomas
Abstract,"""Prognostic significance of MRI contrast enhancement in newly diagnosed glioblastoma, IDH-wildtype according to WHO 2021 classification.""",https://pubmed.ncbi.nlm.nih.gov/38913230,associate,associated,"contrast enhanced glioblastomas, a ring-like pattern was associated with"
Abstract,"""Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.""",https://pubmed.ncbi.nlm.nih.gov/37148304,treat,treated,"left temporal glioblastoma, treated with surgical resection and adjuvant chemo- and"
Abstract,"""Challenges in the diagnosis of leptomeningeal dissemination of glioblastoma in a patient with fever and xanthochromic CSF: a case report.""",https://pubmed.ncbi.nlm.nih.gov/37148304,associate,associated,"patient with glioblastoma associated leptomeningeal dissemination, as high fever and xanthochromic"
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,base,based,"glioblastoma, grade iv malignant glioma based on the world"
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,cause,caused,prognosis of glioblastoma patients is largely caused by the striking radioresistance of
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,provide,provide,phenotype of glioblastomas and plausible mechanisms of radiation resistance can provide new
Abstract,"""Molecular advances of brain tumors in radiation oncology.""",https://pubmed.ncbi.nlm.nih.gov/19464632,result,result,patients with glioblastoma and result in a better prognosis for these patients
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,identify,identified,associated with glioblastoma development have been identified.
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,evaluate,evaluated,patients with glioblastomas were retrospectively evaluated.
Abstract,"""The importance of IDH1, ATRX and WT-1 mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32729303,have,had,"patients with glioblastoma; however, radiotherapy and chemotherapy had a positive"
Abstract,"""Recent advances in subtyping tumors of the central nervous system using molecular data.""",https://pubmed.ncbi.nlm.nih.gov/27893285,have,have,and pediatric glioblastomas have divergent biology with differing prognoses.
Title,"""A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.""",https://pubmed.ncbi.nlm.nih.gov/37619245,diagnose,diagnosed,young adult glioblastomas diagnosed using 2016 who guidelines for central nervous system
Abstract,"""A Retrospective Genomic Landscape of 661 Young Adult Glioblastomas Diagnosed Using 2016 WHO Guidelines for Central Nervous System Tumors.""",https://pubmed.ncbi.nlm.nih.gov/37619245,diagnose,diagnosed,young adult glioblastomas diagnosed using 2016 who world health organization classification of
Title,"""Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.""",https://pubmed.ncbi.nlm.nih.gov/38676720,base,based,-wildtype glioblastomas based on the new rano-resect classification.
Abstract,"""Supramaximal resection: retrospective study on IDH-wildtype Glioblastomas based on the new RANO-Resect classification.""",https://pubmed.ncbi.nlm.nih.gov/38676720,debate,debated,"management of glioblastoma is a long-debated topic, recently widened"
Abstract,"""A molecular genetic model of astrocytoma histopathology.""",https://pubmed.ncbi.nlm.nih.gov/9161727,emerge,emerge,"finally, glioblastomas may emerge from the microenvironmental outgrowth of more malignant"
Abstract,"""A molecular genetic model of astrocytoma histopathology.""",https://pubmed.ncbi.nlm.nih.gov/9161727,arise,arise,well that glioblastoma multiforme can arise via a number of independent genetic
Abstract,"""Chromatin accessibility analysis identifies GSTM1 as a prognostic marker in human glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/34732244,predict,predict,"management of glioblastoma patients, new biomarkers that could predict patient survival"
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,improve,improved,and secondary glioblastomas were factors that improved survival (p<0.001).
Abstract,"""Prognostic implications of epilepsy in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26489387,predict,predict,symptom in glioblastomas predict longer survival.
Abstract,"""Application of novel PACS-based informatics platform to identify imaging based predictors of CDKN2A allelic status in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/38135704,use,using,biomarkers in glioblastomas using a new informatics workflow that enables rapid analysis
Title,"""Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.""",https://pubmed.ncbi.nlm.nih.gov/29788733,make,making,differentiation of glioblastoma stem cells making them more sensitive to oxidative stress
Abstract,"""Sulindac induces differentiation of glioblastoma stem cells making them more sensitive to oxidative stress.""",https://pubmed.ncbi.nlm.nih.gov/29788733,arise,arise,proposes that glioblastomas arise from mutations that transform normal neural stem cells
Title,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,transplant,transplanted,of human glioblastoma transplanted on chicken chorioallantoic membrane.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,take,taken,survival of glioblastoma tumors taken immediately from operating theatre and transplanted on
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,obtain,obtained,glioblastoma samples obtained from 10 patients were transplanted onto 200
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,reveal,revealed,were not glioblastomas as it was revealed later.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,exhibit,exhibited,transplanted glioblastomas exhibited the same features as original glioblastomas - necrosis
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,show,showed,while transplanted glioblastomas also showed glial fibrillary acidic protein (gfap)
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,show,show,transplanted glioblastomas did not show any immunoreactivity of p53.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,survive,survive,pieces of glioblastoma survive with all cytological features.
Abstract,"""Histology of human glioblastoma transplanted on chicken chorioallantoic membrane.""",https://pubmed.ncbi.nlm.nih.gov/19289902,remain,remains,"that transplanted glioblastoma remains as insulated unit, which survives from nourishment"
Title,"""Radiosensitization of orthotopic GIC-driven glioblastoma by doxycycline causes skin damage.""",https://pubmed.ncbi.nlm.nih.gov/30961616,cause,causes,-driven glioblastoma by doxycycline causes skin damage.
Title,"""Discovery of key molecular signatures for diagnosis and therapies of glioblastoma by combining supervised and unsupervised learning approaches.""",https://pubmed.ncbi.nlm.nih.gov/39528802,combine,combining,therapies of glioblastoma by combining supervised and unsupervised learning approaches.
Title,"""Identification of glioblastoma immune subtypes and immune landscape based on a large cohort.""",https://pubmed.ncbi.nlm.nih.gov/34412691,base,based,identification of glioblastoma immune subtypes and immune landscape based on a large
Abstract,"""Dendritic cell immunotherapy for brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/26037466,characterize,characterized,"glioblastomas are characterized by immunosuppression, rapid proliferation, angiogenesis"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,recognize,recognized,) in glioblastomas is recognized as an important treatment target.
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,use,using,"-mediated glioblastoma progression by using cell proliferation (3-(4,5-dimethylthiazol-2"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,bear,bearing,", a glioblastoma-bearing animal model was used to validate the"
Abstract,"""Induction of apoptosis through extrinsic/intrinsic pathways and suppression of ERK/NF-kappaB signalling participate in anti-glioblastoma of imipramine.""",https://pubmed.ncbi.nlm.nih.gov/32149465,induce,induces,anti-glioblastoma drug which induces apoptosis and has the capacity to
Title,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,exhibit,exhibit,-derived glioblastoma cell line while exhibit moderate effect on normal stem
Abstract,"""Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth.""",https://pubmed.ncbi.nlm.nih.gov/37162706,know,known,"glioblastomas (gbm), also known as glioblastoma multiforme"
Abstract,"""MicroRNAs in brain tumors : a new diagnostic and therapeutic perspective?""",https://pubmed.ncbi.nlm.nih.gov/21739238,summarize,summarized,adults (glioblastomas) and children (medulloblastomas) will be summarized
Abstract,"""[Genetic diseases and glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/20869734,relate,related,review discusses glioblastomas related to these diseases and the current knowledge on
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,have,have,tumorigenesis in glioblastomas that do not have alterations of egfr.
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,occur,occur,mutated in glioblastomas; most deletions occur in nonclassical subtypes of the
Abstract,"""NFKBIA deletion in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21175304,associate,associated,pathogenesis of glioblastoma and is associated with comparatively short survival.
Abstract,"""Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/29286221,observe,observed,", with glioblastomas as the most frequently observed histologic subtype, are"
Abstract,"""Prognostic Significance of Indicators of Systemic Inflammatory Responses in Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/29286221,evaluate,evaluated,treated for glioblastoma were retrospectively evaluated.
Abstract,"""Therapeutic strategies for inhibiting invasion in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19344303,invade,invade,patients with glioblastomas is the propensity of the tumor to invade into
Abstract,"""Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/26924115,associate,associated,observed in glioblastoma where gtr was associated only with a 24%
Abstract,"""Superior Efficacy of Gross Total Resection in Anaplastic Astrocytoma Patients Relative to Glioblastoma Patients.""",https://pubmed.ncbi.nlm.nih.gov/26924115,correspond,corresponding,"for glioblastoma patients, the corresponding numbers for median survival were"
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,let,let,structure of glioblastoma let us to investigate hmga2 expression in the border
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,analyze,analyzed,grade 4 glioblastomas were analyzed for hmga2 expression using quantitative real-
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,compare,compared,"expressed in glioblastoma compared to healthy brain tissue (qpcr, p=0.013"
Abstract,"""Significantly higher expression of high-mobility group AT hook protein 2 (HMGA2) in the border zone of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36987772,seem,seems,"zone of glioblastomas; thus, the expression cluster of hmga2 seems"
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,suggest,suggests,"expression in glioblastomas are unknown, but evidence suggests that transforming growth"
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,display,display,upregulated in glioblastomas and display a significant positive correlation.
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,include,including,"broadly in glioblastoma tissues, including tumor parenchyma regions in the immediate"
Abstract,"""Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/33494271,derive,derived,", and glioblastoma-derived endothelial and fap+ mesenchymal cells, but"
Title,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,confirm,confirmed,"metastases from glioblastoma, as confirmed with the oncoscan assay."
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,base,based,metastasis from glioblastoma is usually based on the histopathology and immunohistochemical staining
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,locate,located,with a glioblastoma located in the left temporal lobe underwent resection followed
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,confirm,confirmed,metastases from glioblastoma was confirmed with an oncoscan assay and pathologic analysis
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,spread,spread,"carcinomas, glioblastomas can spread via the lymphatic route."
Abstract,"""Extensive Therapies for Extraneural Metastases from Glioblastoma, as Confirmed with the OncoScan Assay.""",https://pubmed.ncbi.nlm.nih.gov/26852708,alleviate,alleviate,"metastases from glioblastoma can alleviate discomfort and prolong survival, especially in"
Abstract,"""LINGO1, C7orf31 and VEGFA are prognostic genes of primary glioblastoma: analysis of gene expression microarray.""",https://pubmed.ncbi.nlm.nih.gov/30064229,grade,grade,glioblastoma is the most prevalent malignant glioma in who grade
Title,"""Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.""",https://pubmed.ncbi.nlm.nih.gov/38822538,revisit,revisited,"-wildtype glioblastomas revisited: comprehensive analysis of incidence, risk factors"
Abstract,"""Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.""",https://pubmed.ncbi.nlm.nih.gov/38822538,enrol,enrolled,-wildtype glioblastoma were enrolled between 2005 and 2022.
Abstract,"""Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.""",https://pubmed.ncbi.nlm.nih.gov/38822538,=,=,"-wildtype glioblastoma (hazard ratio = 1.42, p = .011"
Abstract,"""Leptomeningeal metastases in isocitrate dehydrogenase-wildtype glioblastomas revisited: Comprehensive analysis of incidence, risk factors, and prognosis based on post-contrast fluid-attenuated inversion recovery.""",https://pubmed.ncbi.nlm.nih.gov/38822538,correlate,correlated,"-wildtype glioblastoma, and aggressive molecular and imaging factors are correlated"
Abstract,"""The transcription factor ATF5: role in neurodevelopment and neural tumors.""",https://pubmed.ncbi.nlm.nih.gov/19046351,indicate,indicates,atf5 in glioblastoma cells indicates that interference with its expression or activity
Abstract,"""Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.""",https://pubmed.ncbi.nlm.nih.gov/31561040,undergo,undergoing,patients with glioblastoma (gbm) undergoing microsurgical tumor resection as part
Title,"""Prognostic factors in patients with glioblastoma multiforme: focus on the pathologic variants.""",https://pubmed.ncbi.nlm.nih.gov/31222512,focus,focus,patients with glioblastoma multiforme: focus on the pathologic variants.
Abstract,"""Preoperative inflammation markers and IDH mutation status predict glioblastoma patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28223536,take,taking,") in glioblastomas (gbms), taking into consideration the role"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,divide,divided,glioblastoma can be divided into genetic subsets.
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,"third of glioblastomas have tp53 mutations, one third"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,", secondary glioblastomas have a much higher incidence of tp53 mutations than"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,have,have,"onset, glioblastomas in young adults are likely to have tp53 mutations"
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,define,defined,between the glioblastoma sites and the genetic subsets defined by the presence
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,seat,seated,suggest that glioblastomas deep-seated in the thalamus and basal ganglia
Abstract,"""Molecular genetic analysis of deep-seated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15325097,originate,originate,where the glioblastomas originate may be associated with the genetic features.
Abstract,"""Glioblastoma multiforme and the meningeal syndrome.""",https://pubmed.ncbi.nlm.nih.gov/185547,detect,detected,irritants of glioblastomas and craniopharyngiomas are similar chemically and can be detected
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,target,targeted,") in glioblastoma pathogenesis, egfr targeted therapies have achieved limited clinical"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,express,expressing,"revealed that glioblastoma cells over-expressing egfrviii, an oncogenic variant"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,cause,caused,"expression in glioblastoma cells caused increased levels of ros, dna strand"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,correlate,correlated,"of primary glioblastoma lines, sensitivity to parp1 inhibition correlated with the"
Abstract,"""Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.""",https://pubmed.ncbi.nlm.nih.gov/20532243,correlate,correlated,genes in glioblastomas with high egfr expression correlated with improved patient survival
Title,"""Management of patients with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/25791534,use,using,with recurrent glioblastoma using hypofractionated stereotactic radiotherapy.
Title,"""Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.""",https://pubmed.ncbi.nlm.nih.gov/28541497,present,presenting,surgery in glioblastoma patients presenting with seizure.
Abstract,"""Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.""",https://pubmed.ncbi.nlm.nih.gov/28541497,investigate,investigated,"prognosis in glioblastoma patients, but studies to date have not investigated"
Abstract,"""Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure.""",https://pubmed.ncbi.nlm.nih.gov/28541497,focus,focusing,"prognosis in glioblastoma patients, focusing on the development of tumor growth"
Abstract,"""Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes.""",https://pubmed.ncbi.nlm.nih.gov/24122361,play,play,"patients with glioblastoma, and sociodemographic factors play a significant role in"
Title,"""N-acetylcysteine decreases malignant characteristics of glioblastoma cells by inhibiting Notch2 signaling.""",https://pubmed.ncbi.nlm.nih.gov/30606241,inhibit,inhibiting,characteristics of glioblastoma cells by inhibiting notch2 signaling.
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,characterize,characterized,"glioblastoma is one of the most fatal cancers, characterized"
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,have,has,patients with glioblastomas and has potential as a novel tumor biomarker.
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,understand,understood,"ykl-40 in glioblastoma development, however, are poorly understood."
Abstract,"""Role of YKL-40 in the angiogenesis, radioresistance, and progression of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21385870,reveal,revealed,"of human glioblastomas revealed a correlation between ykl-40, vegf, and"
Abstract,"""MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/21879257,tmz,tmz,of some glioblastomas to tmz and the hypothesis that glioma stem cells
Abstract,"""Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.""",https://pubmed.ncbi.nlm.nih.gov/33887763,base,based,identify midh glioblastoma based on radiomic features derived from magnetic resonance imaging
Abstract,"""Detection of Isocitrate Dehydrogenase Mutated Glioblastomas Through Anomaly Detection Analytics.""",https://pubmed.ncbi.nlm.nih.gov/33887763,use,using,mutation in glioblastoma using preoperative t1 postcontrast imaging.
Abstract,"""Selective destruction of glioblastoma cells by interference with the activity or expression of ATF5.""",https://pubmed.ncbi.nlm.nih.gov/16170340,assess,assessed,29 human glioblastomas and eight human and rat glioma cell lines assessed
Abstract,"""Overexpression of LncRNA PSMG3-AS1 Distinguishes Glioblastomas from Sarcoidosis.""",https://pubmed.ncbi.nlm.nih.gov/32529538,misdiagnose,misdiagnosed,"practices, glioblastomas (gbm) in some cases can be misdiagnosed"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,induce,induce,"glioblastomas are notorious for their capacity to induce neovascularization,"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,associate,associated,"regulated in glioblastoma-associated endothelial cells, resulting in increased expression"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,condition,conditioned,"cells to glioblastoma-conditioned medium or vegf, resulting in increased"
Abstract,"""Myc-associated zinc finger protein (MAZ) is regulated by miR-125b and mediates VEGF-induced angiogenesis in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22415301,relate,related,"loop in glioblastoma-related angiogenesis, in which vegf inhibits the"
Abstract,"""Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study.""",https://pubmed.ncbi.nlm.nih.gov/21344375,ascertain,ascertained,incidence of glioblastoma of the brain was ascertained via linkage to the
Abstract,"""Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study.""",https://pubmed.ncbi.nlm.nih.gov/21344375,diagnose,diagnosed,of 67 glioblastomas was diagnosed in the cohort during follow-up
Abstract,"""Alcohol consumption and risk of glioblastoma; evidence from the Melbourne Collaborative Cohort Study.""",https://pubmed.ncbi.nlm.nih.gov/21344375,associate,associated,hr for glioblastoma associated with alcohol consumption were 1.07 (0.55 to
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,regulate,regulated,dichotomy between glioblastoma cell migration and proliferation is regulated by various parameters
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,induce,induces,"in glioblastoma stem-like cells, hypoxia induces downregulation of"
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,separate,separated,"or migrating glioblastoma cells were separated, and enzyme profiles were compared"
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,decrease,decreased,"rapidly dividing glioblastoma cells, whereas glycolysis enzymes were decreased."
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,decrease,decreased,"g6pd reduced glioblastoma cell proliferation, whereas aldoc knockdown decreased migration."
Abstract,"""Glycolysis and the pentose phosphate pathway are differentially associated with the dichotomous regulation of glioblastoma cell migration versus proliferation.""",https://pubmed.ncbi.nlm.nih.gov/26917237,result,resulted,but noninvasive glioblastoma cell line resulted in prolonged survival of mice with
Abstract,"""Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.""",https://pubmed.ncbi.nlm.nih.gov/21829433,reproduce,reproduce,subgroups of glioblastoma are difficult to reproduce.
Abstract,"""Why is there a lack of consensus on molecular subgroups of glioblastoma? Understanding the nature of biological and statistical variability in glioblastoma expression data.""",https://pubmed.ncbi.nlm.nih.gov/21829433,suggest,suggests,"inconsistencies in glioblastoma but also suggests that biological variability, abnormal data"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,suggest,suggesting,"tumors including glioblastomas, suggesting an oncogenic role for the long noncoding"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,remain,remains,h19 in glioblastomas remains unclear.
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,relate,related,"expression in glioblastoma cell lines, which was related to hypoxia-"
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,depend,depending,in human glioblastoma samples depending on pten status.
Abstract,"""Hypoxia induces H19 expression through direct and indirect Hif-1alpha activity, promoting oncogenic effects in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28327666,suggest,suggest,effects in glioblastomas and suggest h19 might be a promising therapeutic target
Title,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,derive,derived,subventricular zone glioblastoma-derived stem-like cells display different molecular
Abstract,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,use,used,"-dissociated glioblastomas and a2b5+ magnetic cell sorting, were used"
Abstract,"""Cortical and subventricular zone glioblastoma-derived stem-like cells display different molecular profiles and differential in vitro and in vivo properties.""",https://pubmed.ncbi.nlm.nih.gov/21989663,contain,contained,a cortical glioblastoma and contained a high number of cd133(+) cells
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,associate,associated,"of 98 glioblastoma patients, idh1 ( r132 ) mutations were associated"
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,carry,carried,to 51 glioblastoma samples of which 16 carried an idh1 (r132
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,provide,provided,capacity in glioblastoma was provided for 65% by idh activity and
Abstract,"""The prognostic IDH1( R132 ) mutation is associated with reduced NADP+-dependent IDH activity in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20127344,explain,explaining,"may sensitize glioblastoma to irradiation and chemotherapy, thus explaining the prolonged"
Abstract,"""Spinal Drop Metastasis of Glioblastoma-Two Case Reports, Clinicopathologic Features, Current Modalities of Evaluation, and Treatment with a Review of the Literature.""",https://pubmed.ncbi.nlm.nih.gov/33161132,dehydrogenase,dehydrogenase,"diagnosis of glioblastoma world health organization grade iv, isocitrate dehydrogenase 1"
Abstract,"""Spinal Drop Metastasis of Glioblastoma-Two Case Reports, Clinicopathologic Features, Current Modalities of Evaluation, and Treatment with a Review of the Literature.""",https://pubmed.ncbi.nlm.nih.gov/33161132,explain,explained,patients with glioblastoma with signs and symptoms not explained by primary lesion
Abstract,"""Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24731571,associate,associated,factors in glioblastoma patients that are closely associated with communicating hydrocephalus.
Abstract,"""Hydrocephalus after resection and adjuvant radiochemotherapy in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24731571,undergo,underwent,with a glioblastoma between 2007 and 2011 and underwent complete surgical resection
Title,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,alkylate,alkylating,resistance of glioblastoma cells to the mono-alkylating agent temozolomide.
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,alkylate,alkylating,resistance of glioblastoma cells to the mono-alkylating agent temozolomide is
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,investigate,investigated,resistance of glioblastoma cell lines to temozolomide was investigated.
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,show,show,"in most glioblastomas, we next show that the resistance of glioblastoma"
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,temozolomide,temozolomide,resistance of glioblastoma cells to temozolomide and to a combined treatment of
Abstract,"""CUX1 stimulates APE1 enzymatic activity and increases the resistance of glioblastoma cells to the mono-alkylating agent temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/29036362,identify,identifies,response of glioblastoma cells to treatment and identifies the cut domains as
Title,"""18F-Labeled WBC PET/CT Scan in a Case of Recurrent Glioblastoma Multiforme, Presented as Pyrexia of Unknown Origin.""",https://pubmed.ncbi.nlm.nih.gov/35384872,present,presented,"of recurrent glioblastoma multiforme, presented as pyrexia of unknown origin."
Abstract,"""18F-Labeled WBC PET/CT Scan in a Case of Recurrent Glioblastoma Multiforme, Presented as Pyrexia of Unknown Origin.""",https://pubmed.ncbi.nlm.nih.gov/35384872,present,presented,"of recurrent glioblastoma multiforme, who presented with puo."
Title,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,lymphocytes in glioblastoma are associated with specific genomic alterations and related to
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,define,defined,roles in glioblastoma have not been fully defined.
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,"tils in glioblastoma are associated with molecular alterations, histologies, and"
Abstract,"""Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.""",https://pubmed.ncbi.nlm.nih.gov/23864165,associate,associated,"enriched in glioblastomas of the mesenchymal class, strongly associated with mutations"
Title,"""miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.""",https://pubmed.ncbi.nlm.nih.gov/24643683,temozolomide,temozolomide,chemosensitivity of glioblastoma stem cells to temozolomide by targeting bak1.
Abstract,"""miR-125b inhibitor enhance the chemosensitivity of glioblastoma stem cells to temozolomide by targeting Bak1.""",https://pubmed.ncbi.nlm.nih.gov/24643683,cause,causing,glioblastoma stem cells (gscs) causing resistance to drug
Title,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,depend,depends,cells towards glioblastoma cells depends on hepatocyte-growth factor and is
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,contribute,contributes,"expressed by glioblastomas and contributes to their growth, migration and invasion"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,exploit,exploited,"tropism for glioblastomas, which is exploited in gene therapy to deliver"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,mediate,mediated,msc by glioblastoma cells and whether aminolaevulinic acid-mediated photodynamic therapy
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,affect,affects,"apoptosis in glioblastoma cells, affects hgf release and this migratory response"
Abstract,"""Migration of mesenchymal stem cells towards glioblastoma cells depends on hepatocyte-growth factor and is enhanced by aminolaevulinic acid-mediated photodynamic treatment.""",https://pubmed.ncbi.nlm.nih.gov/23333382,express,express,"thus, glioblastoma cells express hgf, which contributes to the attraction"
Title,"""Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/26033544,receive,receiving,hospitalization among glioblastoma patients receiving chemoradiation.
Abstract,"""Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/26033544,include,including,"hospitalization among glioblastoma patients, including risks during chemoradiation (crt)"
Abstract,"""Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/26033544,treat,treated,newly diagnosed glioblastoma patients treated at our institution from 2006-2010
Abstract,"""Incidence, risk factors, and reasons for hospitalization among glioblastoma patients receiving chemoradiation.""",https://pubmed.ncbi.nlm.nih.gov/26033544,associate,associated,common among glioblastoma patients in the temozolomide era and is associated with
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,suppress,suppress,"of human glioblastomas, and re-introduction of p53 can suppress"
Abstract,"""Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivo.""",https://pubmed.ncbi.nlm.nih.gov/8824552,analyze,analyzed,"therapy of glioblastoma, we have analyzed the response of human glioblastoma"
Title,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,revisit,revisited,resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival
Abstract,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,diagnose,diagnosed,"approximately 12,000 glioblastomas are diagnosed annually in the united states."
Abstract,"""Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.""",https://pubmed.ncbi.nlm.nih.gov/24516010,model,model,patients with glioblastoma (from 1993 to 2010) to model the
Abstract,"""Cochlear implants in the etiopathogenesis of glioblastoma--an interesting observation or independent finding?""",https://pubmed.ncbi.nlm.nih.gov/26858207,include,including,pathogenesis of glioblastomas including ionizing radiation.
Abstract,"""Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25455996,have,had,determined that glioblastomas with few mss and vcs had many gvps and
Abstract,"""Classification of microvascular patterns via cluster analysis reveals their prognostic significance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25455996,categorize,categorized,mvps in glioblastoma can be categorized properly by certain histopathologic and statistical
Title,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,matter,matter,heterogeneity of glioblastomas: does location matter?
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,develop,develop,glioblastomas in adults are highly heterogeneous tumors that can develop
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,demonstrate,demonstrated,derived two glioblastoma cell lines from cortical and periventricular locations and demonstrated
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,select,selected,to correlate glioblastoma locations with the expression of ten selected genes (
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,include,included,newly diagnosed glioblastomas were retrospectively included.
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,characterize,characterized,"to cortical glioblastomas, periventricular glioblastomas were characterized by a higher expression"
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,characterize,characterized,", periventricular glioblastomas were characterized by a higher expression of two mesenchymal"
Abstract,"""Molecular heterogeneity of glioblastomas: does location matter?""",https://pubmed.ncbi.nlm.nih.gov/26637806,associate,associated,-o glioblastomas were associated with lower expression of vegfc (p
Abstract,"""Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20665905,include,included,histologically proven glioblastoma or metastasis were included in the study.
Abstract,"""Diffusion tensor imaging discriminates between glioblastoma and cerebral metastases in vivo.""",https://pubmed.ncbi.nlm.nih.gov/20665905,discriminate,discriminated,"combination, glioblastoma can be reliably discriminated from cerebral metastases."
Abstract,"""Microarray Analysis in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26113463,do,done,analysis in glioblastomas is done using either cell lines or patient samples
Abstract,"""Microarray Analysis in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26113463,plo,plos,"of the glioblastoma cells (jiang et al., plos one"
Abstract,"""Seasonal patterns of birth in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17050217,exhibit,exhibits,"that the glioblastoma birth rate exhibits a statistically significant annual variation,"
Title,"""Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?""",https://pubmed.ncbi.nlm.nih.gov/33674992,increase,increased,patients with glioblastoma or brain metastases and atrial fibrillation: an increased
Abstract,"""Prophylactic anticoagulation in patients with glioblastoma or brain metastases and atrial fibrillation: an increased risk for intracranial hemorrhage?""",https://pubmed.ncbi.nlm.nih.gov/33674992,brain,brain,patients with glioblastoma (gbm) or brain metastases (met)
Abstract,"""Quantitative T1-mapping detects cloudy-enhancing tumor compartments predicting outcome of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27891815,cause,caused,enhancement of glioblastomas (gbm) is caused by the decrease in
Abstract,"""Mitochondrial energy metabolism and signalling in human glioblastoma cell lines with different PTEN gene status.""",https://pubmed.ncbi.nlm.nih.gov/29209894,characterize,characterized,three human glioblastoma cell lines characterized by a different pten gene status
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,enhance,enhancing,glioblastomas with a substantial proportion of noncontrast-enhancing tumour
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,demonstrate,demonstrating,determine whether glioblastomas demonstrating a substantial proportion (>33%)
Abstract,"""Morphologic patterns of noncontrast-enhancing tumor in glioblastoma correlate with IDH1 mutation status and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/28988652,review,reviewed,diagnosis of glioblastoma were reviewed.
Abstract,"""Between-hospital variation in rates of complications and decline of patient performance after glioblastoma surgery in the dutch Quality Registry Neuro Surgery.""",https://pubmed.ncbi.nlm.nih.gov/33511509,obtain,obtained,-time glioblastoma surgery at 13 hospitals were obtained from a prospective
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,arise,arise,most congenital glioblastomas arise in the cerebral hemispheres.
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,report,reported,of congenital glioblastoma have been reported in the literature from asian countries
Abstract,"""Localization of congenital glioblastomas in the Japanese: a case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/11981623,recognize,recognized,"on congenital glioblastomas, we recognized that in japanese patients this tumor"
Abstract,"""Neuro-oncology: unmasking the multiforme in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20531430,require,required,classification of glioblastomas into various molecular entities is required for the successful
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,occur,occur,whereas some glioblastomas occur with no prior evidence of a lower-
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,identify,identified,groups of glioblastomas have been identified previously.
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,associate,associated,to identify glioblastoma-associated genes (gag) that are associated
Abstract,"""Distinct transcription profiles of primary and secondary glioblastoma subgroups.""",https://pubmed.ncbi.nlm.nih.gov/16397228,confirm,confirmed,staining of glioblastoma tissue arrays confirmed expression differences.
Title,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,identify,identify,and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,classify,classified,glioblastoma is classified into two subtypes on the basis of
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,arise,arising,'primary glioblastoma' arising de novo without detectable antecedent disease and
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,evolve,evolve,and secondary glioblastomas evolve through similar or different molecular pathogenetic routes.
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,subject,subjected,and secondary glioblastoma samples were subjected to high-resolution copy number
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,remain,remaining,"defined primary glioblastomas, the remaining two stratified secondary glioblastoma into two"
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,show,shown,"and secondary glioblastomas that were previously unappreciated, and has shown for"
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,compose,composed,conclude that glioblastoma is composed of at least three distinct molecular subtypes
Abstract,"""Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.""",https://pubmed.ncbi.nlm.nih.gov/17114236,benefit,benefit,"of secondary glioblastoma, which may benefit from different therapeutic strategies."
Abstract,"""IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.""",https://pubmed.ncbi.nlm.nih.gov/31388723,transfecte,transfected,"used the glioblastoma cell line u87mg, fap-transfected fibrosarcoma"
Abstract,"""IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.""",https://pubmed.ncbi.nlm.nih.gov/31388723,observe,observed,"in glioblastomas, we observed spots with increased uptake in projection"
Abstract,"""Dephosphorylation of beta-arrestin 1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19404096,show,showed,of the glioblastoma samples (58/81) showed nearly complete beta-
Title,"""The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.""",https://pubmed.ncbi.nlm.nih.gov/32762776,bridge,bridging,factor in glioblastoma by bridging cancer metabolism and epigenetic regulation.
Title,"""Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.""",https://pubmed.ncbi.nlm.nih.gov/25361004,mediate,mediated,"in human glioblastoma stem cells, via inhibition of clic1-mediated"
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,grade,grade,glioblastomas (who grade iv) may develop de novo
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,(secondary glioblastomas) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,show,show,) both glioblastomas show similar histological features.
Abstract,"""[Clinicopathological diagnosis of gliomas by genotype analysis].""",https://pubmed.ncbi.nlm.nih.gov/19618854,involve,involve,subtypes of glioblastoma involve distinct disease entities that evolve through different genetic
Title,"""Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.""",https://pubmed.ncbi.nlm.nih.gov/25821160,associate,associated,and secondary glioblastoma is associated with differential molecular subtype distribution.
Abstract,"""Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.""",https://pubmed.ncbi.nlm.nih.gov/25821160,classify,classified,glioblastoma multiforme (gbm) is classified into primary (
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,increase,increasing,dissemination of glioblastomas is very rare but is increasing as patients live
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,operate,operated,histologically proven glioblastoma multiforme were operated on in the neurosurgical department of
Abstract,"""Spinal drop metastases in recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/9856242,include,including,spread of glioblastoma multiforme including spinal drop metastases.
Abstract,"""Functional diversity of PFKFB3 splice variants in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34234350,understand,understood,prognosis of glioblastomas is only partially understood.
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,develop,develop,"majority of glioblastomas develop de novo (primary glioblastomas), without"
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,evolve,evolve,"subtypes of glioblastoma evolve through different genetic pathways, affect patients at"
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,occur,occur,primary glioblastomas occur in older patients and typically show epidermal growth
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,develop,develop,secondary glioblastomas develop in younger patients and often contain tp53 mutations
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,show,shown,variants of glioblastoma were shown to have intermediate clinical and genetic profiles
Abstract,"""Phenotype vs genotype in the evolution of astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/10669004,occupy,occupies,giant cell glioblastoma clinically and genetically occupies a hybrid position between primary
Abstract,"""Scale to predict survival after surgery for recurrent glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20644085,recur,recurs,"chemotherapy, glioblastoma multiforme (gbm) virtually always recurs."
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,characterize,characterized,subtype of glioblastoma is characterized by overexpression of extracellular matrix (ecm)/mesenchymal
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,associate,associated,overexpressed in glioblastomas and associated with worse outcome.
Abstract,"""Matrix gla protein (MGP): an overexpressed and migration-promoting mesenchymal component in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19712474,perform,performed,"mgp in glioblastomas, we performed expression, migration and proliferation studies"
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,describe,described,-molecular glioblastoma subtypes have been described: 'primary' glioblastomas
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,arise,arise,primary' glioblastomas arise de novo in older patients and often overexpress
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,know,known,of molecular glioblastoma subtype are known.
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,classify,classified,"reviewed 75 glioblastomas, classified as tp53-mutated (n=11)"
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,mutate,mutated,"-amplified glioblastomas, greater than that of tp53-mutated glioblastomas"
Abstract,"""Magnetic resonance imaging characteristics predict epidermal growth factor receptor amplification status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16361543,amplify,amplified,all 15 glioblastomas with t2 bsc<30.8 were egfr-amplified.
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,reach,reach,assumption that glioblastomas reach a plateau phase and thus exhibit gompertzian growth
Abstract,"""Growth dynamics of untreated glioblastomas in vivo.""",https://pubmed.ncbi.nlm.nih.gov/25758748,show,shown,"rate of glioblastoma shown in this study, it is evident that"
Title,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,of hypermutated glioblastoma: a patient with germline pole deficiency treated with
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,hypermutate,hypermutated,left frontal glioblastoma with primitive neuroectodermal tumor features and hypermutated genotype in
Abstract,"""Immunogenomics of Hypermutated Glioblastoma: A Patient with Germline POLE Deficiency Treated with Checkpoint Blockade Immunotherapy.""",https://pubmed.ncbi.nlm.nih.gov/27683556,treat,treated,principle that glioblastomas with dna-repair defects treated with checkpoint blockade
Abstract,"""Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/29649215,grow,grown,p53 proficient glioblastoma line (u87) when the cells were grown
Abstract,"""IDH1 mutations is prognostic marker for primary glioblastoma multiforme but MGMT hypermethylation is not prognostic for primary glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25455102,base,based,screened primary glioblastoma multiforme (gbm) in a population-based
Title,"""ell clusters isolation in glioblastomas and their functional and molecular characterization using new morphometric approaches.""",https://pubmed.ncbi.nlm.nih.gov/37582322,use,using,isolation in glioblastomas and their functional and molecular characterization using new morphometric
Abstract,"""A case report of sinoatrial arrest caused by temporal lobe epilepsy in subclinical glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32000671,diagnose,diagnosed,stage iv glioblastoma was diagnosed and the patient was treated surgically.
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,raise,raised,subsets among glioblastomas has raised the question whether distinct mutations in glioblastoma
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,associate,associated,mutations in glioblastoma-associated genes may serve as prognostic markers.
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,sample,sampled,study on glioblastomas (gbm) from 97 consecutively sampled adult patients
Abstract,"""Impact of genotype and morphology on the prognosis of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11939587,provide,provide,genotyping of glioblastoma may provide clinical information of prognostic importance.
Title,"""Patient and treatment factors associated with survival among adult glioblastoma patients: A USA population-based study from 2000-2010.""",https://pubmed.ncbi.nlm.nih.gov/26122381,base,based,among adult glioblastoma patients: a usa population-based study from
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,suggest,suggesting,newly diagnosed glioblastoma patients with clinical characteristics suggesting poor prognosis.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergoing,newly diagnosed glioblastoma undergoing surgery.
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergo,newly diagnosed glioblastoma undergo pretreatment radio-labeled amino acid tracer positron
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of radiation
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of chemotherapy
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of molecular
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,enrol,enrolled,newly diagnosed glioblastomas be enrolled in properly designed clinical trials of immunologically
Abstract,"""Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of emerging developments in the management of newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33215345,undergo,undergone,newly diagnosed glioblastoma who have undergone surgical debulking and completed concurrent chemoradiation
Abstract,"""The zinc finger transcription factor ZFX is required for maintaining the tumorigenic potential of glioblastoma stem cells.""",https://pubmed.ncbi.nlm.nih.gov/24831540,contain,containing,glioblastomas are highly lethal brain tumors containing tumor-propagating
Abstract,"""Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications.""",https://pubmed.ncbi.nlm.nih.gov/27628965,analyze,analyzed,57 elderly glioblastoma patients (â‰¥70 years) were analyzed retrospectively.
Abstract,"""Genetic association between mitochondrial DNA copy number and glioma risk: insights from causality.""",https://pubmed.ncbi.nlm.nih.gov/39574033,remain,remains,glioma and glioblastoma (gbm) remains unclear.
Abstract,"""Genetic association between mitochondrial DNA copy number and glioma risk: insights from causality.""",https://pubmed.ncbi.nlm.nih.gov/39574033,observe,observed,"cn and glioblastoma was observed (or = 1.42, 95%ci ="
Abstract,"""Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.""",https://pubmed.ncbi.nlm.nih.gov/22385772,have,had,newly diagnosed glioblastoma multiforme had detectable cytomegalovirus dna in their peripheral blood
Abstract,"""Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.""",https://pubmed.ncbi.nlm.nih.gov/22385772,show,showed,that five glioblastoma patients showed no circulating cmv detected either with rt
Abstract,"""Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.""",https://pubmed.ncbi.nlm.nih.gov/22385772,take,taken,"genesis of glioblastoma multiforme, if age at infection is taken into"
Abstract,"""Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.""",https://pubmed.ncbi.nlm.nih.gov/22385772,relate,related,of both glioblastoma multiforme and cmv infection are inversely related to socioeconomic
Abstract,"""Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor.""",https://pubmed.ncbi.nlm.nih.gov/22385772,resemble,resemble,"so, glioblastoma multiforme occurrence would resemble paralytic polio, where low"
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,base,based,cases of glioblastoma within a population-based study (1)
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,have,had,small cell glioblastomas had frequent egfr amplification and p16 deletion but infrequent
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,contain,containing,glioblastomas containing >or=5% multinucleated giant cells showed more
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,pseudopalisade,pseudopalisading,"in all glioblastomas, whereas large ischemic and/or pseudopalisading necrosis was observed"
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,associate,associated,glioblastomas with necrosis were associated with older age (59.2
Abstract,"""Correlation among pathology, genotype, and patient outcomes in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16957578,associate,associated,features in glioblastomas are associated with specific genetic alterations and with clinical
Abstract,"""[Epidemiological features of brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/24502107,be,is,"diagnosed with glioblastoma and significant brain tumor morbidity, there is a"
Abstract,"""Prevalence of glioblastoma multiforme in subjects with prior therapeutic radiation.""",https://pubmed.ncbi.nlm.nih.gov/1318344,receive,received,subjects with glioblastoma multiforme (gbm) who had previously received therapeutic
Title,"""Venous thromboembolic complications with and without intermittent intraoperative and postoperative pneumatic compression in patients with glioblastoma multiforme using intraoperative magnetic resonance imaging. A retrospective study.""",https://pubmed.ncbi.nlm.nih.gov/29859696,use,using,patients with glioblastoma multiforme using intraoperative magnetic resonance imaging.
Abstract,"""Venous thromboembolic complications with and without intermittent intraoperative and postoperative pneumatic compression in patients with glioblastoma multiforme using intraoperative magnetic resonance imaging. A retrospective study.""",https://pubmed.ncbi.nlm.nih.gov/29859696,use,using,surgery for glioblastoma multiforme (gbm) using intraoperative magnetic resonance imaging
Abstract,"""Venous thromboembolic complications with and without intermittent intraoperative and postoperative pneumatic compression in patients with glioblastoma multiforme using intraoperative magnetic resonance imaging. A retrospective study.""",https://pubmed.ncbi.nlm.nih.gov/29859696,expect,expected,in a glioblastoma multiforme patient population expected to be at a high
Abstract,"""MR imaging and single-photon emission CT findings after gene therapy for human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11559499,undergo,underwent,single lesion glioblastoma underwent tumor resection and intracerebral injection of murine retroviral
Title,"""Temporal glioblastoma causing trigeminal neuralgia. Case illustration.""",https://pubmed.ncbi.nlm.nih.gov/10470832,cause,causing,temporal glioblastoma causing trigeminal neuralgia.
Abstract,"""Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/24938515,increase,increased,"tissue, glioblastomas exhibit significantly increased glucose uptake."
Abstract,"""Strong adverse prognostic impact of hyperglycemic episodes during adjuvant chemoradiotherapy of glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/24938515,evaluate,evaluated,radiotherapy of glioblastoma should be evaluated in a prospective clinical trial.
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,show,showing,"with primary glioblastomas showing prominent adipocytic (lipomatous) differentiation, hence"
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,contain,contained,features of glioblastoma but additionally contained areas consisting of glial fibrillary acidic
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,indicate,indicate,a rare glioblastoma differentiation pattern and indicate that glioblastomas with adipocyte-
Abstract,"""Glioblastoma with adipocyte-like tumor cell differentiation--histological and molecular features of a rare differentiation pattern.""",https://pubmed.ncbi.nlm.nih.gov/18691268,share,share,indicate that glioblastomas with adipocyte-like tumor cell differentiation share common
Abstract,"""Effect of Piezo1 Overexpression on Peritumoral Brain Edema in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32675337,analyze,analyzed,patients with glioblastomas were analyzed retrospectively.
Abstract,"""Effect of Piezo1 Overexpression on Peritumoral Brain Edema in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32675337,enrol,enrolled,patients with glioblastomas were enrolled in further study.
Title,"""Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20736849,treat,treated,-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of
Abstract,"""Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20736849,diagnose,diagnosed,"-induced glioblastomas (rig), which are often diagnosed solely"
Abstract,"""Radiation-induced glioblastoma multiforme in children treated for medulloblastoma with characteristics of both medulloblastoma and glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/20736849,base,based,"from spontaneous glioblastoma multiforme (gbm), based on microarray gene"
Abstract,"""Genomic landscapes by multiregion sequencing combined with circulation tumor DNA detection contribute to molecular diagnosis in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/31822636,include,including,patients with glioblastoma (including one patient with samples available from the
Title,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,convert,convert,rays in glioblastoma cells: a strategy to convert a radio-
Abstract,"""Tp53-gene transfer induces hypersensitivity to low doses of X-rays in glioblastoma cells: a strategy to convert a radio-resistant phenotype into a radiosensitive one.""",https://pubmed.ncbi.nlm.nih.gov/16356835,show,show,"activity, glioblastomas show a high degree of radioresistance."
Abstract,"""[Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].""",https://pubmed.ncbi.nlm.nih.gov/25536822,distinguish,distinguished,"two glioblastoma groups, which are distinguished from each other by"
Abstract,"""[Determination of molecular glioblastoma subclasses on the basis of analysis of gene expression].""",https://pubmed.ncbi.nlm.nih.gov/25536822,reflect,reflect,of the glioblastomas into two groups may reflect two pathways of astrocytic
Abstract,"""Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26597591,identify,identified,diagnosis of glioblastoma between september 2007 and december 2010 were identified.
Abstract,"""Incidence and prognostic significance of non-enhancing cortical signal abnormality in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26597591,occur,occurring,"feature of glioblastomas, occurring in about half of cases."
Title,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,treat,treated,newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: a multicenter cohort study
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,involve,involves,treatment of glioblastomas involves maximal safe resection and adjuvant temozolomide chemo-
Abstract,"""Determining a cut-off residual tumor volume threshold for patients with newly diagnosed glioblastoma treated with temozolomide chemoradiotherapy: A multicenter cohort study.""",https://pubmed.ncbi.nlm.nih.gov/30712777,mean,mean,147 adult glioblastoma patients (mean age 53 years) that underwent
Abstract,"""Failure pattern following complete resection plus radiotherapy and temozolomide is at the resection margin in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23054563,invade,invade,glioblastomas (gbm) are highly motile cancers that invade
Abstract,"""The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/19161638,expose,exposed,in malignant glioblastomas exposed to hypoxia than in low grade astrocytic glial
Title,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,define,defined,subtypes of glioblastoma defined by array-based comparative genomic hybridization (
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,use,using,investigated 70 glioblastomas using the array-based comparative genomic hybridization (
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,subdivide,subdivided,suggests that glioblastomas can be subdivided into clinically relevant genetic subsets.
Abstract,"""Genetically distinct and clinically relevant subtypes of glioblastoma defined by array-based comparative genomic hybridization (array-CGH).""",https://pubmed.ncbi.nlm.nih.gov/16557391,provide,provide,"screening of glioblastomas could provide clinically useful information and, perhaps,"
Abstract,"""A mechanism for the upregulation of EGF receptor levels in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23770238,associate,associated,upregulated in glioblastoma and associated with decreased patient survival.
Abstract,"""A mechanism for the upregulation of EGF receptor levels in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23770238,express,express,t98g glioblastoma cells that normally express low levels of ttg caused
Abstract,"""Assessment of genetic and non-genetic risk factors for venous thromboembolism in glioblastoma - The predictive significance of B blood group.""",https://pubmed.ncbi.nlm.nih.gov/31677594,select,selecting,"patients with glioblastoma, information that may be potentially valuable when selecting"
Abstract,"""In vitro assessment of Taxol for human glioblastoma: chemosensitivity and cellular locomotion.""",https://pubmed.ncbi.nlm.nih.gov/7795275,slow,slow,"taxol for glioblastoma may slow the growth of bulk disease, but"
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,use,using,and recurrent glioblastomas using targeted sequencing and investigate the differences in mutational
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,develop,developed,: fourteen glioblastoma patients who developed local (n=10) or distal
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,demonstrate,demonstrated,locally recurrent glioblastomas demonstrated concordant mutational profiles between the primary and recurrent
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,show,showed,distally recurrent glioblastomas showed changes in mutational profiles with newly acquired mutations
Abstract,"""Targeted Genomic Sequencing Reveals Different Evolutionary Patterns Between Locally and Distally Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33099481,exhibit,exhibit,distally recurrent glioblastomas exhibit different evolutionary patterns.
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,patients with glioblastoma multiforme treated with alkylating agents.
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,analyze,analyzed,53 primary glioblastomas by the immunohistochemistry (ihc) and analyzed the
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,show,showed,-immunonegative glioblastomas showed significantly longer progression-free survival (pfs
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,treat,treated,in 41 glioblastomas treated with temozolomide (tmz) therapy (mgmt
Abstract,"""O6-methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21331613,receive,receiving,with primary glioblastoma receiving tmz and suggest the use of mgmt-
Abstract,"""Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis.""",https://pubmed.ncbi.nlm.nih.gov/12626129,metastasize,metastasize,glioblastomas rarely metastasize outside the cns.
Abstract,"""Biologic characterization of a secondary glioblastoma with extracranial progression and systemic metastasis.""",https://pubmed.ncbi.nlm.nih.gov/12626129,associate,associated,of secondary glioblastoma associated with extracranial progression and distant metastasis.
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,carry,carry,"subtypes of glioblastoma which carry very different prognoses, both defined by"
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,use,using,mutated secondary glioblastoma using evolutionary game theory to investigate the interactions between
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,reproduce,reproduce,model recapitulates glioblastoma behavior well and is able to reproduce two recent
Abstract,"""The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view.""",https://pubmed.ncbi.nlm.nih.gov/21301070,experience,experience,that a glioblastoma will experience under different microenvironmental constraints.
Abstract,"""Suppression of the tissue factor-dependent coagulation cascade: a contributing factor for the development of intratumoral hemorrhage in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/10934288,use,used,on the glioblastomas and used immunoblot- and immunohistochemical methods to compare the
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,investigate,investigated,mirnas on glioblastoma radioresistance was investigated.
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,promote,promotes,mir425 in glioblastoma promotes radioresistance through upregulation of the cell-cycle
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,suggest,suggesting,"antagomirs sensitizes glioblastoma cells to irradiation, suggesting their potential as targets"
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,correlate,correlate,expressed in glioblastoma patient specimens and correlate with tgfÎ² signaling.
Abstract,"""A functional screen identifies miRs that induce radioresistance in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25256711,provide,provide,radioresistance in glioblastomas and provide insight into the therapeutic application of tgfÎ²
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,suggest,suggested,"bearing orthotopic glioblastomas, it also suggested the administration did not completely"
Abstract,"""Postoperative resveratrol administration improves prognosis of rat orthotopic glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30176837,inoculate,inoculated,rat rg2 glioblastoma cells were inoculated into the brains of 36 rats
Abstract,"""Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.""",https://pubmed.ncbi.nlm.nih.gov/25514975,conduct,conducting,") in glioblastoma, by conducting a bioinformatics analysis."
Abstract,"""Identification of differentially expressed genes regulated by transcription factors in glioblastomas by bioinformatics analysis.""",https://pubmed.ncbi.nlm.nih.gov/25514975,use,used,with the glioblastoma gene expression profile were used to construct a regulatory
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,determine,determined,our human glioblastoma cases and determined the molecules that possibly influenced the
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,determine,determined,of 38 glioblastomas were determined.
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,show,showed,patients with glioblastomas showed that a high mib-1 li correlated with poor
Abstract,"""The expression level of sphingosine-1-phosphate receptor type 1 is related to MIB-1 labeling index and predicts survival of glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/19937366,result,resulting,"malignancy of glioblastomas, resulting in a poor survival."
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,expect,expected,"in primary glioblastoma, thus the expected mgmt promoter methylation was low"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,show,showed,glioblastoma patients with mgmt promoter methylation showed better response to
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,treat,treated,"32 primary glioblastomas, treated with radiotherapy and surgery, for tp53"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,lead,lead,"in primary glioblastoma, but does not lead to g:c"
Abstract,"""High incidence of MGMT promoter methylation in primary glioblastomas without correlation with TP53 gene mutations.""",https://pubmed.ncbi.nlm.nih.gov/19100509,treat,treated,marker unless glioblastoma patients are treated with chemotherapy.
Abstract,"""Cerebellar glioblastomas: pathophysiology, clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/19319469,affect,affects,glioblastoma multiforme usually affects the cerebral hemispheres with the peak
Abstract,"""Cerebellar glioblastomas: pathophysiology, clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/19319469,develop,develop,(secondary glioblastoma) or can develop de novo (primary glioblastoma
Abstract,"""Cerebellar glioblastomas: pathophysiology, clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/19319469,develop,develop,primary glioblastomas develop in older patients while secondary glioblastomas develop in
Abstract,"""Cerebellar glioblastomas: pathophysiology, clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/19319469,develop,develop,while secondary glioblastomas develop in younger patients and contain tp53 mutations as
Abstract,"""Cerebellar glioblastomas: pathophysiology, clinical presentation and management.""",https://pubmed.ncbi.nlm.nih.gov/19319469,review,review,"focal cerebellar glioblastoma multiforme and review the pathophysiology, clinical presentation,"
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,outline,outline,egfr in glioblastomas and outline the therapeutic approaches aimed against this receptor
Abstract,"""[Epidermic growth factor receptor (EGFR) in glioblastomas: the mechanism of tumorigenesis and its role as a therapeutic target].""",https://pubmed.ncbi.nlm.nih.gov/26156444,base,based,"therapies for glioblastomas, based on inhibiting the egfr function."
Abstract,"""Multiscale modelling of palisade formation in gliobastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/26235287,show,show,as of glioblastomas growth dynamics; (2) we show that
Abstract,"""IL-6 gene amplification and expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11506489,contribute,contribute,feature in glioblastomas and may contribute to the il-6 over-expression
Abstract,"""Multifocal glioblastoma with liver metastases in the absence of surgery. Case report.""",https://pubmed.ncbi.nlm.nih.gov/2553882,differ,differing,two intracerebral glioblastomas of differing histology with metastases to the liver in
Abstract,"""Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/34262079,get,got,"of 20 glioblastomas and 10 metastases, we got 93% accuracy"
Abstract,"""Distinct tumor signatures using deep learning-based characterization of the peritumoral microenvironment in glioblastomas and brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/34262079,use,using,metastases from glioblastomas using majority voting on patches.
Abstract,"""Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.""",https://pubmed.ncbi.nlm.nih.gov/28218903,have,had,resistant patient glioblastomas and both novel xenograft models of resistance had less
Abstract,"""Macrophage migration inhibitory factor downregulation: a novel mechanism of resistance to anti-angiogenic therapy.""",https://pubmed.ncbi.nlm.nih.gov/28218903,drive,driving,"-resistant glioblastomas, driving a tumor edge m1-to-"
Title,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,glioblastomas located in proximity to the subventricular zone (svz
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,results: glioblastoma located in proximity to the svz showed increased mrna
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibit,"suggesting that glioblastoma stem cells exhibit increased dna repair capacity, glioblastomas"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,show,showed,"capacity, glioblastomas in proximity to the svz also showed increased expression"
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,harbor,harbored,genomes of glioblastomas in svz proximity harbored fewer single nucleotide polymorphisms relative
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,exhibit,exhibited,patients with glioblastoma in proximity to svz exhibited poorer progression free and
Abstract,"""Glioblastomas located in proximity to the subventricular zone (SVZ) exhibited enrichment of gene expression profiles associated with the cancer stem cell state.""",https://pubmed.ncbi.nlm.nih.gov/32556864,locate,located,suggests that glioblastomas located in proximity to the svz exhibited mrna expression
Abstract,"""Calcification in glioblastoma multiforme of the cervical spinal cord.""",https://pubmed.ncbi.nlm.nih.gov/3014673,accompany,accompanied,patient having glioblastoma accompanied with calcification in the cervical spinal cord is
Abstract,"""Calcification in glioblastoma multiforme of the cervical spinal cord.""",https://pubmed.ncbi.nlm.nih.gov/3014673,contain,containing,in differentiating glioblastomas containing calcified masses from benign tumors with areas of
Abstract,"""Activation of EGFR signaling from pilocytic astrocytomas to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24170555,analyze,analyze,egfr in glioblastomas (gbms) but do not analyze all grades
Abstract,"""The early infiltrative phase of GBM hypothesis: are molecular glioblastomas histological glioblastomas in the making? A preliminary multicenter study.""",https://pubmed.ncbi.nlm.nih.gov/35699848,classify,classified,features of glioblastoma (that would have otherwise been classified as grade
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,account,accounts,glioblastoma accounts for more than half of diffuse gliomas.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,patients with glioblastoma remains poor despite comprehensive and intensive treatments.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,remain,remains,prediction of glioblastomas remains limited.
Abstract,"""Stratification according to recursive partitioning analysis predicts outcome in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28496000,aid,aid,model for glioblastomas may aid in clinical prognosis evaluation.
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,remain,remain,enhancement in glioblastoma patients remain poorly understood.
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,segment,segmented,of 148 glioblastoma subjects from the cancer imaging archive were segmented using
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,enhance,enhancing,cimp) glioblastomas were poorly enhancing.
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,associate,associated,ce in glioblastoma is associated with distinct biological processes involved in inflammatory
Abstract,"""Molecular physiology of contrast enhancement in glioblastomas: An analysis of The Cancer Imaging Archive (TCIA).""",https://pubmed.ncbi.nlm.nih.gov/29934058,guide,guide,state of glioblastomas and guide future therapeutic paradigms.
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,correlate,correlate,subclasses of glioblastomas that correlate with survival phenotypes.
Abstract,"""Genomic expression patterns distinguish long-term from short-term glioblastoma survivors: a preliminary feasibility study.""",https://pubmed.ncbi.nlm.nih.gov/18343632,perform,performed,stratify unknown glioblastomas between survival groups and performed this task with 100
Abstract,"""A novel path-specific effect statistic for identifying the differential specific paths in systems epidemiology.""",https://pubmed.ncbi.nlm.nih.gov/32770935,identify,identified,"data of glioblastoma multiforme (gbm), we successfully identified 14"
Abstract,"""The Value of Immunohistochemical Methods and Preoperative Magnetic Resonance Imaging Findings in Diagnosis of IDH1 Mutant Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34859824,use,using,mutation in glioblastomas using real-time polymerase chain reaction (rt
Abstract,"""The Value of Immunohistochemical Methods and Preoperative Magnetic Resonance Imaging Findings in Diagnosis of IDH1 Mutant Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/34859824,apply,applied,"diagnosed with glioblastoma, and idh1 stain was applied to the same"
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,analyse,analysed,55 % glioblastomas analysed.
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,have,had,only one glioblastoma had both c228t and c250t mutations.
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,show,showed,glioblastoma patients with tert mutations showed a shorter survival than
Abstract,"""TERT promoter mutations in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23955565,analyse,analysed,and secondary glioblastomas were separately analysed.
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,include,including,"in 109 glioblastomas, including 98 primary glioblastomas and 11 secondary glioblastomas"
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,exhibit,exhibited,although glioblastomas with egfr gene amplification invariably exhibited egfr overexpression at
Abstract,"""Amplification of the epidermal growth factor receptor gene in glioblastoma: an analysis of the relationship between genotype and phenotype by CISH method.""",https://pubmed.ncbi.nlm.nih.gov/18021194,compose,composed,% of glioblastomas with egfr gene amplification were composed of areas with
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,64 primary glioblastomas and 4 secondary glioblastomas were involved in this study
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,involve,involved,4 secondary glioblastomas were involved in this study.
Abstract,"""Human Cytomegalovirus (HCMV) infection was not correlated with overall survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29788727,target,targeting,treatment of glioblastomas targeting hcmv was needed to be revalued by studied
Title,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,specimen,specimens,factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and
Abstract,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,exist,exist,that in glioblastomas there exist a clear correlation between the tumor-
Abstract,"""Expression of vascular permeability factor in glioblastoma specimens: correlation with tumor vascular endothelial surface and peritumoral edema.""",https://pubmed.ncbi.nlm.nih.gov/11131986,relate,related,"that in glioblastomas, tumor angiogenesis is clearly related to the expression"
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,accompany,accompanied,astrocytoma to glioblastoma is often accompanied by increased angiogenesis and the upregulation
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transduce,transduced,glioblastoma cells were transduced with an adenoviral vector encoding bai1
Abstract,"""Antiangiogenic activity of BAI1 in vivo: implications for gene therapy of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16244591,transplant,transplanted,-transduced glioblastoma cells transplanted into transparent skinfold chambers of scid mice
Title,"""[Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].""",https://pubmed.ncbi.nlm.nih.gov/16960645,present,presenting,[familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and
Abstract,"""[Familiar glioblastoma presenting as a true multicentric tumor: etiopathogenic and prognostic features].""",https://pubmed.ncbi.nlm.nih.gov/16960645,associate,associated,metachronous glioblastomas have been associated to better prognosis in some studies
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,have,has,"glioblastoma multiformae, the most aggressive glioma subtype, has"
Abstract,"""A REST derived gene signature stratifies glioblastomas into chemotherapy resistant and responsive disease.""",https://pubmed.ncbi.nlm.nih.gov/23216891,correlate,correlates,rest in glioblastoma but how rest function correlates with disease outcome has
Abstract,"""Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.""",https://pubmed.ncbi.nlm.nih.gov/23063752,develop,developed,operational in glioblastomas that developed from lower-grade lesions.
Abstract,"""Identification of Hedgehog pathway responsive glioblastomas by isocitrate dehydrogenase mutation.""",https://pubmed.ncbi.nlm.nih.gov/23063752,lack,lacked,operational in glioblastomas that lacked idh mutation or history of antecedent lower
Abstract,"""The neural adhesion molecule L1CAM confers chemoresistance in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22948185,represent,represents,glioblastoma multiforme (gbm) represents the most common and
Title,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,promote,promotes,upregulated in glioblastomas and promotes tumor cell adhesion.
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,relate,related,prognosis of glioblastoma patients is related to diffuse brain invasion and interaction
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,compare,compared,protein in glioblastomas as compared to normal cortex.
Abstract,"""Collagen XVI expression is upregulated in glioblastomas and promotes tumor cell adhesion.""",https://pubmed.ncbi.nlm.nih.gov/18804107,remain,remained,migration of glioblastoma cells on this substrate remained unchanged.
Abstract,"""Growth factor receptors and their ligands.""",https://pubmed.ncbi.nlm.nih.gov/7760103,detect,detected,"in most glioblastomas, but no ssr were detected."
Abstract,"""Isocitrate Dehydrogenase (IDH)1/2 Mutations as Prognostic Markers in Patients With Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/26945349,provide,provided,patients with glioblastomas that provided idh mutation and survival data were included
Title,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,promote,promotes,upregulated in glioblastomas and promotes migration.
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,use,using,vat-1 in glioblastoma tissue and cell lines on mrna levels using reverse
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,compare,compared,found in glioblastoma tissues and cell lines compared with normal human brain
Abstract,"""Vesicle amine transport protein-1 (VAT-1) is upregulated in glioblastomas and promotes migration.""",https://pubmed.ncbi.nlm.nih.gov/19508442,involve,involved,"overexpressed in glioblastomas and functionally involved in glioma cell migration, representing"
Abstract,"""Stable radiobiological features in a genetically unstable glioblastoma cell line.""",https://pubmed.ncbi.nlm.nih.gov/9298111,inherit,inherited,radioresistance of glioblastomas might be inherited from the normal tissue from which
Abstract,"""Different angiogenic phenotypes in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16331629,suppose,supposed,"and secondary glioblastomas (pgbm, sgbm) are supposed to evolve"
Abstract,"""Different angiogenic phenotypes in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16331629,know,known,"in these glioblastoma subtypes is not known so far, but this"
Abstract,"""Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21499306,assay,assayed,"of human glioblastoma, as assayed by northern hybridization and real-"
Abstract,"""Dual-specificity phosphatase DUSP6 has tumor-promoting properties in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/21499306,exacerbate,exacerbating,in human glioblastomas exacerbating the malignant phenotype.
Abstract,"""A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/23859240,base,based,"to differentiate glioblastomas from solitary metastases, based on multimodality mr examination"
Abstract,"""A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/23859240,base,based,"accurately differentiates glioblastomas from solitary metastases, based on mr-derived"
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,establish,established,orthotopic c6 glioblastomas were established in wistar rats.
Abstract,"""Encapsulation of packaging cell line results in successful retroviral-mediated transfer of a suicide gene in vivo in an experimental model of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12711288,increase,increased,"model of glioblastoma, encapsulation of a xenogeneic packaging cell line increased"
Title,"""Reply to: age as a predictive factor in glioblastomas: population-based study.""",https://pubmed.ncbi.nlm.nih.gov/20068359,base,based,factor in glioblastomas: population-based study.
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,increase,increased,"of nine glioblastoma with five normal brain sage libraries, 44 increased"
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,both in glioblastomas and in glioblastoma cell lines suggesting their expression in
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,and in glioblastoma cell lines suggesting their expression in transformed cells.
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,"only in glioblastomas, not in glioblastoma cell lines suggesting an expression"
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,suggest,suggesting,not in glioblastoma cell lines suggesting an expression possibly originated from host
Abstract,"""Characterization of genes with increased expression in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16396319,produce,produce,"overexpressed in glioblastomas produce extracellular proteins, thereby providing possible therapeutic targets"
Abstract,"""A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32748499,show,showed,"-wildtype glioblastomas, 33 samples (58.9%) showed a"
Abstract,"""A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32748499,reveal,revealed,-wildtype glioblastomas revealed 3 distinct groups of idh-wildtype glioblastomas
Abstract,"""The superior longitudinal fasciculus and speech arrest.""",https://pubmed.ncbi.nlm.nih.gov/18520547,involve,involving,with recurrent glioblastoma multiforme involving the left medial frontal and cingulate gyri
Abstract,"""Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations.""",https://pubmed.ncbi.nlm.nih.gov/28076842,identify,identified,"taking glioblastoma multiforme as a case study, we identified a"
Abstract,"""MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.""",https://pubmed.ncbi.nlm.nih.gov/25415048,have,have,and secondary glioblastomas have similar expression pattern in mirna level.
Title,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,use,using,differentiation in glioblastomas using dwi and dsc-pwi in the enhancing
Abstract,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,combine,combining,"for discriminating glioblastomas idh genotypes, and the diagnostic values of combining"
Abstract,"""IDH genotypes differentiation in glioblastomas using DWI and DSC-PWI in the enhancing and peri-enhancing region.""",https://pubmed.ncbi.nlm.nih.gov/31084193,tend,tended,-m glioblastomas tended to present in frontal lobes and younger patients
Title,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,use,using,-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,review,reviewed,-type glioblastomas were reviewed retrospectively and their efficacy was analysed using
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,use,using,compared between glioblastomas with different molecular statuses using the mann-whitney
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,demonstrate,demonstrated,glioblastomas in the high-ki-67-li group demonstrated
Abstract,"""Non-invasive prediction of p53 and Ki-67 labelling indices and O-6-methylguanine-DNA methyltransferase promoter methylation status in adult patients with isocitrate dehydrogenase wild-type glioblastomas using diffusion-weighted imaging and dynamic susceptibility contrast-enhanced perfusion-weighted imaging combined with conventional MRI.""",https://pubmed.ncbi.nlm.nih.gov/35469666,indicate,indicate,of the glioblastoma and indicate that dwi and dsc-pwi may
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,assess,assess,"mutations in glioblastomas at a population level, and to assess whether"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,progress,progressed,novo) glioblastomas and secondary glioblastomas that progressed from low-grade
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,progress,progressed,and secondary glioblastomas that progressed from low-grade or anaplastic astrocytoma
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,base,based,we screened glioblastomas from a population-based study for idh1 mutations
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,mean,mean,"glioblastoma patients with idh1 mutations were younger (mean,"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,frequent in glioblastomas diagnosed as secondary (22 of 30; 73
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,correspond,corresponded,of secondary glioblastoma corresponded to the respective clinical diagnosis in 95%
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,glioblastomas with idh1 mutation diagnosed as primary had clinical and
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,suggest,suggesting,"of secondary glioblastomas, suggesting that they may have rapidly progressed from"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,diagnose,diagnosed,"conversely, glioblastomas without idh1 mutations clinically diagnosed as secondary typically developed"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,misclassifie,misclassified,"actually primary glioblastomas, that may have been misclassified, possibly due"
Abstract,"""IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19755387,complement,complements,of secondary glioblastomas that complements clinical criteria for distinguishing them from primary
Abstract,"""Establishment and characterization of human glioblastoma cell line (HUBT-n).""",https://pubmed.ncbi.nlm.nih.gov/16130901,establish,established,", but glioblastoma cell line (hubt-n) was established"
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,characterize,characterized,novo) glioblastomas are characterized by amplification/overexpression of the egf
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,characterize,characterized,"to secondary glioblastomas, is characterized by the frequent occurrence of p53"
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,contain,contained,giant cell glioblastomas contained a p53 mutation.
Abstract,"""p53 mutations versus EGF receptor expression in giant cell glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9370234,develop,develop,giant cell glioblastomas develop de novo with a short preoperative history (
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,screen,screened,"against human glioblastomas, we screened 12 parvoviruses at a high multiplicity"
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,test,tested,five human glioblastomas tested. h-1
Abstract,"""LuIII parvovirus selectively and efficiently targets, replicates in, and kills human glioma cells.""",https://pubmed.ncbi.nlm.nih.gov/22553327,infect,infected,", human glioblastoma xenografts were selectively infected by luiii when administered intratumorally"
Title,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,mediate,mediate,arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,grow,growing,"-temozolomide glioblastomas, particularly those growing more rapidly during temozolomide treatment"
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,identify,identified,and postchemotherapy glioblastomas identified by the cancer genome atlas (tcga)
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,match,matched,posttreatment tcga glioblastomas but absent in matched pretreatment tumors.
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,result,resulted,-type glioblastoma line to temozolomide resulted in resistant clones; one
Abstract,"""MSH6 mutations arise in glioblastomas during temozolomide therapy and mediate temozolomide resistance.""",https://pubmed.ncbi.nlm.nih.gov/19584161,increase,increased,in the glioblastoma line u251 increased resistance to temozolomide cytotoxicity and reconstitution
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,examine,examined,glioblastomas were examined for abnormalities in fibroblast growth factor receptor
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,exhibit,exhibited,protein in glioblastomas: glioblastoma cells exhibited intense fgfr1 immunoreactivity in frozen
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,exhibit,exhibited,glioblastomas: glioblastoma cells exhibited intense fgfr1 immunoreactivity in frozen sections of
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,evaluate,evaluated,all glioblastomas evaluated in the present study expressed fgfr1 mrna and
Abstract,"""Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/8168112,result,result,mrna in glioblastomas did not result from gene amplification.
Abstract,"""High dose hyperfractionated radiotherapy for adults with glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8280367,treat,treated,patients with glioblastoma multiforme or anaplastic astrocytoma of the brain were treated
Abstract,"""PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/14642363,observe,observed,"dissemination of glioblastomas is often observed, but the underlying mechanism is"
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,develop,develop,and secondary glioblastomas develop through different genetic pathways.
Abstract,"""Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.""",https://pubmed.ncbi.nlm.nih.gov/22865003,confirm,confirming,"in primary glioblastoma, confirming that this mutation is a hallmark of"
Abstract,"""Diagnostic utility of diffusion tensor imaging in differentiating glioblastomas from brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/24503556,identify,identified,patients with glioblastomas and 93 with brain metastases were retrospectively identified.
Abstract,"""Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.""",https://pubmed.ncbi.nlm.nih.gov/29355809,associate,associated,factor in glioblastomas and may be associated with clinical properties.
Abstract,"""Correlation Between Tumor Location and Clinical Properties of Glioblastomas in Frontal and Temporal Lobes.""",https://pubmed.ncbi.nlm.nih.gov/29355809,compare,compared,"and tl glioblastomas were compared to define their clinical properties, including"
Title,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,outcome in glioblastomas given temozolomide and radiotherapy.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,survival in glioblastomas treated with alkylating agents.
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,treat,treated,methylation in glioblastomas treated with temozolomide and radiotherapy in a single uk
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,show,showed,of 109 glioblastomas showed average methylation >non-neoplastic brain in
Abstract,"""Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/19536096,give,given,"significant in glioblastomas given chemoradiotherapy in the routine clinic; furthermore,"
Abstract,"""Differentiation of metastases from high-grade gliomas using short echo time 1H spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/15269942,carcinoma,carcinomas,from 23 glioblastoma patients and 24 metastases patients (3 breast carcinomas
Title,"""Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.""",https://pubmed.ncbi.nlm.nih.gov/12884028,treat,treated,patients with glioblastoma multiforme treated with a combined modality approach.
Abstract,"""Multivariate analysis of clinical prognostic factors in patients with glioblastoma multiforme treated with a combined modality approach.""",https://pubmed.ncbi.nlm.nih.gov/12884028,treat,treated,patients with glioblastoma multiforme (gbm) treated with a combined modality
Abstract,"""Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/20966543,contain,contains,subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (
Abstract,"""Glioblastomas with oligodendroglial component - common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/20966543,analyze,analyzed,classic' glioblastoma parts of 13 gbmo were analyzed separately by interphase
Abstract,"""Complementary but distinct roles for MRI and 18F-fluoromisonidazole PET in the assessment of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19091885,know,known,glioblastoma multiforme is a primary brain tumor known for its
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,mount,mounting,"prognosis of glioblastomas is still poor, mounting evidence suggests that more"
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,operate,operated,results of glioblastoma resection in 104 patients operated on between march 2005
Abstract,"""Operability of glioblastomas: 'sins of action' versus 'sins of non-action'.""",https://pubmed.ncbi.nlm.nih.gov/23479032,find,found,removal of glioblastoma with many complexities (group 1) was found
Abstract,"""Aquaporin-1 expression in human glial tumors suggests a potential novel therapeutic target for tumor-associated edema.""",https://pubmed.ncbi.nlm.nih.gov/14753494,suggest,suggests,aquaporins in glioblastomas suggests a pathologic role for these membrane water channels
Title,"""Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/19151620,associate,associated,) in glioblastomas is associated with multiple tp53 mutations.
Abstract,"""Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/19151620,carry,carrying,glioblastomas carrying 2 or more tp53 mutations.
Abstract,"""Mutational inactivation of the nijmegen breakage syndrome gene (NBS1) in glioblastomas is associated with multiple TP53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/19151620,develop,developed,secondary glioblastomas that developed through progression from low-grade or
Abstract,"""MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30343277,exist,exists,"patients with glioblastoma, no consensus exists as to which assay is"
Abstract,"""MGMT Gene Promoter Methylation Status - Assessment of Two Pyrosequencing Kits and Three Methylation-specific PCR Methods for their Predictive Capacity in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30343277,accord,according,patients with glioblastoma according to assay results.
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,acute,acute,a congenital glioblastoma due to acute fetal internal hydrocephalus in the 37th
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,stage,stage,a congenital glioblastoma (who stage iv) was confirmed by subtotal
Abstract,"""[Prenatal manifestation of a congenital glioblastoma - Case report].""",https://pubmed.ncbi.nlm.nih.gov/11887251,report,reported,"prenatally diagnosed glioblastomas have so far been reported, all of which"
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,progress,progressed,glioblastomas and 16 secondary glioblastomas that had progressed from low
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,progress,progressed,16 secondary glioblastomas that had progressed from low-grade diffuse astrocytomas
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,have,had,of 29 glioblastomas (58%) had a p14arf homozygous deletion
Abstract,"""p14ARF deletion and methylation in genetic pathways to glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11303791,show,showed,"thirteen glioblastomas showed both p14arf and p16ink4a homozygous deletion, while"
Abstract,"""Combined radiotherapy and chemotherapy with dibromodulcitol and CCNU in the postoperative treatment of malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/6306179,randomize,randomized,with supratentorial glioblastomas and malignant astrocytomas were randomized to one of three
Title,"""Gene therapy of glioblastomas: from suicide to homicide.""",https://pubmed.ncbi.nlm.nih.gov/11545030,homicide,homicide,therapy of glioblastomas: from suicide to homicide.
Abstract,"""Tumour-associated epilepsy: clinical impact and the role of referring centres in a cohort of glioblastoma patients. A multicentre study from the Lombardia Neurooncology Group.""",https://pubmed.ncbi.nlm.nih.gov/17122945,collect,collected,histologically proven glioblastomas from 9 lombardy hospitals collected in the same database
Title,"""Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.""",https://pubmed.ncbi.nlm.nih.gov/20621092,define,defined,pediatric infratentorial glioblastomas defined by acgh.
Abstract,"""Distinct molecular signatures in pediatric infratentorial glioblastomas defined by aCGH.""",https://pubmed.ncbi.nlm.nih.gov/20621092,show,show,pediatric infratentorial glioblastomas show a molecular karyotype that was more characteristic of
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,deteriorate,deteriorated,"primary cerebellar glioblastoma, who rapidly deteriorated due to cerebrospinal fluid dissemination"
Abstract,"""[A case of primary cerebellar glioblastoma in childhood].""",https://pubmed.ncbi.nlm.nih.gov/12491584,carry,carry,primary cerebellar glioblastomas in children carry a very poor prognosis and tend
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,develop,develop,glioblastomas develop de novo (primary glioblastomas) or through
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,develop,develop,that these glioblastoma subtypes develop through different genetic pathways.
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,characterize,characterized,primary glioblastomas are characterized by egfr and mdm2 amplification/overexpression
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,contain,contain,whereas secondary glioblastomas frequently contain p53 mutations.
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,show,showed,"of primary glioblastomas with loh#10 showed loh at all informative markers,"
Abstract,"""Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10653004,show,showed,", secondary glioblastomas with loh#10 showed partial or complete loss of chromosome"
Abstract,"""Primary brain tumour presenting as spontaneous intracerebral haemorrhage.""",https://pubmed.ncbi.nlm.nih.gov/230705,invade,invading,"(two glioblastomas, one oligodendroglioma invading the leptomeninges, and one"
Abstract,"""Primary brain tumour presenting as spontaneous intracerebral haemorrhage.""",https://pubmed.ncbi.nlm.nih.gov/230705,show,showed,into a glioblastoma of the basal ganglia showed a rapidly lethal course
Title,"""Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method.""",https://pubmed.ncbi.nlm.nih.gov/31422371,use,using,primary diagnosed glioblastomas using the quantitative methyqesd method.
Abstract,"""Correlation of the quantitative level of MGMT promoter methylation and overall survival in primary diagnosed glioblastomas using the quantitative MethyQESD method.""",https://pubmed.ncbi.nlm.nih.gov/31422371,relate,relating,primary diagnosed glioblastoma (gbm) relating to survival using a quantitative
Title,"""Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.""",https://pubmed.ncbi.nlm.nih.gov/23334798,use,using,differentiation of glioblastomas from intracranial metastases using 3t mr spectroscopic and
Abstract,"""Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data.""",https://pubmed.ncbi.nlm.nih.gov/23334798,develop,developed,"differentiation of glioblastomas multiforme (gb) from metastases, we developed"
Abstract,"""Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15558549,increase,increased,area in glioblastomas and meningiomas and as the area of increased t2
Abstract,"""Contribution of diffusion tensor imaging to delineation of gliomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15558549,see,saw,"meningiomas and glioblastomas, we saw a trend (without significance)"
Abstract,"""The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.""",https://pubmed.ncbi.nlm.nih.gov/27655705,use,using,differentiation of glioblastomas from solitary brain metastases using conventional mri remains an
Abstract,"""The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions.""",https://pubmed.ncbi.nlm.nih.gov/27655705,undergo,underwent,patients with glioblastoma or a solitary metastatic lesion underwent three-dimensional
Abstract,"""Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23991844,observe,observed,de novo glioblastomas but was not observed in lower-grade gliomas
Abstract,"""Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23991844,compare,compared,de novo glioblastomas as compared with those in primary tumors (14.5
Abstract,"""Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/23991844,express,expressed,", secondary glioblastomas rarely expressed cd133 antigen even after malignant progression following"
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,show,show,glioblastomas frequently show genetic alterations in the tp53 pathway.
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,correlate,correlated,"in 360 glioblastomas, and correlated these with patient age and survival"
Abstract,"""Common polymorphisms in the MDM2 and TP53 genes and the relationship between TP53 mutations and patient outcomes in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18462472,carry,carrying,"patients with glioblastomas carrying a tp53 mutation, and among those treated"
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,investigate,investigated,and 115 glioblastomas) were investigated using immunohistochemistry with an anti-
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,express,expressed,"of 115 glioblastomas (47.0%), podoplanin was expressed on"
Abstract,"""Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression.""",https://pubmed.ncbi.nlm.nih.gov/16596424,proliferate,proliferating,"cells and glioblastoma cells, especially around necrotic areas and proliferating endothelial"
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,regulate,regulated,glioblastoma growth is a genetically regulated process.
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,follow,followed,glioblastoma multiforme is followed by a number of genetic breakages
Abstract,"""[Glial tumors of the brain: current aspects of the immunopathogenesis and immunogenodiagnosis].""",https://pubmed.ncbi.nlm.nih.gov/17642197,show,showed,studies of glioblastomas showed that there were at least two immunologic phenotypes
Abstract,"""Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.""",https://pubmed.ncbi.nlm.nih.gov/26862025,enrol,enrolled,a recurrent glioblastoma multiforme were enrolled in a larger phase 1 multicenter
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,represent,represent,glioblastomas represent an important cause of cancer-related mortality
Abstract,"""Effect of human skin-derived stem cells on vessel architecture, tumor growth, and tumor invasion in brain tumor animal models.""",https://pubmed.ncbi.nlm.nih.gov/17409412,distribute,distributed,"directly into glioblastomas, hsdscs distributed themselves extensively throughout the tumor mass"
Abstract,"""Transcriptome analysis of glioma cells for the dynamic response to gamma-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24176853,characterize,characterized,"importance for glioblastoma therapy; however, the recurrence of glioma characterized"
Abstract,"""Transcriptome analysis of glioma cells for the dynamic response to gamma-irradiation and dual regulation of apoptosis genes: a new insight into radiotherapy for glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24176853,contribute,contribute,transcription in glioblastomas can contribute to the understanding of radioresistance mechanisms.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,amplify,amplified,"of all glioblastomas have amplified the egfr gene, and about half"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,remain,remain,"versus primary glioblastomas remain controversial, but such data are highly relevant"
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,assess,assessed,-amplified glioblastomas from 106 patients were assessed for egfrviii positivity.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,evaluate,evaluated,to recurrent glioblastomas were evaluated in 40 patients with egfr-amplified
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,acquire,acquired,-nonamplified glioblastomas acquired egfr amplification or egfrviii at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,maintain,maintain,-positive glioblastomas maintain egfrviii positivity at recurrence.
Abstract,"""Epidermal Growth Factor Receptor Variant III (EGFRvIII) Positivity in EGFR-Amplified Glioblastomas: Prognostic Role and Comparison between Primary and Recurrent Tumors.""",https://pubmed.ncbi.nlm.nih.gov/28855349,receive,receive,with recurrent glioblastoma to receive egfrviii-targeting agents.
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,use,using,"analysis of glioblastoma, using data from the cancer genome atlas to"
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,identify,identify,to 162 glioblastomas from the cancer genome atlas to identify morphology-
Abstract,"""Integrated morphologic analysis for the identification and characterization of disease subtypes.""",https://pubmed.ncbi.nlm.nih.gov/22278382,identify,identified,analysis of glioblastoma identified three prognostically significant patient clusters (median survival
Abstract,"""Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24129546,identify,identified,cases of glioblastoma identified between 2005 and 2012.
Abstract,"""Correlation between the prognostic value and the expression of the stem cell marker CD133 and isocitrate dehydrogenase1 in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24129546,identify,identify,markers in glioblastoma may help identify new therapeutic targets.
Abstract,"""The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial.""",https://pubmed.ncbi.nlm.nih.gov/7671460,evaluate,evaluated,human glioblastomas were evaluated for overexpression of the epidermal growth factor
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,exist,exist,"grade iv glioblastomas exist in two forms, primary (de novo"
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,arise,arise,"novo) glioblastomas (pgbm) that arise without precursor lesions,"
Abstract,"""Stability of the CpG island methylator phenotype during glioma progression and identification of methylated loci in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25012071,develop,develop,common secondary glioblastomas (sgbm) which develop from earlier lower grade
Title,"""Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.""",https://pubmed.ncbi.nlm.nih.gov/23494632,have,have,secondary glioblastomas with idh1/2 mutations have longer glioma history from preceding
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,grade,grade,% of glioblastomas (who grade iv).
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,progress,progressed,novo) glioblastomas and in 21 secondary glioblastomas that had progressed from
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,progress,progressed,21 secondary glioblastomas that had progressed from low-grade diffuse astrocytoma
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,be,was,"majority of glioblastomas with loss of rb1 expression, there was promoter"
Abstract,"""Promoter hypermethylation of the RB1 gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11204276,microdissecte,microdissected,"in three glioblastomas, areas with and without rb1 expression were microdissected"
Abstract,"""Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12483326,occur,occurs,background: glioblastoma is a malignant tumor that occurs in the cerebrum
Abstract,"""Severe ocular and orbital toxicity after intracarotid injection of carboplatin for recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/12483326,have,have,patients with glioblastoma sometimes have intracarotid injection of carcinostatics added to the
Abstract,"""Robust discrimination of glioblastomas from metastatic brain tumors on the basis of single-voxel (1)H MRS.""",https://pubmed.ncbi.nlm.nih.gov/22081447,obtain,obtained,discrimination between glioblastomas and metastases were obtained using a small number of
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,remain,remains,tumors from glioblastomas on conventional magnetic resonance imaging remains particularly challenging.
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,undergo,underwent,patients with glioblastomas underwent conventional magnetic resonance imaging and ce-fiesta
Abstract,"""Evaluation of Peritumoral Brain Parenchyma Using Contrast-Enhanced 3D Fast Imaging Employing Steady-State Acquisition at 3T for Differentiating Metastatic Brain Tumors and Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30165229,focus,focusing,"tumors from glioblastomas, especially when focusing on differences in the peritumoral"
Abstract,"""Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/21538026,contain,contains,subgroup of glioblastomas contains areas with histological features of oligodendroglial differentiation (
Abstract,"""Glioblastomas with oligodendroglial component-common origin of the different histological parts and genetic subclassification.""",https://pubmed.ncbi.nlm.nih.gov/21538026,analyze,analyzed,classic' glioblastoma parts of 13 gbmo were analyzed separately by interphase
Title,"""Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/18997474,base,based,gene in glioblastomas: a population-based study.
Abstract,"""Promoter methylation and polymorphisms of the MGMT gene in glioblastomas: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/18997474,diagnose,diagnosed,in 371 glioblastomas diagnosed at the population level.
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,define,defined,"in secondary glioblastoma, have not yet been defined."
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,evolve,evolved,", primary glioblastomas, and secondary glioblastomas that had evolved from lower"
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,evolve,evolved,and secondary glioblastomas that had evolved from lower grade astrocytomas.
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,identify,identified,in primary glioblastomas identified two sites of minimally deleted regions at 22q12.3
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,share,shared,23 secondary glioblastomas affected shared a deletion in the same small (
Abstract,"""Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/15592495,rule,ruled,of primary glioblastomas cannot be ruled out.
Title,"""[Metastizing glioblastoma causing total bilateral deafness].""",https://pubmed.ncbi.nlm.nih.gov/13474104,cause,causing,[metastizing glioblastoma causing total bilateral deafness].
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,describe,described,of intracranial glioblastomas have been described for the first time more than
Abstract,"""[Secondary intraspinal localizations of glioblastoma. Apropos of a case].""",https://pubmed.ncbi.nlm.nih.gov/8577358,suggest,suggested,diagnosis of glioblastoma metastasis was suggested by intra-operative pathological findings
Abstract,"""Genomic alterations in low-grade, anaplastic astrocytomas and glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17387387,perform,performed,"astrocytomas to glioblastomas, histopathologic and comparative genomic hybridization analyses were performed"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,analyze,analyzed,"in human glioblastomas, we analyzed a cohort of astrocytic tumors for"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,evolve,evolved,"64 primary glioblastomas, and 28 secondary glioblastomas that had evolved from"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,evolve,evolved,28 secondary glioblastomas that had evolved from either 24 low-grade
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,compare,compared,"of secondary glioblastomas as compared to other types of tumors, and"
Abstract,"""Frequent HRK inactivation associated with low apoptotic index in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16155764,associate,associated,in secondary glioblastoma were further associated with wild-type p53.
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,undergo,underwent,patients with glioblastomas and 916 patients with brain metastases who underwent radiotherapy
Abstract,"""Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1346 patients with glioblastomas or brain metastases.""",https://pubmed.ncbi.nlm.nih.gov/15666327,determine,determined,patients with glioblastomas or brain metastases was not determined by age-
Abstract,"""Proliferative activity in human glioblastomas: evaluation of different Ki67 equivalent antibodies.""",https://pubmed.ncbi.nlm.nih.gov/9350303,include,included,: eleven glioblastomas were included in the study.
Abstract,"""Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18464291,observe,observed,"on 71 glioblastoma patients, we observed a clear underrepresentation of h1"
Abstract,"""Haplotype-specific expression of the human PDGFRA gene correlates with the risk of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/18464291,derive,derived,"heterozygous human glioblastoma cell lines, h1-derived mrna levels were"
Title,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,use,using,astrocytomas and glioblastoma using adult f344 rats and n-methyl-
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,report,reported,astrocytomas and glioblastomas is reported.
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,form,formed,"astrocytomas and glioblastomas of an astrocytic type formed the majority, whereas"
Abstract,"""An experimental model for anaplastic astrocytomas and glioblastoma using adult F344 rats and N-methyl-N-nitrosourea.""",https://pubmed.ncbi.nlm.nih.gov/8237366,predominate,predominated,", whereas glioblastomas of mixed oligo-astrocytic type predominated in aci"
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,determine,determine,mutations in glioblastomas and to determine whether gene mutation is inevitably associated
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,have,had,"in 44 glioblastomas, half of which had egfr amplification."
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,examine,examined,additional 26 glioblastomas with egfr amplification were then examined to establish more
Abstract,"""Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10728703,have,have,suggests that glioblastomas with egfr amplification have the capacity to produce a
Abstract,"""The relationship between the capillary structure and hemorrhage in gliomas.""",https://pubmed.ncbi.nlm.nih.gov/3031239,relate,related,and three glioblastomas multiforme) were related to clinically significant hemorrhages.
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,express,express,malignant glioblastoma may over-express the epidermal-growth-
Abstract,"""Intratumoral infusion of the monoclonal antibody, mAb 425, against the epidermal-growth-factor receptor in patients with advanced malignant glioma.""",https://pubmed.ncbi.nlm.nih.gov/9191875,enter,entered,"-positive glioblastomas entered the study, which was designed to evaluate"
Abstract,"""Synchronous occurrence of glioblastoma multiforme in a husband and wife.""",https://pubmed.ncbi.nlm.nih.gov/3018184,develop,developed,glioblastomas developed within two years of each other in an
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,support,supports,bearing intracranial glioblastomas and supports the development of dc-based clinical
Abstract,"""Dendritic cells pulsed with glioma lysates induce immunity against syngeneic intracranial gliomas and increase survival of tumor-bearing mice.""",https://pubmed.ncbi.nlm.nih.gov/16808884,respond,respond,patients with glioblastomas that do not respond to standard therapies.
Abstract,"""Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17369134,consider,considered,"dissemination of glioblastomas is considered rare, and unambiguous pathologic or molecular"
Abstract,"""Gains at the 1p36 chromosomal region are associated with symptomatic leptomeningeal dissemination of supratentorial glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17369134,use,using,of 8 glioblastomas with symptomatic leptomeningeal dissemination by using fluorescence in situ
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,grade,grade,"glioblastoma multiforme (who grade iv), the most"
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,occur,occur,"of secondary glioblastomas but rarely occur in primary glioblastomas, suggesting the"
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,suggest,suggesting,"in primary glioblastomas, suggesting the presence of different genetic pathways ("
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,screen,screened,and secondary glioblastomas were screened by immunohistochemistry for mdm2 overexpression and by
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,contain,contained,15 primary glioblastomas overexpressing mdm2 contained a p53 mutation.
Abstract,"""Amplification and overexpression of MDM2 in primary (de novo) glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9034372,lack,lack,of primary glioblastomas that typically lack p53 mutations.
Title,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,identify,identified,pathway in glioblastomas identified by gene expression-based classification using tgfbeta
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,report,reported,overproduction in glioblastoma and other high-grade gliomas has been reported
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,analyze,analyzed,"% of glioblastoma samples analyzed showed strong tgfbeta activation, while the"
Abstract,"""Heterogeneous activation of the TGFbeta pathway in glioblastomas identified by gene expression-based classification using TGFbeta-responsive genes.""",https://pubmed.ncbi.nlm.nih.gov/19192267,cause,cause,"activation in glioblastomas, which may cause potential differences in responses to"
Title,"""Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.""",https://pubmed.ncbi.nlm.nih.gov/10987250,show,shows,expression in glioblastomas shows regional variation and down-regulation with therapy
Abstract,"""Quantitative telomerase expression in glioblastomas shows regional variation and down-regulation with therapy but no correlation with patient outcome.""",https://pubmed.ncbi.nlm.nih.gov/10987250,range,ranging,", the glioblastomas (gbms), ranging from 26% to"
Abstract,"""Chromosome 7 in glioblastoma tissue. Parenchymal vs. endothelial cells.""",https://pubmed.ncbi.nlm.nih.gov/7497447,proliferate,proliferated,feature of glioblastomas and sometimes these proliferated areas transform into a malignant
Abstract,"""Chromosome 7 in glioblastoma tissue. Parenchymal vs. endothelial cells.""",https://pubmed.ncbi.nlm.nih.gov/7497447,result,resulting,"component of glioblastoma, resulting in gliosarcomas."
Title,"""[Intracranial multiform glioblastomas of a young subject, manifesting themselves originally by a lower radiculospinal compression].""",https://pubmed.ncbi.nlm.nih.gov/4322824,manifest,manifesting,"intracranial multiform glioblastomas of a young subject, manifesting themselves originally by"
Abstract,"""Grave cranio-cerebral trauma 30 years ago as cause of the brain glioma at the locus of the trauma particulars of the case.""",https://pubmed.ncbi.nlm.nih.gov/208326,develop,developed,a glioblastoma multiforma developed 30 years after a penetrating craniocerebral injury
Abstract,"""Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10616524,use,using,20 secondary glioblastomas using fluorescence in situ hybridization (fish) on
Abstract,"""Fluorescence in situ hybridization study of aneuploidy of chromosomes 7, 10, X, and Y in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/10616524,allow,allow,"of a glioblastoma subtype; therefore, they do not allow the"
Title,"""Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.""",https://pubmed.ncbi.nlm.nih.gov/15933420,apply,applying,radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses
Abstract,"""Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.""",https://pubmed.ncbi.nlm.nih.gov/15933420,compare,compared,gy against glioblastomas was compared retrospectively with the standard scheme of 60
Abstract,"""Dose-escalated conformal radiotherapy of glioblastomas -- results of a retrospective comparison applying radiation doses of 60 and 70 Gy.""",https://pubmed.ncbi.nlm.nih.gov/15933420,treat,treated,patients with glioblastomas was treated by surgery and postoperative radiotherapy.
Abstract,"""[Expression of p53 protein and proliferative activity in multiform glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/9864716,consider,considered,"in multiform glioblastoma cells, generally considered as the indirect index of"
Title,"""Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.""",https://pubmed.ncbi.nlm.nih.gov/14628128,fractionate,fractionated,of xenografted glioblastomas to fractionated irradiation.
Abstract,"""Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.""",https://pubmed.ncbi.nlm.nih.gov/14628128,perform,performed,of the glioblastomas was performed resulting in a growth delay with subsequent
Abstract,"""Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation.""",https://pubmed.ncbi.nlm.nih.gov/14628128,fractionate,fractionated,of xenografted glioblastomas to fractionated irradiation.
Title,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,treat,treated,significance in glioblastomas treated with radiotherapy.
Abstract,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,receive,received,) with glioblastomas who have received radiotherapy.
Abstract,"""p53 status has no prognostic significance in glioblastomas treated with radiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/9401801,involve,involved,presence in glioblastomas of genetic abnormalities that are also involved in the
Abstract,"""TP53 mutations in malignant astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/9529927,identify,identified,%) glioblastomas; the mutations were most frequently identified in the
Abstract,"""[Analysis of peritumoral edema--with special reference to the value of contrast-enhanced CT scan and dynamic CT scan].""",https://pubmed.ncbi.nlm.nih.gov/6098291,demonstrate,demonstrated,of 34 glioblastomas and all of 15 metastatic tumors demonstrated moderate or
Abstract,"""[Analysis of peritumoral edema--with special reference to the value of contrast-enhanced CT scan and dynamic CT scan].""",https://pubmed.ncbi.nlm.nih.gov/6098291,demonstrate,demonstrated,"of 9 glioblastomas which demonstrated slight peritumoral edema, grade i,"
Abstract,"""Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/17167979,undergo,underwent,"patients with glioblastoma multiforme underwent conventional mri, proton mr spectroscopic imaging"
Abstract,"""Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/17167979,offer,offering,"delineation of glioblastomas, offering information not available with conventional mri."
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,mark,marked,aims: glioblastomas display marked phenotypic and molecular heterogeneity.
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,show,shows,"protein in glioblastomas also shows great intratumour heterogeneity, but the significance"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,divide,divided,", paraffin glioblastomas were divided into positive (homogeneous staining) and"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,find,found,"in homogeneous glioblastomas, no correlation was found between pten protein expression"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,find,found,"the heterogeneous glioblastomas, loh was found significantly more frequently (p"
Abstract,"""Biological and clinical significance of the intratumour heterogeneity of PTEN protein expression and the corresponding molecular abnormalities of the PTEN gene in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24417635,present,presenting,patients with glioblastomas presenting either loh of 10q23 or heterogeneous pten expression
Abstract,"""[Ultrastructure of capillary permeability in human brain tumors. Part 1: Gliomas associated with cerebral edema (low density area)].""",https://pubmed.ncbi.nlm.nih.gov/2989720,astrocytoma,astrocytoma,between the glioblastomas with remarkable edema (4 cases) and astrocytoma
Abstract,"""[Ultrastructure of capillary permeability in human brain tumors. Part 1: Gliomas associated with cerebral edema (low density area)].""",https://pubmed.ncbi.nlm.nih.gov/2989720,increase,increasing,"vessels of glioblastomas with severe perifocal edema, in addition to increasing"
Abstract,"""Lymphocytic infiltration in long-survival glioblastomas: possible host's resistance.""",https://pubmed.ncbi.nlm.nih.gov/199052,analyze,analyzed,for primary glioblastoma is analyzed.
Abstract,"""Heterogeneity of subcellular localization of p53 protein in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8261427,know,known,in human glioblastomas with known genetic profiles of p53 mutations and allele
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,grade,grade,"in glioblastomas (gbm, who grade iv), the"
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,decrease,decreased,in human glioblastoma t98g cells decreased their proliferation and migration and
Abstract,"""Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.""",https://pubmed.ncbi.nlm.nih.gov/25529918,strengthen,strengthen,proliferation of glioblastoma t98g cells and strengthen the antiproliferative effect evoked
Abstract,"""[Prognostic implications of the proliferation index (H3-TdR-labeling index) and ploidy in neuroectodermal tumors (astrocytomas and glioblastomas)].""",https://pubmed.ncbi.nlm.nih.gov/1313162,obtain,obtain,astrocytomas and glioblastomas to obtain reliable prognostic information.
Title,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,mediate,mediated,lipopolysaccharide against glioblastoma multiforme are mediated in part by toll-like
Abstract,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,assess,assessed,lps on glioblastomas was assessed in wild-type balb/c
Abstract,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,treat,treated,"with dbt glioblastoma cells intracranially or subcutaneously, were treated with intratumoral"
Abstract,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,increase,increased,"with intracranial glioblastomas, lps increased survival times modestly in wild-"
Abstract,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,suggest,suggested,"and human glioblastoma cells in vitro, and western blotting suggested that"
Abstract,"""The in vivo antitumoral effects of lipopolysaccharide against glioblastoma multiforme are mediated in part by Toll-like receptor 4.""",https://pubmed.ncbi.nlm.nih.gov/17290189,mediate,mediated,"effects on glioblastoma multiforme are mediated, in part, by the"
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,transplant,transplanted,u251 human glioblastoma cell lines and subcutaneously transplanted u87 cells in scid
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,lead,lead,cytotoxicity toward glioblastoma cells in vitro and its intratumoral injections lead to
Abstract,"""Oncolytic Effect of Adenoviruses Serotypes 5 and 6 Against U87 Glioblastoma Cancer Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/31704835,internalize,internalize,capability of glioblastoma cancer stem cells to internalize a fluorescent-labeled
Abstract,"""Intraoperative monopolar mapping during 5-ALA-guided resections of glioblastomas adjacent to motor eloquent areas: evaluation of resection rates and neurological outcome.""",https://pubmed.ncbi.nlm.nih.gov/25434385,carry,carries,resection of glioblastoma adjacent to motor cortex or subcortical motor pathways carries
Abstract,"""Clinical and Molecular Characterization of Adult Glioblastomas in Southern Brazil.""",https://pubmed.ncbi.nlm.nih.gov/30840759,support,supporting,profile of glioblastomas in latin america possibly supporting new target therapies.
Abstract,"""[Malignant brain tumors after radiation - glioblastomas after operation and radiation of meningiomas - 2 case reports].""",https://pubmed.ncbi.nlm.nih.gov/11786936,describe,described,development of glioblastomas is described as a rare complication in the literature
Abstract,"""An additive score optimized by a genetic learning algorithm predicts readmission risk after glioblastoma resection.""",https://pubmed.ncbi.nlm.nih.gov/33099328,correlate,correlated,readmission following glioblastoma (gbm) resection is not only correlated with
Abstract,"""An additive score optimized by a genetic learning algorithm predicts readmission risk after glioblastoma resection.""",https://pubmed.ncbi.nlm.nih.gov/33099328,identify,identified,-confirmed glioblastoma were retrospectively identified.
Abstract,"""An additive score optimized by a genetic learning algorithm predicts readmission risk after glioblastoma resection.""",https://pubmed.ncbi.nlm.nih.gov/33099328,develop,developed,"the glioblastoma readmission risk score, developed from the multivariate model"
Abstract,"""DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/35868257,remain,remains,stratification of glioblastomas remains inconclusive.
Abstract,"""DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/35868257,subject,subjected,newly diagnosed glioblastoma subjected to global dna methylation profiling.
Abstract,"""Hypermethylation of testis derived transcript gene promoter significantly correlates with worse outcomes in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/23769558,identify,identify,nine secondary glioblastomas (sgbms) with the expectation to identify valuable
Abstract,"""VEGF promotes tumorigenesis and angiogenesis of human glioblastoma stem cells.""",https://pubmed.ncbi.nlm.nih.gov/17618600,express,expressing,"from human glioblastomas and a retrovirus expressing vegf, we examined the"
Title,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,harbor,harboring,of cerebral glioblastomas harboring p53 mutations.
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,determine,determined,patients with glioblastomas whose p53 status was determined by a sensitive yeast
Abstract,"""Selective sensitivity to radiation of cerebral glioblastomas harboring p53 mutations.""",https://pubmed.ncbi.nlm.nih.gov/9581814,result,results,"response in glioblastomas, and this results in significantly longer survival."
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,recruit,recruit,glioblastoma cells recruit innate immune cells and change their phenotype
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,induce,induced,", after glioblastoma-induced phenotypic modifications, normal cells cooperate with"
Abstract,"""Multidimensional communication in the microenvirons of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29985475,involve,involves,this glioblastoma takeover of the brain involves multiple modes of communication
Abstract,"""[Genetic disorders in primary brain glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/30475532,characterize,characterized,glioblastomas are characterized by a variety of genetic and epigenetic
Abstract,"""[Genetic disorders in primary brain glioblastomas].""",https://pubmed.ncbi.nlm.nih.gov/30475532,allow,allowed,patients with glioblastomas allowed revealing changes relevant to this disease and determining
Title,"""Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.""",https://pubmed.ncbi.nlm.nih.gov/19287454,display,display,within human glioblastomas and display different tumorigenicity and independent genomic evolution.
Abstract,"""Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution.""",https://pubmed.ncbi.nlm.nih.gov/19287454,contain,contain,"glioblastomas (gbms) contain transformed, self-maintaining"
Title,"""Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.""",https://pubmed.ncbi.nlm.nih.gov/15494095,use,using,profiles of glioblastomas using array-based comparative genomic hybridization.
Abstract,"""Detrended fluctuation analysis of genome-wide copy number profiles of glioblastomas using array-based comparative genomic hybridization.""",https://pubmed.ncbi.nlm.nih.gov/15494095,base,based,19 independent glioblastomas by array-based comparative genomic hybridization analysis.
Abstract,"""Fatal pulmonary embolism despite an inferior vena cava filter in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/16377838,develop,developed,with a glioblastoma multiforme who developed a fatal pulmonary embolism in spite
Abstract,"""Clinical significance of angiopoietin-like protein 3 expression in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26639238,provide,provides,angptl3 in glioblastomas and provides an independent predictive factor.
Title,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,reveal,reveal,recurrent glioblastomas reveal molecular subtypes associated with mechanistic implications of drug
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,achieve,achieved,"recurrence of glioblastomas could be achieved by transcriptomic reprograming of tumors,"
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,perform,performed,"of recurrent glioblastomas, gene expression profiling was performed on the 43"
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,include,including,cases of glioblastomas including 15 paired primary and recurrent cases.
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,show,showed,the recurrent glioblastomas showed two distinct expression types.
Abstract,"""Recurrent Glioblastomas Reveal Molecular Subtypes Associated with Mechanistic Implications of Drug-Resistance.""",https://pubmed.ncbi.nlm.nih.gov/26466313,choose,choose,that recurrent glioblastomas may choose two different strategies for transcriptomic reprograming to
Abstract,"""Screen for IDH1, IDH2, IDH3, D2HGDH and L2HGDH mutations in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21625441,look,looking,screened 47 glioblastoma samples looking for changes in these genes.
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,aim,aimed,"features of glioblastoma, we aimed to assess the role of mgmt"
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,use,used,-mutant glioblastomas and used 173 idh-wildtype glioblastomas for comparison
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,show,showed,"-wildtype glioblastomas, idh-mutant glioblastomas showed significantly higher ("
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,show,showed,-mutant glioblastomas showed significantly higher (p < 0.0001) mgmt
Abstract,"""Predictive value of MGMT promoter methylation on the survival of TMZ treated IDH-mutant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33628600,receive,receiving,-mutant glioblastomas receiving temozolomide therapy (cohort a); this
Abstract,"""Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/25712375,test,tested,"cafs in glioblastoma, we tested the effect of caf conditioned media"
Abstract,"""Effect of cancer-associated fibroblasts on the migration of glioma cells in vitro.""",https://pubmed.ncbi.nlm.nih.gov/25712375,perform,performed,"in human glioblastomas, immunofluorescence staining was performed on tissue samples from"
Title,"""Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.""",https://pubmed.ncbi.nlm.nih.gov/33972663,ensure,ensures,network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate
Abstract,"""Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.""",https://pubmed.ncbi.nlm.nih.gov/33972663,augment,augmented,"-mutant glioblastomas, or augmented by adding both real and synthetic"
Title,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,include,including,"therapeutics in glioblastomas, including targeted molecular therapies, current and future"
Abstract,"""Novel medical therapeutics in glioblastomas, including targeted molecular therapies, current and future clinical trials.""",https://pubmed.ncbi.nlm.nih.gov/20708556,target,targeted,"therapies for glioblastoma, with an emphasis on targeted agents."
Abstract,"""Sirtuin-2 activity is required for glioma stem cell proliferation arrest but not necrosis induced by resveratrol.""",https://pubmed.ncbi.nlm.nih.gov/23955573,exist,existing,suggest that glioblastoma resistance to existing radio- and chemotherapies rely on glioblastoma
Abstract,"""Clonal analysis in glioblastoma with epithelial differentiation.""",https://pubmed.ncbi.nlm.nih.gov/11145202,associate,associated,differentiation in glioblastomas (gbm) may be associated with circumscribed growth
Title,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,recapitulate,recapitulate,specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human
Abstract,"""Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.""",https://pubmed.ncbi.nlm.nih.gov/23333277,use,using,of orthotopic glioblastoma (gbm) xenograft models using surgical samples of
Abstract,"""Treatment of glioblastoma multiforme in elderly patients. Clinico-therapeutic remarks in 22 patients older than 80 years.""",https://pubmed.ncbi.nlm.nih.gov/16724687,exclude,excluded,diagnosis of glioblastoma multiforme are thus generally excluded from clinical trials of
Abstract,"""EGFR Amplification and IDH Mutations in Glioblastoma Patients of the Northeast of Morocco.""",https://pubmed.ncbi.nlm.nih.gov/28785587,diagnose,diagnosed,in 65 glioblastoma tumors diagnosed at the university hospital of fez between
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,remain,remained,effect on glioblastomas remained unclear.
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,base,based,the multicenter glioblastoma cohorts based on the oxidative-stress-responsive
Abstract,"""Oxidative stress is involved in immunosuppression and macrophage regulation in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37866784,discover,discovered,potential in glioblastoma and discovered sod3's potential role in regulating macrophage
Abstract,"""Perfusion Parameter Obtained on 3-Tesla Magnetic Resonance Imaging and the Ki-67 Labeling Index Predict the Overall Survival of Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33567368,undergo,underwent,"patients with glioblastomas underwent pulsed arterial spin-labeling, dti,"
Abstract,"""The Glycoprotein M6a Is Associated with Invasiveness and Radioresistance of Glioblastoma Stem Cells.""",https://pubmed.ncbi.nlm.nih.gov/35883571,target,target,"treatment of glioblastoma since it would simultaneously target proliferation, invasion,"
Abstract,"""Seizures as presenting symptom in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30536819,present,presenting,patients with glioblastoma presenting with seizures are poorly understood.
Abstract,"""Seizures as presenting symptom in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30536819,divide,divided,patients with glioblastoma were divided into 2 groups: symptomatic and asymptomatic
Abstract,"""Seizures as presenting symptom in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30536819,identify,identified,diagnosed with glioblastoma in this period were identified.
Abstract,"""Seizures as presenting symptom in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30536819,have,had,"seizures from glioblastoma had significantly smaller tumors, which caused less edema"
Abstract,"""Seizures as presenting symptom in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/30536819,present,presenting,significance: glioblastoma presenting with seizures is morphologically different from asymptomatic tumors
Abstract,"""Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.""",https://pubmed.ncbi.nlm.nih.gov/38985083,know,known,"glioblastomas are known for their poor clinical prognosis, with"
Abstract,"""Endothelial cell ferroptosis influences IDH wild-type glioblastoma growth in recurrent glioblastoma multiforme patients.""",https://pubmed.ncbi.nlm.nih.gov/38985083,require,requires,treatment of glioblastomas requires careful consideration of its effects on endothelial cells
Title,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,reveal,reveals,paired idhwt glioblastomas reveals recurrent alterations of mpdz at relapse after radiotherapy
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,screen,screened,frozen idhwt glioblastoma samples were screened by cgh array.
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,include,included,nineteen idhwt glioblastoma patients were included.
Abstract,"""Genomic analysis of paired IDHwt glioblastomas reveals recurrent alterations of MPDZ at relapse after radiotherapy and chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35259554,suggest,suggesting,"chemotherapy in glioblastoma idhwt patients, suggesting that mpdz impairment could contribute"
Abstract,"""Recent advances in the molecular genetics of primary gliomas.""",https://pubmed.ncbi.nlm.nih.gov/12778011,remain,remain,", particularly glioblastomas, remain a challenge for oncology."
Abstract,"""Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21481277,relate,related,"in primary glioblastoma of older patients, age-related differences in"
Abstract,"""Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21481277,determine,determined,of secondary glioblastoma were not included.extent of brain edema was determined in
Abstract,"""Does age matter? - A MRI study on peritumoral edema in newly diagnosed primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21481277,reflect,reflect,of a glioblastoma at diagnosis does not reflect biology in the elderly
Title,"""The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.""",https://pubmed.ncbi.nlm.nih.gov/26914704,modify,modified,mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.
Abstract,"""The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.""",https://pubmed.ncbi.nlm.nih.gov/26914704,exhibit,exhibited,glioblastomas (gbm) exhibited the highest frequency of tertp
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,repress,represses,"downregulated in glioblastoma, and ndrg2 overexpression represses glioblastoma cell proliferation in"
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,compare,compared,in primary glioblastomas as compared to diffuse and anaplastic astrocytomas.
Abstract,"""Frequent promoter hypermethylation and transcriptional downregulation of the NDRG2 gene at 14q11.2 in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18709645,detect,detected,"to primary glioblastomas, ndrg2 promoter hypermethylation was detected in only 1"
Abstract,"""Flow cytometric DNA and nuclear antigen content in astrocytic neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/2895977,have,had,"of ten glioblastomas had an identifiable aneuploid peak, while all four"
Title,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,stratify,stratified,idhwt glioblastomas can be stratified by their transcriptional response to standard
Abstract,"""IDHwt glioblastomas can be stratified by their transcriptional response to standard treatment, with implications for targeted therapy.""",https://pubmed.ncbi.nlm.nih.gov/38326875,lack,lacking,background: glioblastoma (gbm) brain tumors lacking idh1 mutations (
Abstract,"""Alterations in the RB Pathway With Inactivation of RB1 Characterize Glioblastomas With a Primitive Neuronal Component.""",https://pubmed.ncbi.nlm.nih.gov/34850045,define,defining,of some glioblastomas but defining molecular alterations of this histologic variant remains
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,include,included,patients with glioblastoma multiforme were included.
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,show,show,-six glioblastomas did not show allelic loss for any locus.
Abstract,"""Loss of heterozygosity at 11p15 and p53 alterations in malignant gliomas.""",https://pubmed.ncbi.nlm.nih.gov/11355148,characterize,characterized,prognosis in glioblastomas characterized by loh 11p15.
Title,"""Glioblastoma Unique Features Drive the Ways for Innovative Therapies in the Trunk-branch Era.""",https://pubmed.ncbi.nlm.nih.gov/31237849,drive,drive,glioblastoma unique features drive the ways for innovative therapies in
Abstract,"""Glioblastoma Unique Features Drive the Ways for Innovative Therapies in the Trunk-branch Era.""",https://pubmed.ncbi.nlm.nih.gov/31237849,remain,remains,optimally treated glioblastoma patients remains dismal despite recent fundamental progress in neurosurgical
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,progress,progressed,in secondary glioblastomas that have progressed from low-grade or anaplastic
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,misclassifie,misclassified,to secondary glioblastomas and are probably misclassified.
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,account,account,", secondary glioblastomas account for approximately 10% of all glioblastomas."
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,derive,derived,and secondary glioblastomas derived thereof suggests these tumors share a common progenitor
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,suggest,suggests,in primary glioblastomas suggests a different cell of origin; both glioblastoma
Abstract,"""Genetic profile of astrocytic and oligodendroglial gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21442241,acquire,acquire,; both glioblastoma subtypes acquire a similar histological phenotype as a result
Title,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,derive,derived,cd133(-) glioblastoma-derived cancer stem cells show differential growth characteristics
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,show,show,"although glioblastomas show the same histologic phenotype, biological hallmarks such"
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,originate,originate,"subtypes of glioblastomas might originate from different cells of origin, we"
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,favor,favoring,from 22 glioblastomas under medium conditions favoring the growth of neural and
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,show,show,secondary glioblastoma (n = 7)-derived cells did not show any
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,contain,contained,11/15 primary glioblastomas contained a significant cd133(+) subpopulation that displayed neurosphere
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,grow,grew,from primary glioblastomas grew adherently in vitro and were driven by cd133(-
Abstract,"""CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.""",https://pubmed.ncbi.nlm.nih.gov/17483311,characterize,characterized,"cd133(-) glioblastomas were characterized by a lower proliferation index, whereas"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,continue,continues,"patients with glioblastoma continues to be limited, despite an aggressive,"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,induce,inducing,"agent in glioblastoma, is cytotoxic to cells by inducing dna damage"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,methylate,methylated,"subset of glioblastomas, the mgmt promoter is methylated, impairing the"
Abstract,"""Treatment considerations for MGMT-unmethylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25394859,provide,providing,% of glioblastomas providing an inherent resistance to alkylating agents and challenging
Title,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,stratify,stratified,from independent glioblastoma cohorts stratified by age and idh mutation status.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,derive,derived,r132h1 immunonegative glioblastomas derived from patients aged 60 years and older enrolled
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,study,studied,"population of glioblastomas, we studied 80 idh-wildtype glioblastomas from"
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,age,aged,-wildtype glioblastomas from patients aged 18-60 years.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,include,included,with primary glioblastomas included in these cohorts.
Abstract,"""PROX1 is a novel pathway-specific prognostic biomarker for high-grade astrocytomas; results from independent glioblastoma cohorts stratified by age and IDH mutation status.""",https://pubmed.ncbi.nlm.nih.gov/27626492,corroborate,corroborated,"in primary glioblastomas, was corroborated by gene expression data extracted from"
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,-,-,both human glioblastoma cells and pre-established human glioblastoma mouse model
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,compare,compared,established human glioblastoma mouse model compared with an srrv system.
Abstract,"""Split genome-based retroviral replicating vectors achieve efficient gene delivery and therapeutic effect in a human glioblastoma xenograft model.""",https://pubmed.ncbi.nlm.nih.gov/36195571,inject,injected,"u-87 mg glioblastomas, the group of mice injected with sprrv expressing"
Abstract,"""Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/20523076,locate,located,occurrence of glioblastoma at one jet engine manufacturing facility located in north
Abstract,"""Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/20523076,compare,compared,"risk of glioblastoma compared with hourly workers (17 cases, rr"
Abstract,"""Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/20523076,elevate,elevated,rates for glioblastoma and other malignant cns neoplasm histologies were not elevated
Abstract,"""Long-term health experience of jet engine manufacturing workers: III. Incidence of malignant central nervous system neoplasms.""",https://pubmed.ncbi.nlm.nih.gov/20523076,observe,observed,the glioblastoma excesses observed among nh workers may reflect external occupational
Title,"""Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3beta and causes increased cell migration.""",https://pubmed.ncbi.nlm.nih.gov/27654922,affect,affects,slc39a9 in glioblastoma cells affects phosphorylation states of p53 and gsk-3beta and
Abstract,"""Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3beta and causes increased cell migration.""",https://pubmed.ncbi.nlm.nih.gov/27654922,cause,cause,levels in glioblastoma cells can cause enhanced cell survival and cell migration
Abstract,"""Expression of the zinc importer protein ZIP9/SLC39A9 in glioblastoma cells affects phosphorylation states of p53 and GSK-3beta and causes increased cell migration.""",https://pubmed.ncbi.nlm.nih.gov/27654922,tpen,tpen,to untreated glioblastoma cells tpen treatment or expression of zip9 results in
Abstract,"""Middle cerebral artery occlusion within an irradiated glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/205005,present,presented,within a glioblastoma multiforme is presented.
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,have,have,"background: glioblastomas have a high degree of malignancy, high recurrence"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,improve,improving,"markers of glioblastomas is of great significance for improving the diagnosis,"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,express,expressed,: eight glioblastoma-specific differentially expressed genes were screened using geo
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,reveal,revealing,"to analyze glioblastoma samples in 34 microarray datasets, revealing novel diagnostic"
Abstract,"""Integrated analysis of 34 microarray datasets reveals CBX3 as a diagnostic and prognostic biomarker in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31138312,provide,providing,patients with glioblastoma and providing a new direction for screening tumor markers
Title,"""Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.""",https://pubmed.ncbi.nlm.nih.gov/20118769,distinguish,distinguished,versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of
Abstract,"""Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6.""",https://pubmed.ncbi.nlm.nih.gov/20118769,share,share,and rhabdoid glioblastomas are rare entities that share some overlapping morphologic features
Title,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,dehydrogenase,dehydrogenase,-mutated glioblastomas than in isocitrate dehydrogenase wild-type glioblastomas:
Abstract,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,recruit,recruited,patients with glioblastoma were prospectively recruited and imaged preoperatively.
Abstract,"""Less Invasive Phenotype Found in Isocitrate Dehydrogenase-mutated Glioblastomas than in Isocitrate Dehydrogenase Wild-Type Glioblastomas: A Diffusion-Tensor Imaging Study.""",https://pubmed.ncbi.nlm.nih.gov/27849434,have,have,-mutated glioblastomas have a less invasive phenotype compared with idh wild
Abstract,"""Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/27619981,compare,compared,"survival for glioblastoma patients, when compared to moderate and high timp-1"
Abstract,"""Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/27619981,measure,measuring,on 33 glioblastoma biopsies and by measuring levels of timp-1 in plasma
Abstract,"""Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/27619981,link,linked,including 21 glioblastomas) by enzyme-linked immunosorbent assay (elisa
Abstract,"""Comparative studies of TIMP-1 immunohistochemistry, TIMP-1 FISH analysis and plasma TIMP-1 in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/27619981,cause,caused,levels in glioblastomas were not caused by timp-1 gene amplification and timp-1
Title,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,improve,improving,amplification in glioblastoma in vivo: improving patient selection to mdm2-
Abstract,"""Next-generation repeat-free FISH probes for DNA amplification in glioblastoma in vivo: Improving patient selection to MDM2-targeted inhibitors.""",https://pubmed.ncbi.nlm.nih.gov/28212808,exhibit,exhibited,% of glioblastomas exhibited high mdm2 amplification (in vivo) with
Abstract,"""Safety of stereotactic laser ablations performed as treatment for glioblastomas in a conventional magnetic resonance imaging suite.""",https://pubmed.ncbi.nlm.nih.gov/27690648,perform,performed,sla for glioblastoma (gbm) treatment was performed entirely within a
Title,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,use,use,metastatic glioblastoma cells use common pathways via blood and lymphatic vessels
Abstract,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,grade,grade,with a glioblastoma multiforme who grade iv and distant metastases in several
Abstract,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,grade,grade,the glioblastoma multiforme who grade iv of a young male patient
Abstract,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,contain,containing,local extracranial glioblastoma recurrence and containing metastases within lymph nodes and lymphatic
Abstract,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,alter,altered,stimulated by glioblastoma-environment interaction altered the properties of glioblastoma cells
Abstract,"""Metastatic glioblastoma cells use common pathways via blood and lymphatic vessels.""",https://pubmed.ncbi.nlm.nih.gov/19484696,cause,caused,"properties of glioblastoma cells, whether caused by a spontaneous genetic shift"
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,store,stored,deregulated in glioblastomas and highly stable in stored tissue specimens.
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,include,included,from 40 glioblastoma patients were included retrospectively; patients were comparable on
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,survival,survival,dendrograms dichotomized glioblastomas into prognostic subgroups with a significant association to survival
Abstract,"""A 4-miRNA signature to predict survival in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29136645,stratify,stratifying,biomarkers in glioblastoma stratifying patients into short- and long-term survivors
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,evaluate,evaluated,biomarkers in glioblastomas was evaluated.
Abstract,"""Prognostic significance of tetraspanin CD151 in newly diagnosed glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22926763,overexpresse,overexpressed,") of glioblastomas, while cd151 was rarely overexpressed in most of"
Abstract,"""[Epidemiology of glioblastoma].""",https://pubmed.ncbi.nlm.nih.gov/20869733,observe,observed,incidence of glioblastoma has been observed over the last 30 years.
Abstract,"""Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.""",https://pubmed.ncbi.nlm.nih.gov/9591629,have,had,four glioblastomas of 122 had patterns suggestive of homozygous deletions at
Abstract,"""Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades.""",https://pubmed.ncbi.nlm.nih.gov/9591629,lose,lost,"most glioblastomas lost one entire chromosome 10, while astrocytomas preferentially"
Abstract,"""Comparative analysis of molecular and histological glioblastomas: insights into prognostic variance.""",https://pubmed.ncbi.nlm.nih.gov/39115615,identify,identify,whether molecular glioblastomas (gbms) identify with a similar dismal prognosis
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,confirm,confirmed,mrna on glioblastomas confirmed the immunohistochemical expression of timp-1.
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,have,had,showed that glioblastoma patients with the lowest timp-1 expression had a significantly
Abstract,"""Low expression of tissue inhibitor of metalloproteinases-1 (TIMP-1) in glioblastoma predicts longer patient survival.""",https://pubmed.ncbi.nlm.nih.gov/19430729,suggest,suggesting,"survival in glioblastoma patients, suggesting a role for timp-1 as a"
Abstract,"""Prognostic value of ALDH1A3 promoter methylation in gliob;astoma: a single center experience in Western China.""",https://pubmed.ncbi.nlm.nih.gov/25684492,remain,remains,of primary glioblastomas (gbms) in western china remains unclear.
Title,"""Evaluating the prognostic factors effective on the outcome of patients with glioblastoma multiformis: does maximal resection of the tumor lengthen the median survival?""",https://pubmed.ncbi.nlm.nih.gov/20860940,lengthen,lengthen,patients with glioblastoma multiformis: does maximal resection of the tumor lengthen
Title,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,dictate,dictates,required for glioblastoma development but its inhibition dictates glioma stem cell responsivity
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,inhibit,inhibiting,"effects in glioblastoma stem cells (gscs) inhibiting clic1 activity,"
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,use,using,"from human glioblastomas, in vitro using 2d and 3d cultures and"
Abstract,"""Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives.""",https://pubmed.ncbi.nlm.nih.gov/35135603,act,acts,"subset of glioblastomas, it acts as a booster of proliferation in"
Abstract,"""Long-term survival with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17785346,recruit,recruited,55 primary glioblastoma long-term survivors recruited at the six clinical
Abstract,"""Long-term survival with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17785346,register,registered,consecutive unselected glioblastoma patients registered in the german glioma network revealed significantly
Abstract,"""The relationship between genetic aberrations as detected by comparative genomic hybridization and vascularization in glioblastoma xenografts.""",https://pubmed.ncbi.nlm.nih.gov/11386408,characterize,characterized,glioblastomas (gbms) are histologically characterized by striking microvascular
Title,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,reveal,reveals,and recurrent glioblastomas reveals a reduced level of pentraxin 3 in recurrent
Abstract,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,identify,identified,and recurrent glioblastoma samples from 18 patients were identified and expression profiling
Abstract,"""Expression Profiling of Primary and Recurrent Glioblastomas Reveals a Reduced Level of Pentraxin 3 in Recurrent Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32791527,set,set,in recurrent glioblastomas and the gene set analysis results suggest an altered
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,affect,affect,glioblastomas are incurable primary brain tumors that affect patients of
Abstract,"""Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/28358371,alter,altered,together with glioblastoma stem-like cells efficiently altered the tumor development
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,include,including,", especially glioblastomas, including amplifications, deletions and single nucleotide polymorphisms"
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,discuss,discussed,glioblastomas are discussed as a separate entity due to their
Abstract,"""EGFR as a clinical marker in glioblastomas and other gliomas.""",https://pubmed.ncbi.nlm.nih.gov/28885661,target,targeted,"and specifically glioblastomas, as a means for targeted treatment and prognosis"
Abstract,"""The EphA2 receptor drives self-renewal and tumorigenicity in stem-like tumor-propagating cells from human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/23238013,propagate,propagating,"in human glioblastomas (hgbms), tumor-propagating cells with"
Title,"""Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/24366773,treat,treated,pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.
Abstract,"""Optic nerve and visual pathways primary glioblastoma treated with radiotherapy and temozolomide chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/24366773,treat,treated,"and chiasm glioblastoma (gbm), treated with radiotherapy and concomitant"
Title,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,regulate,regulated,growth of glioblastoma cells through down-regulated nf-kappab.
Abstract,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,study,studied,role in glioblastomas have not been studied.
Abstract,"""Knockdown of CypA inhibits interleukin-8 (IL-8) and IL-8-mediated proliferation and tumor growth of glioblastoma cells through down-regulated NF-kappaB.""",https://pubmed.ncbi.nlm.nih.gov/20454998,rnai)-mediate,rnai)-mediated,"cypa in glioblastoma, stable rna interference (rnai)-mediated knockdown of cypa"
Abstract,"""Tumor Vessels Fuel the Fire in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34204510,deploy,deploy,"glioblastoma, a subset of aggressive brain tumors, deploy"
Abstract,"""Tumor Vessels Fuel the Fire in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34204510,hamper,hampered,"modality in glioblastoma, and, how they can be hampered mechanistically"
Title,"""Case report. Glioblastoma multiforme presenting as a haemorrhagic minimally enhancing mass of the trigone.""",https://pubmed.ncbi.nlm.nih.gov/19759207,present,presenting,glioblastoma multiforme presenting as a haemorrhagic minimally enhancing mass of
Abstract,"""Validation of the Effectiveness and Safety of Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas: 10-year Experience of a Single Institution.""",https://pubmed.ncbi.nlm.nih.gov/26539003,treat,treated,diagnosed with glioblastoma who were treated with temozolomide during concurrent chemoradiotherapy and
Title,"""Socioeconomic status and glioblastoma risk: a population-based analysis.""",https://pubmed.ncbi.nlm.nih.gov/25421378,base,based,status and glioblastoma risk: a population-based analysis.
Abstract,"""Socioeconomic status and glioblastoma risk: a population-based analysis.""",https://pubmed.ncbi.nlm.nih.gov/25421378,yield,yielded,association between glioblastoma and occupational or ses factors have yielded inconsistent results
Abstract,"""Socioeconomic status and glioblastoma risk: a population-based analysis.""",https://pubmed.ncbi.nlm.nih.gov/25421378,use,using,"ses and glioblastoma risk using a large, population-based cancer"
Abstract,"""Socioeconomic status and glioblastoma risk: a population-based analysis.""",https://pubmed.ncbi.nlm.nih.gov/25421378,represent,represent,and greater glioblastoma risk is unlikely to represent an ascertainment effect because
Title,"""Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.""",https://pubmed.ncbi.nlm.nih.gov/29576531,derive,derived,arrest in glioblastoma-patient-derived cells.
Abstract,"""Copper-Binding Small Molecule Induces Oxidative Stress and Cell-Cycle Arrest in Glioblastoma-Patient-Derived Cells.""",https://pubmed.ncbi.nlm.nih.gov/29576531,derive,derived,and arrest glioblastoma-patient-derived cells at picomolar concentrations.
Abstract,"""Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study.""",https://pubmed.ncbi.nlm.nih.gov/33486440,be,is,"outcome of glioblastoma (gbm) in italy, where there is"
Abstract,"""Fas ligand expression in glioblastoma cell lines and primary astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/9217971,express,express,that all glioblastoma cell lines and primary astrocytic brain tumors express fasl
Abstract,"""Ventricular entry during surgical resection is associated with intracranial leptomeningeal dissemination in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/36273377,associate,associated,purpose: glioblastoma (gbm) is associated with a poorer prognosis
Abstract,"""A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.""",https://pubmed.ncbi.nlm.nih.gov/38305926,accord,according,astrocytoma and glioblastoma according to the 2021 who cns5 classification.
Abstract,"""A subregion-based RadioFusionOmics model discriminates between grade 4 astrocytoma and glioblastoma on multisequence MRI.""",https://pubmed.ncbi.nlm.nih.gov/38305926,collect,collected,and 289 glioblastomas) with histologic diagnosis was retrospectively collected from our
Title,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,glioblastoma-activated pericytes support tumor growth via immunosuppression.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,restrict,restricts,involved in glioblastoma development restricts the design of efficient therapies.
Abstract,"""Glioblastoma-activated pericytes support tumor growth via immunosuppression.""",https://pubmed.ncbi.nlm.nih.gov/29479841,activate,activated,"glioblastoma-activated pericytes develop an immunosuppressive phenotype, reducing"
Abstract,"""Immune cell infiltrates in atypical teratoid/rhabdoid tumors.""",https://pubmed.ncbi.nlm.nih.gov/22931701,contain,contain,"like glioblastomas, at/rts contain brain cancer stem cells"
Abstract,"""Immune cell infiltrates in atypical teratoid/rhabdoid tumors.""",https://pubmed.ncbi.nlm.nih.gov/22931701,correlate,correlates,"noted in glioblastomas, which correlates with poor prognosis."
Abstract,"""STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25736961,display,display,"glioblastomas (gbm), however, display an important"
Title,"""Fluoxetine, an antidepressant, suppresses glioblastoma by evoking AMPAR-mediated calcium-dependent apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/25671301,evoke,evoking,", suppresses glioblastoma by evoking ampar-mediated calcium-dependent apoptosis"
Abstract,"""Fibrin deposition in primary and metastatic human brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/8874864,detect,detected,in glioblastomas fibrin deposits could be detected within and around tumour
Abstract,"""Fibrin deposition in primary and metastatic human brain tumours.""",https://pubmed.ncbi.nlm.nih.gov/8874864,accumulate,accumulated,areas in glioblastomas and to be accumulated at the interface of tumorous
Abstract,"""Investigation gene and microRNA expression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21143783,indentifie,indentified,pathogenesis of glioblastoma have not been indentified clearly.
Abstract,"""Investigation gene and microRNA expression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21143783,implicate,implicated,to affect glioblastoma and 50 of which were implicated in other cancers
Abstract,"""Investigation gene and microRNA expression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/21143783,give,gave,expression in glioblastoma and gave a comprehensive function study of differential expressed
Abstract,"""Impact of p53 status to response of temozolomide in low MGMT expression glioblastomas: preliminary results.""",https://pubmed.ncbi.nlm.nih.gov/18647495,receive,receiving,"study, glioblastomas with low mgmt expression receiving surgical resection, radiotherapy"
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,grade,grade,for supratentorial glioblastoma (who grade iv) between 2013 and 2017
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,correlate,correlate,snp in glioblastoma samples did not correlate with presence of idh1 mutation
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,have,had,idh mutant glioblastoma had a distinctly higher survival profile than both rs11554137
Abstract,"""Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29423539,harbor,harboring,patients with glioblastoma harboring the snp and patients with idh wild type
Title,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,use,using,survivors of glioblastoma using genome- and transcriptome-wide profiling.
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,perform,performed,"aberrations in glioblastomas of long-term survivors, we performed genome-"
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,include,including,"profiling of glioblastoma samples from 94 patients, including 28 long-"
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,show,show,-wildtype glioblastomas from long-term survivors did not show distinct
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,corroborate,corroborate,mutation in glioblastoma long-term survival and corroborate the association of
Abstract,"""Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.""",https://pubmed.ncbi.nlm.nih.gov/24615357,lack,lacked,-wildtype glioblastomas in our cohort of long-term survivors lacked
Title,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,treat,treated,survival of glioblastoma patients treated with radio-chemotherapy.
Abstract,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,treat,treated,"-type glioblastomas, treated with radio-chemotherapy."
Abstract,"""Old and New Systemic Immune-Inflammation Indexes Are Associated with Overall Survival of Glioblastoma Patients Treated with Radio-Chemotherapy.""",https://pubmed.ncbi.nlm.nih.gov/35741816,verify,verifies,"patients with glioblastoma, while the multivariate analysis verifies the prognostic value"
Title,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,require,requires,"(abt-414)-induced glioblastoma cell death requires egfr overexpression, but not egfr(y1068"
Abstract,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,exhibit,exhibit,glioblastomas commonly (40%) exhibit epidermal growth factor
Abstract,"""Depatuxizumab Mafodotin (ABT-414)-induced Glioblastoma Cell Death Requires EGFR Overexpression, but not EGFR(Y1068) Phosphorylation.""",https://pubmed.ncbi.nlm.nih.gov/32371586,target,targeting,"effects in glioblastoma, novel therapeutic agents targeting amplified egfr or egfrviii"
Abstract,"""Chromosomal aberrations detected by comparative genomic hybridization (CGH) in human astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10077222,show,showed,primary glioblastomas showed a high frequency of genomic dna gains (
Title,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,brain,brain,differentiation between glioblastomas and brain metastases and regarding their primary site of
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,challenge,challenging,differentiation between glioblastoma and brain metastasis may be challenging in conventional contrast
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,undergo,underwent,and 38 glioblastomas) underwent conventional contrast-enhanced mri including dynamic
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,mean,mean,higher in glioblastomas than in metastases (mean 3.2 Â± 1.4 and
Abstract,"""Differentiation between glioblastomas and brain metastases and regarding their primary site of malignancy using dynamic susceptibility contrast MRI at 3T.""",https://pubmed.ncbi.nlm.nih.gov/30389510,measure,measuring,to differentiate glioblastomas from metastases by measuring the cbv in the peritumoral
Abstract,"""Tumour microenvironment programming by an RNA-RNA-binding protein complex creates a druggable vulnerability in IDH-wild-type glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38858501,have,have,-type glioblastomas have a poor five-year survival rate along
Abstract,"""GLUT3 upregulation promotes metabolic reprogramming associated with antiangiogenic therapy resistance.""",https://pubmed.ncbi.nlm.nih.gov/28138554,neutralize,neutralizing,duration of glioblastomas to vegf-neutralizing antibody bevacizumab.
Title,"""Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.""",https://pubmed.ncbi.nlm.nih.gov/27542769,control,controlled,-derived glioblastomas under hypoxic stress is controlled by a cxcl12/
Abstract,"""Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.""",https://pubmed.ncbi.nlm.nih.gov/27542769,analyze,analyzed,-derived glioblastomas were analyzed and the therapeutic effect of blocking cxcl12
Abstract,"""Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.""",https://pubmed.ncbi.nlm.nih.gov/27542769,express,express,of human glioblastoma and express markers of gslc.
Abstract,"""Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.""",https://pubmed.ncbi.nlm.nih.gov/27542769,prevent,prevent,"-induced glioblastoma progression, prevent resistance to treatment, and recurrence"
Title,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,invasiveness,invasiveness,regulation of glioblastoma growth and invasiveness.
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,correlate,correlated,"downregulation in glioblastomas, which correlated with shorter glioblastoma patient survival."
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,show,showed,"-deficient glioblastoma cells showed elevated cofilin phosphorylation, an increase in"
Abstract,"""Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasiveness.""",https://pubmed.ncbi.nlm.nih.gov/26549022,xenografte,xenografted,-depleted glioblastoma cells xenografted into the immunodeficient mouse brain was strongly
Abstract,"""Brain cancer and farming in western Canada.""",https://pubmed.ncbi.nlm.nih.gov/1337947,increase,increasing,dying of glioblastomas and increasing fuel/oil expenditures (test for
Abstract,"""Prognostic Value of BRAF Mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/38219188,become,become,"for treating glioblastoma (gbm) patients, has become a centre"
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,compare,compared,"in primary glioblastomas compared to low-grade, anaplastic, or"
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,show,showed,"and primary glioblastoma cells showed a high membrane hsp70 expression density,"
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,show,showed,isolated from glioblastoma tissues only showed a weak staining pattern.
Abstract,"""Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/28849427,compare,compared,harbouring primary glioblastomas compared to those with secondary and low grade glioblastomas
Title,"""Genetic and signaling pathway alterations in glioblastoma: relevance to novel targeted therapies.""",https://pubmed.ncbi.nlm.nih.gov/12700121,novel,novel,alterations in glioblastoma: relevance to novel targeted therapies.
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,respond,respond,glioblastomas respond differently to all-trans retinoic acid (
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,line,lines,"and the glioblastoma cells lines ln18, ln428 and u251 were examined"
Abstract,"""CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid.""",https://pubmed.ncbi.nlm.nih.gov/25797252,improve,improve,sensitivity of glioblastoma cells to ra. dicitabine may improve the sensitivity
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,have,have,highly malignant glioblastomas have a short median survival time mainly due to
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,identify,identify,and recurrent glioblastomas by qpcr and double-immunofluorescence stainings to identify
Abstract,"""Epithelial-to-mesenchymal transition in paired human primary and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25845427,identify,identified,within our glioblastoma collective were identified according to the regulation of mrna
Abstract,"""Revisiting the role of p53 in primary and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17214319,develop,develops,glioblastoma multiforme (gbm) develops from astrocytes and is
Abstract,"""Impact of frailty on surgery for glioblastoma: a critical evaluation of patient outcomes and caregivers' perceptions in a developing country.""",https://pubmed.ncbi.nlm.nih.gov/33002866,assess,assess,patients with glioblastoma (gbm) and to assess caregivers' perceptions
Abstract,"""Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10079373,use,using,and 22 glioblastomas) using the avidin biotin immunoperoxidase technique.
Abstract,"""Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10079373,appear,appeared,"in glioblastomas, the survival rate appeared to be less in"
Abstract,"""Elimination of Radiation-Induced Senescence in the Brain Tumor Microenvironment Attenuates Glioblastoma Recurrence.""",https://pubmed.ncbi.nlm.nih.gov/34580063,treat,treated,glioblastomas (gbm) are routinely treated with ionizing radiation
Abstract,"""A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P(1) signaling axis.""",https://pubmed.ncbi.nlm.nih.gov/37582160,enhance,enhancing,of u251 glioblastoma cells by enhancing signaling mediated by sphingosine-1-phosphate
Abstract,"""A virally encoded GPCR drives glioblastoma through feed-forward activation of the SK1-S1P(1) signaling axis.""",https://pubmed.ncbi.nlm.nih.gov/37582160,activate,activating,signaling promoted glioblastoma cell proliferation and survival by activating the kinases akt
Abstract,"""Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33864561,evaluate,evaluate,recurrent) glioblastomas to evaluate the mutational status of six dna repair
Abstract,"""Incidence, clinicopathologic, and genetic characteristics of mismatch repair gene-mutated glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/33864561,correlate,correlated,in primary glioblastoma and are correlated with high tmb and mgmt promoter
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,undergo,underwent,patients harboring glioblastoma underwent pre-operative mrs evaluation to detect 2hg
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,exhibit,exhibited,-mutant glioblastoma exhibited significantly higher accumulation of 2hg (median 3.191
Abstract,"""Reliable diagnosis of IDH-mutant glioblastoma by 2-hydroxyglutarate detection: a study by 3-T magnetic resonance spectroscopy.""",https://pubmed.ncbi.nlm.nih.gov/28956184,have,have,glioblastoma with high 2hg accumulation did not have significantly longer
Abstract,"""High mobility group A1 expression correlates with the histological grade of human glial tumors.""",https://pubmed.ncbi.nlm.nih.gov/15138557,verify,verify,astrocytomas and glioblastomas in order to verify whether the detection of these
Abstract,"""High mobility group A1 expression correlates with the histological grade of human glial tumors.""",https://pubmed.ncbi.nlm.nih.gov/15138557,compare,compared,higher in glioblastomas compared to astrocytomas.
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,follow,followed,"of the glioblastoma, followed a multimodal therapy including radiotherapy and chemotherapy"
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,identify,identified,"such as glioblastoma, can be identified."
Abstract,"""Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18975243,manage,managed,glioblastomas in these patients should be managed like the usual
Abstract,"""Analysis of Olig2 and YKL-40 expression: a clinicopathological/immunohistochemical study for the distinction between subventricular zone II and III glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/27179219,originate,originates,glioblastomas originates either from astrocytes that have accumulated mutations and
Title,"""Subtle neuropsychiatric symptoms of glioblastoma multiforme misdiagnosed as depression.""",https://pubmed.ncbi.nlm.nih.gov/32188609,misdiagnose,misdiagnosed,symptoms of glioblastoma multiforme misdiagnosed as depression.
Title,"""Identification of prognostic biomarkers for glioblastomas using protein expression profiling.""",https://pubmed.ncbi.nlm.nih.gov/22179774,use,using,biomarkers for glioblastomas using protein expression profiling.
Title,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,reveal,reveals,of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,subdivide,subdivided,glioblastoma is often subdivided into three transcriptional subtypes (classical
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,feature,features,major histomorphologic glioblastoma features to deconvolute and estimate niche proportions in an
Abstract,"""Niche deconvolution of the glioblastoma proteome reveals a distinct infiltrative phenotype within the proneural transcriptomic subgroup.""",https://pubmed.ncbi.nlm.nih.gov/36182941,provide,providing,"profiles of glioblastoma, providing potential new insights into the genetic drivers"
Abstract,"""Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.""",https://pubmed.ncbi.nlm.nih.gov/18816605,exhibit,exhibit,background: glioblastomas exhibit a remarkable tendency toward morphologic diversity.
Abstract,"""Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.""",https://pubmed.ncbi.nlm.nih.gov/18816605,predominate,predominated,adenoid' glioblastomas (a-gbm) predominated (48%
Abstract,"""Disseminated strongyloidiasis complicating glioblastoma therapy: a case report.""",https://pubmed.ncbi.nlm.nih.gov/19333553,develop,developed,patient with glioblastoma who developed disseminated strongyloidiasis 6 weeks after completion of
Abstract,"""Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35138915,image,imaged,-wildtype glioblastomas were imaged with diffusion-weighted imaging using 13
Abstract,"""Gamma distribution model of diffusion MRI for evaluating the isocitrate dehydrogenase mutation status of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35138915,enable,enabled,"-wildtype glioblastomas, and its use enabled the significant differentiation of"
Title,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,deplete,depleting,radiosensitivity of glioblastoma cell lines by depleting cd133+ tumor cells.
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,assess,assessed,) on glioblastoma cell lines u87 and u251 were assessed by mtt
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,sort,sorted,and cd133- glioblastoma cells were sorted by magnetic activated cell sorting (
Abstract,"""gamma-secretase inhibitor-I enhances radiosensitivity of glioblastoma cell lines by depleting CD133+ tumor cells.""",https://pubmed.ncbi.nlm.nih.gov/21167391,examine,examined,"cd133+and cd133- glioblastoma cells were examined, respectively, and the expression"
Abstract,"""Improving morphology-based malignancy grading schemes in astrocytic tumors by means of computer-assisted techniques.""",https://pubmed.ncbi.nlm.nih.gov/9458164,identify,identified,and 164 glioblastomas (gbm) identified in accordance with the who
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,expect,expected,treating human glioblastomas has not been as effective as expected after the
Abstract,"""Variable efficiency of the thymidine kinase/ganciclovir system in human glioblastoma cell lines: implications for gene therapy.""",https://pubmed.ncbi.nlm.nih.gov/9382960,transfecte,transfected,"six human glioblastoma cell lines stably transfected with the tk gene,"
Title,"""Glioblastoma multiforme presenting as postpartum depression: a case report.""",https://pubmed.ncbi.nlm.nih.gov/30567605,present,presenting,glioblastoma multiforme presenting as postpartum depression: a case report
Abstract,"""Glioblastoma multiforme presenting as postpartum depression: a case report.""",https://pubmed.ncbi.nlm.nih.gov/30567605,present,presenting,case of glioblastoma multiforme presenting as postpartum depression without abnormalities in basic
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,have,have,"purpose: glioblastomas, brain metastases, and pcls may have similar"
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,compare,compared,observed in glioblastomas compared with brain metastases and pcls (p <
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,consist,consisted,"to distinguish glioblastomas from nonglioblastomas consisted of adc, cs (or"
Abstract,"""Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.""",https://pubmed.ncbi.nlm.nih.gov/21330399,consist,consisted,"glioblastomas from nonglioblastomas consisted of adc, cs (or fa)"
Abstract,"""Histology-based expression profiling yields novel prognostic markers in human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16254489,provide,provided,", microdissected glioblastomas also provided prognostic information in an independent set of"
Abstract,"""Histology-based expression profiling yields novel prognostic markers in human glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16254489,have,have,of 28 glioblastomas that did not all have perinecrotic palisades.
Abstract,"""The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29036186,collect,collected,from 118 glioblastomas were collected for polymerase chain reaction (pcr)
Title,"""Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.""",https://pubmed.ncbi.nlm.nih.gov/37729723,accord,according,patients with glioblastoma according to the 2021 world health organization classification.
Abstract,"""Risk factors for preoperative and postoperative seizures in patients with glioblastoma according to the 2021 World Health Organization classification.""",https://pubmed.ncbi.nlm.nih.gov/37729723,relate,related,for developing glioblastoma (gbm) related preoperative (prs) and
Abstract,"""Glioma stem cell maintenance: the role of the microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/21827414,provide,provide,glioblastomas are highly lethal cancers for which conventional therapies provide
Title,"""Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter.""",https://pubmed.ncbi.nlm.nih.gov/36444681,methylate,methylated,methylator phenotype glioblastomas with methylated mgmt promoter.
Abstract,"""Potent predictive CpG signature for temozolomide response in non-glioma-CpG island methylator phenotype glioblastomas with methylated MGMT promoter.""",https://pubmed.ncbi.nlm.nih.gov/36444681,have,have,response in glioblastomas (gbms) that do not have the glioma
Title,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,derive,derived,glioblastoma-derived stem cell-enriched cultures form distinct
Abstract,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,use,using,from human glioblastomas by using conditions that select for the expansion of
Abstract,"""Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria.""",https://pubmed.ncbi.nlm.nih.gov/18037961,obtain,obtain,lines from glioblastoma specimens with the goal to obtain model systems for
Title,"""Subventricular zone-associated classification in isocitrate dehydrogenase-wildtype glioblastomas: improved prognostic value through integration of FLAIR with contrast-enhanced imaging.""",https://pubmed.ncbi.nlm.nih.gov/38941641,improve,improved,-wildtype glioblastomas: improved prognostic value through integration of flair with
Abstract,"""Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29258180,consider,considered,glioblastoma (gbm) is considered one of the most
Abstract,"""O(6)-Methylguanine DNA methyltransferase determined by promoter hypermethylation and immunohistochemical expression is correlated with progression-free survival in patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20232102,treat,treated,patients with glioblastomas treated with alkylating agents were analyzed for mgmt expression
Abstract,"""Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.""",https://pubmed.ncbi.nlm.nih.gov/25168214,publish,published,patients with glioblastoma; only small case series have been published.
Abstract,"""Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.""",https://pubmed.ncbi.nlm.nih.gov/25168214,treat,treated,patients with glioblastoma treated at md anderson cancer center to estimate the
Abstract,"""Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.""",https://pubmed.ncbi.nlm.nih.gov/25168214,treat,treated,patients with glioblastoma treated on clinical trials from 2006 to 2012.
Abstract,"""Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution.""",https://pubmed.ncbi.nlm.nih.gov/25168214,lmd,lmd,time of glioblastoma diagnosis to lmd was 11.9 months.
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,establish,established,selectively inhibited glioblastoma cell proliferation and migration in cell lines established from
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,associate,associated,and immortalized glioblastoma cell lines that were associated with downregulation of the
Abstract,"""Microtubule actin cross-linking factor 1, a novel target in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27959385,reduce,reduced,treatment of glioblastomas cooperatively reduced the proliferative capacity of glioblastoma cells.
Abstract,"""Synchronous occurrence of glioblastoma multiforme and esophageal adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/12641354,have,have,although glioblastoma multiforme and esophageal adenocarcinoma have few clinical similarities there
Abstract,"""1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17934521,identify,identified,in nine glioblastomas homozygous deletions at 1p36 were identified.
Abstract,"""The Prognostic Role of Peritumoral Edema in Patients with Newly Diagnosed Glioblastoma: A Retrospective Analysis.""",https://pubmed.ncbi.nlm.nih.gov/34119276,reach,reached,studies on glioblastomas (gbms) have not reached a consensus on
Abstract,"""Novel vaccines for glioblastoma: clinical update and perspective.""",https://pubmed.ncbi.nlm.nih.gov/27993092,have,have,glioblastomas have a formidable tumor microenvironment that is hostile to
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,regard,regarded,glioblastomas are regarded as the most common malignant brain tumours
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,involve,involve,while secondary glioblastomas mostly involve younger people.
Abstract,"""Molecular biology of glioblastoma: Classification and mutational locations.""",https://pubmed.ncbi.nlm.nih.gov/28924284,follow,followed,observed in glioblastomas are loss of heterozygosity at 10q followed by epidermal
Title,"""Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.""",https://pubmed.ncbi.nlm.nih.gov/35849035,randomize,randomized,newly diagnosed glioblastoma: a phase iii randomized clinical trial.
Abstract,"""Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial.""",https://pubmed.ncbi.nlm.nih.gov/35849035,harbor,harbor,newly diagnosed glioblastomas (gbms) harbor epidermal growth factor receptor gene
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,debate,debated,patients with glioblastoma is controversially debated.
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,influence,influence,"nature of glioblastoma, racial and socioeconomic factors influence glioblastoma-specific"
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,associate,associated,factors influence glioblastoma-specific and non-glioblastoma associated mortality.
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,associate,associated,non-glioblastoma associated mortality.
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,associate,associated,impact on glioblastoma-associated mortality independently of tumor and treatment related
Abstract,"""Racial and socioeconomic disparities differentially affect overall and cause-specific survival in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32617722,include,including,"non-glioblastoma mortality, including death from other cancers, cardio-"
Abstract,"""Analysis of the functional role of chromosome 10 loss in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/8104691,suggest,suggesting,in human glioblastoma multiforme suggesting the presence of a glioma-associated
Abstract,"""Predictive and prognostic factors for gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21554053,remain,remain,"and malignant glioblastoma, remain devastating tumors and need a better molecular"
Abstract,"""Predictive and prognostic factors for gliomas.""",https://pubmed.ncbi.nlm.nih.gov/21554053,refine,refines,unraveled new glioblastoma subgroups that further refines the molecular classification of these
Abstract,"""Additional genetic alterations in BRAF-mutant gliomas correlate with histologic diagnoses.""",https://pubmed.ncbi.nlm.nih.gov/33009979,show,showed,"mutations, glioblastomas showed concomitant mutations in tp53 (3/8),"
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,arise,arise,astrocytomas and glioblastomas multiforme) arise mostly either from the progression of
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,identify,identified,and seven glioblastomas multiforme) with their recurrences identified two distinct subgroups
Abstract,"""Comparative molecular genetic profiles of anaplastic astrocytomas/glioblastomas multiforme and their subsequent recurrences.""",https://pubmed.ncbi.nlm.nih.gov/10022821,have,have,between malignant glioblastomas and their subsequent recurrences may have important implications for
Abstract,"""Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.""",https://pubmed.ncbi.nlm.nih.gov/11446316,treat,treated,with a glioblastoma multiforme treated in an academic institute over the last
Abstract,"""Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.""",https://pubmed.ncbi.nlm.nih.gov/11446316,analyze,analyzed,pathologically confirmed glioblastoma multiforme were analyzed.
Abstract,"""Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution.""",https://pubmed.ncbi.nlm.nih.gov/11446316,improve,improved,with a glioblastoma multiforme has not improved in our institution.
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,glioblastomas may develop de novo (primary glioblastomas) or
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,constitute,constitute,subtypes of glioblastoma constitute distinct disease entities that evolve through different genetic
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,primary glioblastomas develop in older patients and typically show egfr overexpression
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,develop,develop,secondary glioblastomas develop in younger patients and often contain tp53 mutations
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,exist,exist,"subtypes of glioblastomas may exist with intermediate clinical and genetic profiles,"
Abstract,"""Primary and secondary glioblastomas: from concept to clinical diagnosis.""",https://pubmed.ncbi.nlm.nih.gov/11550301,occupy,occupies,-cell glioblastoma that clinically and genetically occupies a hybrid position between
Abstract,"""Cluster headache and parietal glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/22735247,present,present,parietal glioblastoma multiforme can present as ch.
Title,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,base,based,pathways to glioblastoma: a population-based study.
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,diagnose,diagnosed,", 715 glioblastomas were diagnosed."
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,prevail,prevailed,"novo) glioblastomas prevailed (95%), whereas secondary glioblastomas"
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,progress,progressed,whereas secondary glioblastomas that progressed from low-grade or anaplastic gliomas
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,characterize,characterized,secondary glioblastomas were characterized by frequent loh 10q (63%
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,distribute,distributed,"in primary glioblastomas, mutations were more equally distributed."
Abstract,"""Genetic pathways to glioblastoma: a population-based study.""",https://pubmed.ncbi.nlm.nih.gov/15466178,occur,occurs,in these glioblastoma subtypes occurs through different mechanisms.
Abstract,"""Primary glioblastomas and anaplastic astrocytoma in a glioma family.""",https://pubmed.ncbi.nlm.nih.gov/16678736,die,died,"with a glioblastoma, and a son who had died with a"
Abstract,"""Primary glioblastomas and anaplastic astrocytoma in a glioma family.""",https://pubmed.ncbi.nlm.nih.gov/16678736,kindre,kindred,primary' glioblastoma and anaplastic astrocytoma in the same kindred.
Title,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,predict,predicts,cpeb4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.
Abstract,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,evaluate,evaluated,98 primary glioblastomas) and evaluated its association with pathological grades and
Abstract,"""CPEB4 regulates glioblastoma cell proliferation and predicts poor outcome of patients.""",https://pubmed.ncbi.nlm.nih.gov/29642043,predict,predicting,in primary glioblastoma is a novel biomarker for predicting poor outcome of
Title,"""Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision.""",https://pubmed.ncbi.nlm.nih.gov/26306931,complicate,complicated,glioblastoma complicated by fatal malignant acute ischemic stroke: mri
Abstract,"""Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision.""",https://pubmed.ncbi.nlm.nih.gov/26306931,associate,associated,"cases, glioblastomas are associated with seizures, headaches, neurological deficits"
Abstract,"""Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision.""",https://pubmed.ncbi.nlm.nih.gov/26306931,produce,produced,frontotemporal enhancing glioblastoma with a perilesional edema which produced an important mass
Abstract,"""Glioblastoma complicated by fatal malignant acute ischemic stroke: MRI finding to assist in tricky surgical decision.""",https://pubmed.ncbi.nlm.nih.gov/26306931,complicate,complicated,"knowledge, glioblastomas complicated by fatal ischemic stroke have not been reported"
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,analyze,analyzed,6) glioblastomas were analyzed using quantitative real-time pcr and
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,compare,compared,in the glioblastoma specimens compared to the non-neoplastic brain tissue
Abstract,"""The role of sphingosine kinase isoforms and receptors S1P1, S1P2, S1P3, and S1P5 in primary, secondary, and recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/24903384,fold,fold,"and secondary glioblastomas, with values of up to 44-fold"
Abstract,"""Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/11563632,contain,contained,"%) glioblastoma tumor samples contained ink4b transcripts, but only nine"
Abstract,"""Alternative splicing of the p15 cdk inhibitor in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/11563632,result,resulting,"in some glioblastomas, resulting in combined loss of p16, p15"
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,report,reported,"metastasis to glioblastomas have been previously reported, but were unsupported by"
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,have,had,foci of glioblastoma and lung adenocarcinoma had the same kras mutation which
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,diagnose,diagnosed,"thus, glioblastoma with tumor-to-tumor metastasis was diagnosed"
Abstract,"""Glioblastoma with tumor-to-tumor metastasis from lung adenocarcinoma.""",https://pubmed.ncbi.nlm.nih.gov/31523853,occur,occur,"metastases to glioblastoma may occur, and they should be considered in"
Abstract,"""Pathological findings and prognostic factors in recurrent glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/22331317,affect,affected,features of glioblastomas are affected by tumor regrowth and the influence of
Abstract,"""Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?""",https://pubmed.ncbi.nlm.nih.gov/16896907,display,displayed,glioblastomas and metastases displayed either a type 1 or a
Abstract,"""Meningiomas with conventional MRI findings resembling intraaxial tumors: can perfusion-weighted MRI be helpful in differentiation?""",https://pubmed.ncbi.nlm.nih.gov/16896907,show,showed,of the glioblastomas or metastases showed a type 3 curve.
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,show,showed,-wildtype glioblastomas showed lower pfkfb3 to pfkfb4 mrna ratios (7.7:1
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,exhibit,exhibiting,-wildtype glioblastomas exhibiting loss of heterozygosity (loh) of the
Abstract,"""Prognostic Value of PFKFB3 to PFKFB4 mRNA Ratio in Patients With Primary Glioblastoma (IDH-Wildtype).""",https://pubmed.ncbi.nlm.nih.gov/31369092,represent,represent,wildtype primary glioblastoma and that pfkfb3 and pfkfb4 might represent promising targets
Abstract,"""Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/15986444,find,found,"overexpressed in glioblastomas but rarely found in normal tissue, ptn may"
Abstract,"""Prognostic relevance of epilepsy at presentation in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/26420896,think,thought,": epileptogenic glioblastomas are thought to convey a favorable prognosis, either"
Abstract,"""Prognostic relevance of epilepsy at presentation in glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/26420896,investigate,investigate,de novo glioblastoma between 2005 and 2013 in order to investigate the
Abstract,"""Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.""",https://pubmed.ncbi.nlm.nih.gov/10485462,find,found,grade (glioblastomas multiforme) tumors and found that insulin-like
Abstract,"""TERT Promoter Mutation Detection in Cell-Free Tumor-Derived DNA in Patients with IDH Wild-Type Glioblastomas: A Pilot Prospective Study.""",https://pubmed.ncbi.nlm.nih.gov/29941484,match,matched,plasma of glioblastoma patients.experimental design: matched csf and plasma samples were
Abstract,"""High intratumoral susceptibility signal grade on susceptibility-weighted imaging: a risk factor for hemorrhage after stereotactic biopsy.""",https://pubmed.ncbi.nlm.nih.gov/35561695,have,had,3 itss glioblastomas (66.7%) had postoperative hemorrhages > 10
Abstract,"""beta1 integrin targeting potentiates antiangiogenic therapy and inhibits the growth of bevacizumab-resistant glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/23644530,mediate,mediating,"-resistant glioblastomas (brg) whereby, mediating tumor-microenvironment"
Abstract,"""MGMT Testing in Glioblastomas: Pitfalls and Opportunities.""",https://pubmed.ncbi.nlm.nih.gov/30444735,predict,predicts,markers in glioblastomas as it not only predicts response to therapy but
Abstract,"""Inhibiting autophagy flux and DNA repair of tumor cells to boost radiotherapy of orthotopic glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/34864449,remain,remains,resistance of glioblastoma (gbm) remains a leading cause of radiotherapy
Abstract,"""Expression of vascular Notch ligands Delta-like 4 and Jagged-1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/22296176,use,using,on 40 glioblastomas and normal brain using validated antibodies against dll4 and
Title,"""Alpha Particle Enhanced Blood Brain/Tumor Barrier Permeabilization in Glioblastomas Using Integrin Alpha-v Beta-3-Targeted Liposomes.""",https://pubmed.ncbi.nlm.nih.gov/28619756,use,using,permeabilization in glioblastomas using integrin alpha-v beta-3-targeted liposomes
Title,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,have,has,upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,use,using,"including 8 glioblastomas and 4 anaplastic astrocytomas, using taqman real-"
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,multivariate,multivariate,of 39 glioblastoma patients by kaplan-meier method and multivariate analysis
Abstract,"""MiRNA-196 is upregulated in glioblastoma but not in anaplastic astrocytoma and has prognostic significance.""",https://pubmed.ncbi.nlm.nih.gov/20601442,suggest,suggested,profiles in glioblastomas and anaplastic astrocytomas suggested that 16 mirnas were candidate
Abstract,"""Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.""",https://pubmed.ncbi.nlm.nih.gov/32280134,characterize,characterized,"glioblastomas (gbms) are characterized by four subtypes,"
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,remain,remain,mechanisms in glioblastoma multiforme (gbm) remain unclear.
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,confer,confer,"expression in glioblastoma cells confer stronger ability of migration, invasion,"
Abstract,"""TPPP3 promote epithelial-mesenchymal transition via Snail1 in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37863960,provide,provides,"tppp3 in glioblastoma in the future, and provides new treatment and"
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,give,given,absent in glioblastoma given the lack of brain fibroblasts.
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,yield,yielded,trypsinization of glioblastoma specimens yielded cells with caf morphology and single-
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,confirm,confirmed,16 patient glioblastomas confirmed caf proximity to mesenchymal glioblastoma stem cells (
Abstract,"""Single-cell RNA sequencing and spatial transcriptomics reveal cancer-associated fibroblasts in glioblastoma with protumoral effects.""",https://pubmed.ncbi.nlm.nih.gov/36856115,make,making,"to identify glioblastoma cafs and their gsc interactions, making them an"
Abstract,"""Is there pseudoprogression in secondary glioblastomas?""",https://pubmed.ncbi.nlm.nih.gov/24267971,sgbm,sgbm,between primary glioblastomas and sgbm in particular as they relate to pp
Abstract,"""Analysis of the IDH1 codon 132 mutation in brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/18985363,characterize,characterized,primary glioblastomas and other entities were characterized by a low frequency
Abstract,"""Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/17048097,associate,associated,subsets of glioblastomas (gbm) associated with different molecular genetic profiles
Title,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,express,express,primary glioblastomas express mesenchymal stem-like properties.
Abstract,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,derive,derived,"in secondary glioblastoma (derived from lower-grade) tumors,"
Abstract,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,derive,derived,of primary glioblastoma tumors and their derived tumor lines express cellular and
Abstract,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,induce,induced,and that glioblastoma cell cultures can be induced to differentiate into multiple
Abstract,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,derive,derive,of primary glioblastomas derive from transformed stem cells containing msc-like
Abstract,"""Primary glioblastomas express mesenchymal stem-like properties.""",https://pubmed.ncbi.nlm.nih.gov/16966431,activate,activate,or that glioblastomas activate a series of genes that result in mesenchymal
Abstract,"""High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29236891,grade,grade,in 30 glioblastomas (who grade iv) and compared to 10
Abstract,"""High expression of XIAP and Bcl-2 may inhibit programmed cell death in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/29236891,compare,compared,in the glioblastoma samples compared to the control samples of normal brain
Title,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,depend,depends,mutation in glioblastomas depends on idh1 mutation.
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,treat,treated,histologically confirmed glioblastomas treated with radiation therapy and chemotherapy were reviewed retrospectively
Abstract,"""Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.""",https://pubmed.ncbi.nlm.nih.gov/25605197,improve,improved,indicate that glioblastomas with mgmt methylation or tp53 mutations have improved survival
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,understand,understood,' in glioblastoma patients are not fully understood.
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,identify,identify,"patients with glioblastomas, identify clinical predictors of a favorable prognosis,"
Abstract,"""[The phenomenon of long-term survival in glioblastoma patients. Part I: the role of clinical and demographic factors and an IDH1 mutation (R 132 H)].""",https://pubmed.ncbi.nlm.nih.gov/28665384,follow,follows,"diagnosis of glioblastoma were as follows: young age, the supratentorial"
Abstract,"""Loss of heterozygosity of microsatellite loci on chromosome 9p in astrocytic tumors and its prognostic implications.""",https://pubmed.ncbi.nlm.nih.gov/8864999,see,seen,"% in glioblastomas, while it was seen in only 8%"
Abstract,"""A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.""",https://pubmed.ncbi.nlm.nih.gov/21294158,contain,contain,glioblastomas contain stem-like cells that can be maintained
Abstract,"""A distinct subset of glioma cell lines with stem cell-like properties reflects the transcriptional phenotype of glioblastomas and overexpresses CXCR4 as therapeutic target.""",https://pubmed.ncbi.nlm.nih.gov/21294158,preserve,preserve,investigated whether glioblastoma stem-like (gs) cell lines preserve
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,constitute,constitute,"among which glioblastomas constitute the largest group, are characterized by a"
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,cure,cured,patient with glioblastoma multiforme (gbm) has been cured to date
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,exert,exerts,"to combat glioblastoma, and this drug exerts its cytotoxic activity through"
Abstract,"""Autophagy, the Trojan horse to combat glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16709038,radiotherapy,radiotherapy,resistance of glioblastoma to radiotherapy and proapoptotic-related chemotherapy.
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,monosomy,monosomy,karyotypes of glioblastomas are very complex with trisomy 7 and monosomy 10
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,arise,arising,"in secondary glioblastomas, the latter arising from preceding low-grade"
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,derive,derived,and secondary glioblastomas derived there- from.
Abstract,"""Concurrent EGFR amplification and TP-53 mutation in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/17907599,arise,arising,"of two glioblastomas, one case arising de novo and the other"
Title,"""Development of glioblastoma multiforme following traumatic cerebral contusion: case report and review of literature.""",https://pubmed.ncbi.nlm.nih.gov/14751638,follow,following,development of glioblastoma multiforme following traumatic cerebral contusion: case report and
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,characterize,characterized,"glioblastomas are characterized by transcriptionally distinct subtypes, but despite"
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,suppress,suppressed,in primary glioblastoma stem cell-like cultures suppressed known mesenchymal master
Abstract,"""Integrative Modeling Reveals Annexin A2-mediated Epigenetic Control of Mesenchymal Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27667176,validate,validate,that determines glioblastoma mesenchymal transformation and validate asics as a general methodology
Abstract,"""Noninvasive radiomics model reveals macrophage infiltration in glioma.""",https://pubmed.ncbi.nlm.nih.gov/37660885,cut,cut,) and glioblastomas (cut-off = 1.80) through three
Abstract,"""Parameters influencing the efficiency of the thymidine kinase/ganciclovir strategy in human glioblastoma cell lines.""",https://pubmed.ncbi.nlm.nih.gov/9711725,expect,expected,treating human glioblastomas has not been as effective as expected after the
Abstract,"""Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance.""",https://pubmed.ncbi.nlm.nih.gov/25978454,comprise,comprised,background: glioblastomas (gbm) are comprised of a heterogeneous population
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,have,have,"glioblastoma patients have poor prognosis, with an average survival"
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,remain,remain,"methods for glioblastoma, and its molecular mechanisms remain elusive."
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,base,based,pathways in glioblastoma patients based on gene expression and dna methylation datasets
Abstract,"""DNA Methylation-based Diagnostic and Prognostic Biomarkers for Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32510239,identify,identified,pathways in glioblastoma and identified four dna methylation-based biomarkers of
Title,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,support,support,glioblastoma hijacks microglial gene expression to support tumor growth.
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,communicate,communicate,"glioblastoma cells communicate with microglia, in part by releasing"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,continue,continue,"microglia in glioblastoma, the tumors continue to grow, and these"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,hijack,hijacked,"define a microgliaglioblastoma specific phenotype, whereby glioblastomas have hijacked gene expression"
Abstract,"""Glioblastoma hijacks microglial gene expression to support tumor growth.""",https://pubmed.ncbi.nlm.nih.gov/32299465,hijack,hijacked,", whereby glioblastomas have hijacked gene expression in the neuroimmune system to"
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,characterize,characterized,for mesenchymal glioblastomas characterized by a greater degree of aggressiveness compared to
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,remain,remain,progression of glioblastoma remain elusive posing a challenge for rationalization of aldh1a3
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,regulate,regulates,"targeting in glioblastoma, and it is also unclear how aldh1a3 regulates"
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,stemness,stemness,aldh1a3 regulates glioblastoma cells stemness.
Abstract,"""ALDH1A3 Contributes to Radiation-Induced Inhibition of Self-Renewal and Promotes Proliferative Activity of p53-Deficient Glioblastoma Stem Cells at the Onset of Differentiation.""",https://pubmed.ncbi.nlm.nih.gov/39513909,model,modelling,impacts on glioblastoma stem cells by modelling aldh1a3 expression in an otherwise
Title,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,innate,innate,talk between glioblastoma and innate immune cells by synthetic genetic tracing.
Abstract,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,exhibit,exhibits,glioblastoma is a lethal brain tumor that exhibits heterogeneity and
Abstract,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,construct,construct,we use glioblastoma subtype signatures to construct synthetic genetic tracing cassettes and
Abstract,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,drive,driven,whereas mesenchymal glioblastoma is an adaptive and metastable cell state driven by
Abstract,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,link,links,"in glioblastoma, the method causally links distinct (micro)environmental,"
Abstract,"""Phenotypic Mapping of Pathologic Cross-Talk between Glioblastoma and Innate Immune Cells by Synthetic Genetic Tracing.""",https://pubmed.ncbi.nlm.nih.gov/33361384,connect,connects,"in glioblastoma, synthetic genetic tracing causally connects cellular and molecular"
Title,"""Contrasts in Glioblastoma-Venous Thromboembolism versus Bleeding Risk.""",https://pubmed.ncbi.nlm.nih.gov/34200229,bleed,bleeding,contrasts in glioblastoma-venous thromboembolism versus bleeding risk.
Abstract,"""Contrasts in Glioblastoma-Venous Thromboembolism versus Bleeding Risk.""",https://pubmed.ncbi.nlm.nih.gov/34200229,find,find,patients with glioblastoma and to find appropriate biomarkers.
Abstract,"""Contrasts in Glioblastoma-Venous Thromboembolism versus Bleeding Risk.""",https://pubmed.ncbi.nlm.nih.gov/34200229,face,face,patients with glioblastoma not only face a high thromboembolic risk but are
Abstract,"""Contrasts in Glioblastoma-Venous Thromboembolism versus Bleeding Risk.""",https://pubmed.ncbi.nlm.nih.gov/34200229,remain,remains,"risk in glioblastoma patients, therapeutic anticoagulation remains challenging in this patient"
Title,"""Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.""",https://pubmed.ncbi.nlm.nih.gov/16951158,associate,associated,"in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase"
Abstract,"""Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.""",https://pubmed.ncbi.nlm.nih.gov/16951158,affect,affect,glioblastomas [glioblastoma multiforme (gbm)] and can affect up
Title,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,detect,detecting,mutated human glioblastoma: implications for detecting idh-mutated glioblastoma with
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,establish,established,marker in glioblastomas has been established.
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,classify,classified,glioblastomas are classified by their idh mutation status under the
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,establish,established,status in glioblastoma patients have not been established so far.
Abstract,"""Increased (14)C-acetate accumulation in IDH-mutated human glioblastoma: implications for detecting IDH-mutated glioblastoma with (11)C-acetate PET imaging.""",https://pubmed.ncbi.nlm.nih.gov/31667733,express,expressing,we established glioblastoma cells (u251) expressing idh1 r132h and examined
Title,"""Brain lipid binding protein mediates the proliferation of human glioblastoma cells by regulating ERK1/2 signaling pathway in vitro.""",https://pubmed.ncbi.nlm.nih.gov/29288341,regulate,regulating,of human glioblastoma cells by regulating erk1/2 signaling pathway in vitro.
Abstract,"""Brain lipid binding protein mediates the proliferation of human glioblastoma cells by regulating ERK1/2 signaling pathway in vitro.""",https://pubmed.ncbi.nlm.nih.gov/29288341,associate,associated,expression in glioblastoma is associated with poor survival and used a double
Abstract,"""Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33661425,grade,grade,update classifies glioblastomas (who grade iv) according to isocitrate dehydrogenase
Abstract,"""Fluid attenuation in non-contrast-enhancing tumor (nCET): an MRI Marker for Isocitrate Dehydrogenase (IDH) mutation in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/33661425,know,known,study included glioblastoma cases (n = 199) with known idh
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,grade,grade,% of glioblastomas (who grade iv).
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,developed,"in primary glioblastomas, which developed clinically de novo, and in"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,evolve,evolved,"in secondary glioblastomas, which evolved from low-grade (who"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,contain,contained,) primary glioblastomas contained a pten mutation and an additional case showed
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,show,showed,) primary glioblastomas showed both a pten mutation and egfr amplification.
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,contain,contained,") secondary glioblastomas contained a pten mutation, and none of them"
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,developed,the secondary glioblastoma with a pten mutation developed from an anaplastic astrocytoma
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,have,have,that secondary glioblastomas have a p53 mutation as a genetic hallmark but
Abstract,"""PTEN (MMAC1) mutations are frequent in primary glioblastomas (de novo) but not in secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9690672,develop,develop,and secondary glioblastomas develop differently on a genetic level.
Title,"""Glioblastoma-educated mesenchymal stem-like cells promote glioblastoma infiltration via extracellular matrix remodelling in the tumour microenvironment.""",https://pubmed.ncbi.nlm.nih.gov/35908277,educate,educated,glioblastoma-educated mesenchymal stem-like cells promote glioblastoma
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,contain,contain,fraction of glioblastoma may contain areas showing oligodendroglioma-like tumor cell
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,indicate,indicate,19q in glioblastoma indicate increased survival.
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,use,using,of 12 glioblastoma and 8 oligodendroglial tumors using fluorescence in situ hybridization
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,classify,classified,of 12 glioblastoma (16.7%) were classified as gbmo.
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,demonstrate,demonstrated,10 ordinary glioblastoma (10%) demonstrated 19q deletion with imbalance
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,show,showed,1 ordinary glioblastoma (90%) showed cdkn2a (p16)
Abstract,"""FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18095137,harbor,harboring,subtype of glioblastoma harboring a characteristic molecular profile.
Abstract,"""Epidermal growth factor receptor extracellular domain mutations in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/19284481,correlate,correlated,consecutive primary glioblastomas and correlated with clinical features of patients in order
Abstract,"""[A case report of interstitial pneumonia caused by granulocyte colony-stimulating factor].""",https://pubmed.ncbi.nlm.nih.gov/7509462,develop,developed,female with glioblastoma multiforme who developed interstitial pneumonia due to administration of
Abstract,"""Genetic pathways to primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17456751,constitute,constitute,"and secondary glioblastoma constitute distinct disease subtypes, affecting patients of different"
Abstract,"""Genetic pathways to primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17456751,develop,develop,"are primary glioblastomas that develop rapidly de novo, without clinical or"
Abstract,"""Genetic pathways to primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17456751,develop,develop,secondary glioblastomas develop through progression from low-grade diffuse astrocytoma
Abstract,"""Genetic pathways to primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17456751,accumulate,accumulate,"progression to glioblastoma, additional mutations accumulate, including loss of heterozygosity"
Abstract,"""Genetic pathways to primary and secondary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17456751,differ,differ,and secondary glioblastomas also differ significantly in their pattern of promoter methylation
Title,"""Global hypo-methylation in a proportion of glioblastoma enriched for an astrocytic signature is associated with increased invasion and altered immune landscape.""",https://pubmed.ncbi.nlm.nih.gov/36412091,enrich,enriched,proportion of glioblastoma enriched for an astrocytic signature is associated with increased
Title,"""Retinoblastoma protein regulates the crosstalk between autophagy and apoptosis, and favors glioblastoma resistance to etoposide.""",https://pubmed.ncbi.nlm.nih.gov/23949216,etoposide,etoposide,and favors glioblastoma resistance to etoposide.
Abstract,"""[Prognostic factors for deep situated malignant gliomas treated with linac radiosurgery].""",https://pubmed.ncbi.nlm.nih.gov/12508664,age,aged,"and 30 glioblastomas (gbm), aged from 7 to 70"
Abstract,"""Two tumor suppressive loci on chromosome 10 involved in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/7539279,result,resulted,into human glioblastoma cells resulted in suppression of their transformed and tumorigenic
Abstract,"""[A plasminogen regulation system in brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/28524122,brain,brain,"meningiomas, glioblastomas, and brain metastases of breast cancer, as"
Abstract,"""[A plasminogen regulation system in brain tumors].""",https://pubmed.ncbi.nlm.nih.gov/28524122,investigate,investigated,", 24 glioblastomas, and 13 meningiomas without perifocal edema were investigated"
Title,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,indicate,indicate,prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,apply,applied,parameters in glioblastomas that can be applied in the setting of a
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,study,studied,107 adult glioblastomas were studied.
Abstract,"""Histological indicators of prognosis in glioblastomas: retinoblastoma protein expression and oligodendroglial differentiation indicate improved survival.""",https://pubmed.ncbi.nlm.nih.gov/15186270,contain,containing,conclusions: glioblastomas containing areas of oligodendroglial differentiation or showing widespread immunocytochemical
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,have,have,"in particular glioblastomas, have a high morbidity and mortality, mainly"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,degrade,degraded,"upregulated in glioblastomas, can be degraded by certain proteases."
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,compare,compared,"expressions in glioblastomas in situ, compared to cultured human glioblastoma cells"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,derive,derived,"vitro, glioblastoma-derived adamts5 degrades recombinant human brevican to several"
Abstract,"""Matrix-degrading proteases ADAMTS4 and ADAMTS5 (disintegrins and metalloproteinases with thrombospondin motifs 4 and 5) are expressed in human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/16003758,contribute,contribute,on proliferating glioblastoma cells and these proteases may contribute to their invasive
Title,"""Glioblastoma hijacks neuronal mechanisms for brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/35914528,hijack,hijacks,glioblastoma hijacks neuronal mechanisms for brain invasion.
Abstract,"""Glioblastoma hijacks neuronal mechanisms for brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/35914528,infiltrate,infiltrating,glioblastomas are incurable tumors infiltrating the brain.
Abstract,"""Glioblastoma hijacks neuronal mechanisms for brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/35914528,form,forms,subpopulation of glioblastoma cells forms a functional and therapy-resistant tumor
Abstract,"""Glioblastoma hijacks neuronal mechanisms for brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/35914528,lack,lack,fueled by glioblastoma cells that lack connections with other tumor cells and
Abstract,"""Glioblastoma hijacks neuronal mechanisms for brain invasion.""",https://pubmed.ncbi.nlm.nih.gov/35914528,follow,followed,signals in glioblastoma cells followed by the de novo formation of tms
Title,"""Multi-platform molecular profiling of a large cohort of glioblastomas reveals potential therapeutic strategies.""",https://pubmed.ncbi.nlm.nih.gov/26933808,reveal,reveals,cohort of glioblastomas reveals potential therapeutic strategies.
Abstract,"""[Gross tumor volume (GTV) and clinical target volume (CTV) in adult gliomas].""",https://pubmed.ncbi.nlm.nih.gov/11715309,define,defined,"for glioblastoma multiform, the gtv can be defined by the"
Abstract,"""Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.""",https://pubmed.ncbi.nlm.nih.gov/28675164,compare,compare,"targets in glioblastoma, and compare the efficacy and toxicity of targeting"
Abstract,"""Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.""",https://pubmed.ncbi.nlm.nih.gov/28675164,affect,affect,changes of glioblastoma that can affect the use of adc-based
Abstract,"""Glioblastoma multiforme from diagnosis to death: a prospective, hospital-based, cohort, pilot feasibility study of patient reported symptoms and needs.""",https://pubmed.ncbi.nlm.nih.gov/25135840,have,have,purpose: glioblastoma (gbm) patients have many palliative care (
Abstract,"""Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24925914,find,found,"five primary glioblastomas, which we found to be inherently variable in"
Abstract,"""Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/24925914,express,expressed,that established glioblastoma subtype classifiers are variably expressed across individual cells within
Abstract,"""Oral prodromal signs of a central nervous system malignant neoplasm--glioblastoma multiforme: report of case.""",https://pubmed.ncbi.nlm.nih.gov/3011871,appear,appearing,"case of glioblastoma multiforme, initially appearing as orofacial pain of unknown"
Title,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,increase,increase,profile in glioblastoma and increase glioblastoma resistance to temozolomide.
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,remain,remains,"chemotherapy, glioblastoma remains incurable."
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,owe,owing,patients with glioblastoma relapse owing to various intrinsic and extrinsic resistance mechanisms
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,infiltrate,infiltrated,glioblastomas are densely infiltrated with tumour-associated microglia and
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,analyse,analysed,-derived glioblastoma spheroids with microglia at different tmz concentrations and analysed
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,include,including,"in the glioblastoma cells after co-culture with microglia, including"
Abstract,"""Microglia induce an interferon-stimulated gene expression profile in glioblastoma and increase glioblastoma resistance to temozolomide.""",https://pubmed.ncbi.nlm.nih.gov/39558550,correspond,corresponded,observed in glioblastoma cells with enhanced tmz resistance corresponded to the interferon
Abstract,"""Subclassification of newly diagnosed glioblastomas through an immunohistochemical approach.""",https://pubmed.ncbi.nlm.nih.gov/25546404,describe,described,signatures in glioblastoma (gbm) have been described that correlate with
Title,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,assess,assessed,"status in glioblastoma patients, assessed by five different methods."
Abstract,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,treat,treated,patients with glioblastomas treated by surgery and radiotherapy with concomitant temozolomide (
Abstract,"""Prognostic value of O6-methylguanine-DNA methyltransferase status in glioblastoma patients, assessed by five different methods.""",https://pubmed.ncbi.nlm.nih.gov/19841865,treat,treated,methylation in glioblastoma patients initially treated with tmz.
Abstract,"""Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28214089,consist,consisting,"of new glioblastoma patients, consisting of at least flair and t1"
Abstract,"""Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/28214089,have,have,a particular glioblastoma does not have a frontal lobe epicentre and has
Abstract,"""Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.""",https://pubmed.ncbi.nlm.nih.gov/10973261,term,termed,"slowly to glioblastoma (termed secondary glioblastomas, in contrast to primary"
Abstract,"""Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.""",https://pubmed.ncbi.nlm.nih.gov/10973261,develop,develop,"termed secondary glioblastomas, in contrast to primary glioblastomas that develop rapidly"
Abstract,"""Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.""",https://pubmed.ncbi.nlm.nih.gov/10973261,develop,develop,to primary glioblastomas that develop rapidly de novo).
Abstract,"""Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.""",https://pubmed.ncbi.nlm.nih.gov/10973261,model,model,"astrocytoma to glioblastoma multiforme, and may accurately model human secondary glioblastoma"
Abstract,"""Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects.""",https://pubmed.ncbi.nlm.nih.gov/10973261,involve,involving,human secondary glioblastoma involving tp53 loss.
Abstract,"""Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.""",https://pubmed.ncbi.nlm.nih.gov/23918605,remain,remained,survival in glioblastoma have remained largely obscure.
Abstract,"""Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.""",https://pubmed.ncbi.nlm.nih.gov/23918605,associate,associated,"in primary glioblastomas, and associated with longer survival."
Abstract,"""Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.""",https://pubmed.ncbi.nlm.nih.gov/23918605,have,had,"-mutant glioblastomas were younger, had almost no egfr amplifications,"
Abstract,"""Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.""",https://pubmed.ncbi.nlm.nih.gov/23918605,exhibit,exhibit,"-type glioblastomas, which exhibit typical molecular features of primary glioblastomas"
Abstract,"""Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.""",https://pubmed.ncbi.nlm.nih.gov/23918605,remain,remain,"of primary glioblastomas, beyond mgmt promoter methylation, remain to be"
Title,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,monitor,monitored,therapy of glioblastoma and can be monitored by mri.
Abstract,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,employ,employed,human g12 glioblastomas in nude mice and rat c6 glioblastomas were employed
Abstract,"""SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.""",https://pubmed.ncbi.nlm.nih.gov/27940247,employ,employed,rat c6 glioblastomas were employed as the animal models.
Abstract,"""Differential expression of MHC class II molecules by microglia and neoplastic astroglia: relevance for the escape of astrocytoma cells from immune surveillance.""",https://pubmed.ncbi.nlm.nih.gov/9775395,express,expressing,areas of glioblastomas where large numbers of cells expressing macrophage markers were
Abstract,"""Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry.""",https://pubmed.ncbi.nlm.nih.gov/29912767,test,tested,-wildtype glioblastomas and tested positive with ihc.
Abstract,"""Genetic Alterations of Epidermal Growth Factor Receptor in Glioblastoma: The Usefulness of Immunohistochemistry.""",https://pubmed.ncbi.nlm.nih.gov/29912767,reveal,revealed,-wildtype glioblastoma patients revealed that none of the egfr alterations significantly
Abstract,"""Earlier diagnosis of progressive disease during bevacizumab treatment using O-(2-18F-fluorethyl)-L-tyrosine positron emission tomography in comparison with magnetic resonance imaging.""",https://pubmed.ncbi.nlm.nih.gov/23759368,suggest,suggesting,in a glioblastoma patient during bevacizumab treatment suggesting an earlier diagnosis of
Title,"""Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/33405205,treat,treated,newly diagnosed glioblastoma patients treated with chemoradiotherapy.
Abstract,"""Predictive factors of human cytomegalovirus reactivation in newly diagnosed glioblastoma patients treated with chemoradiotherapy.""",https://pubmed.ncbi.nlm.nih.gov/33405205,treat,treated,reported in glioblastoma (gbm) patients treated with radio(chemo)therapy.
Abstract,"""Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.""",https://pubmed.ncbi.nlm.nih.gov/19221865,cause,cause,to treat glioblastomas may cause increased contrast enhancement on the first post
Abstract,"""Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression.""",https://pubmed.ncbi.nlm.nih.gov/19221865,treat,treated,scans in glioblastoma patients treated with radiation alone versus patients treated with
Abstract,"""FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32344293,show,showed,pilot study glioblastomas showed elevated tracer uptake with high intratumoral heterogeneity in
Abstract,"""FAP-specific PET signaling shows a moderately positive correlation with relative CBV and no correlation with ADC in 13 IDH wildtype glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32344293,perform,performed,of 13 glioblastoma patients were performed post i. v. administration of 68ga
Abstract,"""Positive CSF HSV PCR in patients with GBM: a note of caution.""",https://pubmed.ncbi.nlm.nih.gov/10680817,have,had,temporal lobe glioblastomas had herpes simplex (hsv) dna detected in
Abstract,"""Survival prognostic factors in patients with glioblastoma: our experience.""",https://pubmed.ncbi.nlm.nih.gov/22854592,kps,kps,patients with glioblastoma in addition to age and kps score.
Abstract,"""Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26501438,seem,seems,-expressing glioblastomas seems to be relatively high in comparison to other
Abstract,"""Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26501438,vary,vary,rates of glioblastomas with pd-l1 protein expression vary and range
Abstract,"""Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26501438,utilize,utilized,"assessment in glioblastoma across studies with heterogeneity in utilized antibodies, tissue"
Abstract,"""Clinical Neuropathology mini-review 6-2015: PD-L1: emerging biomarker in glioblastoma?""",https://pubmed.ncbi.nlm.nih.gov/26501438,need,need,inhibitors in glioblastoma need to be complemented with well designed and stringently
Abstract,"""Nano delivery of natural substances as prospective autophagy modulators in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/32702467,review,reviewed,modulators in glioblastoma are prudently reviewed in this article.
Abstract,"""Evaluation of Microvascular Density in Glioblastomas in Relation to p53 and Ki67 Immunoexpression.""",https://pubmed.ncbi.nlm.nih.gov/38928515,use,using,"and secondary glioblastomas using immunohistochemical markers cd34 and cd105, respectively,"
Abstract,"""Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16454748,treat,treated,"patients with glioblastoma treated by surgery, radiotherapy and chemotherapy is in"
Abstract,"""Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16454748,associate,associated,"most prominent glioblastoma-associated immunosuppressant is the cytokine, transforming growth"
Abstract,"""Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/16454748,employ,employing,"treatment of glioblastoma, employing antisense strategies, inhibition of pro-"
Abstract,"""Effect of carbogen breathing on the radiation response of a human glioblastoma xenograft: analysis of hypoxia and vascular parameters of regrowing tumors.""",https://pubmed.ncbi.nlm.nih.gov/16826360,implant,implanted,a human glioblastoma xenograft tumor line was implanted in nude mice.
Abstract,"""Thalamic glioblastoma with cerebrospinal fluid dissemination in the peritoneal cavity.""",https://pubmed.ncbi.nlm.nih.gov/10681678,undergo,underwent,of thalamic glioblastoma with hydrocephalus who underwent biventriculoperitoneal shunting before tumour decompression
Title,"""Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost.""",https://pubmed.ncbi.nlm.nih.gov/7791979,treat,treated,patients with glioblastoma treated with radiotherapy and brachytherapy boost.
Abstract,"""Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost.""",https://pubmed.ncbi.nlm.nih.gov/7791979,undergo,underwent,with primary glioblastoma multiforme underwent high-activity iodine-125 brain implant boost
Title,"""Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.""",https://pubmed.ncbi.nlm.nih.gov/10433932,associate,associated,of the glioblastoma phenotype during astrocytoma progression is associated with loss of
Abstract,"""Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.""",https://pubmed.ncbi.nlm.nih.gov/10433932,occur,occurs,alteration in glioblastomas and occurs in more than 80% of cases
Abstract,"""Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.""",https://pubmed.ncbi.nlm.nih.gov/10433932,progress,progressed,novo) glioblastomas but rarely in secondary glioblastomas that progressed from low
Abstract,"""Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.""",https://pubmed.ncbi.nlm.nih.gov/10433932,progress,progressed,in secondary glioblastomas that progressed from low-grade or anaplastic astrocytomas
Abstract,"""Acquisition of the glioblastoma phenotype during astrocytoma progression is associated with loss of heterozygosity on 10q25-qter.""",https://pubmed.ncbi.nlm.nih.gov/10433932,show,show,"because secondary glioblastomas also show loh#10, tumor suppressor genes other than"
Title,"""EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-kappaB/ALDH1A3 Axis.""",https://pubmed.ncbi.nlm.nih.gov/36980923,reduce,reduces,transition of glioblastoma multiforme and reduces its sensitivity to temozolomide by regulating
Title,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,correlate,correlates,p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic
Abstract,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,determine,determined,assayed primary glioblastomas for expression and subcellular localization of p53 and determined
Abstract,"""Cytoplasmic localization of wild-type p53 in glioblastomas correlates with expression of vimentin and glial fibrillary acidic protein.""",https://pubmed.ncbi.nlm.nih.gov/12084347,correlate,correlates,"human primary glioblastomas correlates with a certain intermediate filament protein expression,"
Abstract,"""Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.""",https://pubmed.ncbi.nlm.nih.gov/31151460,identify,identify,nscs and glioblastoma cscs to identify copy number dependent and independent differentially
Abstract,"""Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.""",https://pubmed.ncbi.nlm.nih.gov/31151460,account,accounted,nscs and glioblastoma cscs is largely accounted for by copy number alterations
Abstract,"""Single-cell RNA sequencing reveals the impact of chromosomal instability on glioblastoma cancer stem cells.""",https://pubmed.ncbi.nlm.nih.gov/31151460,correlate,correlates,number in glioblastoma cscs correlates with tumor grade and is prognostic for
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,know,known,", ptertwt glioblastomas are not well known."
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,perform,performed,", ptertwt glioblastomas and performed methylation profiling, targeted sequencing, and"
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,suggest,suggesting,"mut) glioblastomas, suggesting that ptert mutation on its own is"
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,show,show,", ptertwt glioblastomas show epigenetic clustering different from idhwt, ptertmut glioblastomas"
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,idhwt,idhwt,", ptertmut glioblastomas, and idhwt glioblastomas which are ptertwt may however"
Abstract,"""Molecular landscape of IDH-wild type, pTERT-wild type adult glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/35815721,show,show,and idhwt glioblastomas which are ptertwt may however not show egfr amplification
Abstract,"""p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11511795,observe,observed,immunopositivities in glioblastomas was observed in 83.3% of the cases.
Abstract,"""p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11511795,lack,lacked,% of glioblastomas with p53 immuno-positivities lacked the relevant mutations
Abstract,"""p53 mutation and epidermal growth factor receptor overexpression in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11511795,observe,observed,immunopositivity in glioblastomas was observed in 91.7% of the cases.
Abstract,"""Short-term survivors in glioblastomas with oligodendroglioma component: a clinical study of 186 Chinese patients from a single institution.""",https://pubmed.ncbi.nlm.nih.gov/24264532,enrol,enrolled,"and 110 glioblastoma multiforme (gbm), enrolled in the study"
Abstract,"""Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/25164322,assess,assessed,"when only glioblastomas were assessed, patients with positive polysia had significantly"
Abstract,"""Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.""",https://pubmed.ncbi.nlm.nih.gov/25164322,assess,assessed,grade iv glioblastomas assessed separately.
Abstract,"""Dexamethasone-induced leukocytosis is associated with poor survival in newly diagnosed glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29349612,describe,describe,"newly diagnosed glioblastoma to describe the incidence, risk factors and clinical"
Abstract,"""The natural history of extracranial metastasis from glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/21512826,disseminate,disseminated,arise from glioblastoma cells disseminated into the blood stream.
Abstract,"""The natural history of extracranial metastasis from glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/21512826,publish,published,of extracranial glioblastoma (5 were gliosarcomas) published between 1928 and
Abstract,"""The natural history of extracranial metastasis from glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/21512826,invade,invaded,or secondary glioblastomas that subsequently invaded organs outside the brain or spinal
Abstract,"""The natural history of extracranial metastasis from glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/21512826,have,have,"patients with glioblastoma extracranial metastasis have poor prognosis, but there has"
Abstract,"""Comparative epidemiology of gliosarcoma and glioblastoma and the impact of Race on overall survival: A systematic literature review.""",https://pubmed.ncbi.nlm.nih.gov/32650210,account,accounts,subtype of glioblastoma (gbm) that accounts for approximately four percent
Title,"""Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/9619833,induce,induced,human malignant glioblastoma cells to cisplatin-induced apoptosis.
Abstract,"""Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis.""",https://pubmed.ncbi.nlm.nih.gov/9619833,grow,grow,malignant glioblastomas grow very rapidly and are generally resistant to either
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,represent,representing,"glioblastoma multiforme, representing about 50% of all gliomas"
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,appear,appearing,"glioblastoma, while sometimes appearing as a distinct 'primary"
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,confirm,confirmed,of most glioblastomas has been confirmed by ultrastructural studies and progressive differentiation
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,progress,progress,"feature of glioblastoma, may occasionally progress to sarcomatous transformation with development"
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,continue,continuing,view that glioblastoma results from neoplastic transformation of glial elements with continuing
Abstract,"""Glioblastoma multiforme: morphology and biology.""",https://pubmed.ncbi.nlm.nih.gov/211808,influence,influence,immunotherapy of glioblastoma only influence the final stages of neoplastic development with
Title,"""Outcome prediction in patients with glioblastoma by using imaging, clinical, and genomic biomarkers: focus on the nonenhancing component of the tumor.""",https://pubmed.ncbi.nlm.nih.gov/24646147,use,using,"patients with glioblastoma by using imaging, clinical, and genomic biomarkers"
Abstract,"""Analysis of Connexin 43 and Spermine Co-localisation in Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/39400836,reveal,revealing,"spermine within glioblastoma, revealing that tumour processes housing the polyamine indeed"
Abstract,"""Invasiveness in vitro and biological markers in human primary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11763417,preculture,precultured,human primary glioblastomas into precultured fetal rat brain tissue in culture has
Abstract,"""[Expression absence of LRRC4 gene in glioblastoma cell lines].""",https://pubmed.ncbi.nlm.nih.gov/17478928,offer,offers,"absent in glioblastoma cell lines, and it offers the important experiment"
Abstract,"""Second primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11273008,consider,considered,"alterations, glioblastomas are considered monoclonal in origin."
Abstract,"""Second primary glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/11273008,contain,contained,"the second glioblastoma also contained multiple, but different mutations: p53"
Abstract,"""Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25130928,analyze,analyzed,with primary glioblastomas were retrospectively analyzed.
Abstract,"""Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25130928,demonstrate,demonstrated,-type glioblastomas were demonstrated using this approach.
Abstract,"""Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25130928,locate,located,-mutated glioblastomas were preferentially located in the frontal lobe in the
Abstract,"""Anatomical localization of p53 mutated tumors: A radiographic study of human glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/25130928,provide,provide,-type glioblastomas provide further evidence that these gliomas arise from distinct
Abstract,"""Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.""",https://pubmed.ncbi.nlm.nih.gov/18663354,characterize,characterized,as glioblastomas are characterized by high expression levels of anti-
Abstract,"""Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.""",https://pubmed.ncbi.nlm.nih.gov/18663354,investigate,investigated,"treatment in glioblastomas, we investigated the effects of abt-737 on the"
Abstract,"""Integration of MicroRNA, mRNA, and Protein Expression Data for the Identification of Cancer-Related MicroRNAs.""",https://pubmed.ncbi.nlm.nih.gov/28056026,rank,ranked,"approaches to glioblastomas (gbms), ranked mirnas depending on their"
Title,"""Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.""",https://pubmed.ncbi.nlm.nih.gov/28459367,synthesize,synthesized,glioblastoma-synthesized g-csf and gm-csf
Abstract,"""Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.""",https://pubmed.ncbi.nlm.nih.gov/28459367,synthesize,synthesize,glioblastoma cells themselves also synthesize g(m)-csf.
Abstract,"""Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.""",https://pubmed.ncbi.nlm.nih.gov/28459367,promote,promoting,deprive a glioblastoma of some of the growth promoting contributions of bone
Title,"""Marked functional improvement after combined chemoradiotherapy for cervical spine glioblastoma causing quadriparesis in an adolescent.""",https://pubmed.ncbi.nlm.nih.gov/24518393,cause,causing,cervical spine glioblastoma causing quadriparesis in an adolescent.
Abstract,"""[Mechanism of antisense epidermal growth factor receptor cDNA in growth suppression of glioblastomas cells].""",https://pubmed.ncbi.nlm.nih.gov/12882691,express,express,"methods: glioblastoma u87mg cells, which over-express epidermal"
Abstract,"""MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/25114226,infiltrate,infiltrate,"glioblastomas (gbms) diffusely infiltrate the brain, making"
Title,"""Traumatic glioblastoma: commentary and suggested mechanism.""",https://pubmed.ncbi.nlm.nih.gov/29708004,suggest,suggested,traumatic glioblastoma: commentary and suggested mechanism.
Abstract,"""Traumatic glioblastoma: commentary and suggested mechanism.""",https://pubmed.ncbi.nlm.nih.gov/29708004,minimize,minimized,development of glioblastoma is highly controversial and has been minimized since first
Abstract,"""Traumatic glioblastoma: commentary and suggested mechanism.""",https://pubmed.ncbi.nlm.nih.gov/29708004,suggest,suggested,injury and glioblastoma is suggested; this role may support a cause
Abstract,"""Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/9301196,match,matched,and 11 glioblastomas) and matched normal brain tissues.
Title,"""The role of neurotransmitters in glioblastoma multiforme-associated seizures.""",https://pubmed.ncbi.nlm.nih.gov/37563091,associate,associated,neurotransmitters in glioblastoma multiforme-associated seizures.
Abstract,"""The role of neurotransmitters in glioblastoma multiforme-associated seizures.""",https://pubmed.ncbi.nlm.nih.gov/37563091,pose,poses,", or glioblastoma multiforme, is a brain tumor that poses a"
Title,"""Recycling drug screen repurposes hydroxyurea as a sensitizer of glioblastomas to temozolomide targeting de novo DNA synthesis, irrespective of molecular subtype.""",https://pubmed.ncbi.nlm.nih.gov/29099956,target,targeting,"sensitizer of glioblastomas to temozolomide targeting de novo dna synthesis, irrespective"
Abstract,"""Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.""",https://pubmed.ncbi.nlm.nih.gov/28963609,influence,influence,irinotecan and glioblastoma cell levels of timp-1 could therefore potentially influence the
Abstract,"""Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.""",https://pubmed.ncbi.nlm.nih.gov/28963609,affect,affect,expression in glioblastoma cell lines would affect the sensitivity to top inhibitors
Abstract,"""Overexpression of TIMP-1 and Sensitivity to Topoisomerase Inhibitors in Glioblastoma Cell Lines.""",https://pubmed.ncbi.nlm.nih.gov/28963609,remain,remains,potential in glioblastoma patients remains to be elucidated.
Abstract,"""miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/20665731,understand,understood,apoptosis of glioblastoma are not completely understood.
Abstract,"""Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review.""",https://pubmed.ncbi.nlm.nih.gov/21468776,give,given,those with glioblastoma multiforme (gbm) given its dismal prognosis despite
Title,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,optimize,optimized,glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,base,based,to optimize glioblastoma therapy based on the use of genetically modified hamscs
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,express,expressing,glioblastoma u87 cells expressing photinus pyralis luciferase (pluc)
Abstract,"""Glioblastoma therapy with cytotoxic mesenchymal stromal cells optimized by bioluminescence imaging of tumor and therapeutic cell response.""",https://pubmed.ncbi.nlm.nih.gov/22529983,follow,following,therapy to glioblastoma surgical borders following tumor resection.
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,develop,develop,majority of glioblastomas develop rapidly with a short clinical history (primary
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,develop,develop,"giant cell glioblastomas are rare histological glioblastoma variants, which usually develop"
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,develop,develop,"rare histological glioblastoma variants, which usually develop rapidly."
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,analyze,analyzed,"giant cell glioblastomas analyzed, indicating that they are histological variants of"
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,have,had,giant cell glioblastomas had loh 10q in 50% and loh 19q
Abstract,"""Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/26443480,occupy,occupies,giant cell glioblastoma occupies a hybrid position between primary and secondary glioblastomas
Abstract,"""An Overview of CD133 as a Functional Unit of Prognosis and Treatment Resistance in Glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/37754516,lack,lacking,"resistance in glioblastoma multiforme (gbm) are lacking, and progress"
Abstract,"""Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29264835,associate,associated,variant of glioblastoma traditionally associated with a poor prognosis.
Abstract,"""Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29264835,support,supporting,"used in glioblastoma, supporting evidence is limited given its rarity."
Abstract,"""Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29264835,diagnose,diagnosed,to 451 glioblastoma patients diagnosed during the same era within the same
Abstract,"""Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/29264835,observe,observed,gliosarcoma and glioblastoma was observed across the entire cohort (11.0 vs.
Abstract,"""Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro.""",https://pubmed.ncbi.nlm.nih.gov/11781071,promise,promising,strategies against glioblastomas have been promising both in vitro and in animal
Abstract,"""Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro.""",https://pubmed.ncbi.nlm.nih.gov/11781071,passage,passaged,"used human glioblastoma cell lines passaged in vitro, which may not"
Abstract,"""Changes in the immunologic phenotype of human malignant glioma cells after passaging in vitro.""",https://pubmed.ncbi.nlm.nih.gov/11781071,culture,culturing,phenotype of glioblastomas after in vitro culturing may in part explain the
Abstract,"""Genetics of glioblastoma: a window into its imaging and histopathologic variability.""",https://pubmed.ncbi.nlm.nih.gov/21997991,defy,defies,glioblastoma is a highly malignant brain tumor that relentlessly defies
Abstract,"""Genetics of glioblastoma: a window into its imaging and histopathologic variability.""",https://pubmed.ncbi.nlm.nih.gov/21997991,target,targeted,"patients with glioblastoma, in the form of targeted, molecularly based"
Abstract,"""Genetics of glioblastoma: a window into its imaging and histopathologic variability.""",https://pubmed.ncbi.nlm.nih.gov/21997991,understand,understanding,) in glioblastomas is important as a basis for understanding imaging findings
Abstract,"""Increased microglia proliferation separates pilocytic astrocytomas from diffuse astrocytomas: a double labeling study.""",https://pubmed.ncbi.nlm.nih.gov/11307624,proliferate,proliferating,astrocytomas and glioblastomas the percentage of proliferating microglia showed a slight increase
Abstract,"""Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17342095,characterise,characterised,glioblastoma multiforme is characterised by invasive growth and frequent recurrence
Abstract,"""Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17342095,embed,embedded,term surviving glioblastoma patient together with paraffin-embedded materials of five
Abstract,"""Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17342095,characterise,characterised,"of five glioblastoma patients, both characterised by enhanced survival time,"
Abstract,"""Dynamics of chemosensitivity and chromosomal instability in recurrent glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/17342095,relapse,relapse,that pretreated glioblastoma patients may relapse with highly chemosensitive tumours confirming the
Title,"""Molecular genetics of glioblastomas: defining subtypes and understanding the biology.""",https://pubmed.ncbi.nlm.nih.gov/25476515,define,defining,genetics of glioblastomas: defining subtypes and understanding the biology.
Abstract,"""Pyk2/FAK Signaling Is Upregulated in Recurrent Glioblastoma Tumors in a C57BL/6/GL261 Glioma Implantation Model.""",https://pubmed.ncbi.nlm.nih.gov/37686276,recur,recur,majority of glioblastomas (gbms) recur shortly after tumor resection and
Abstract,"""Congenital glioblastoma multiforme: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/18504417,have,has,congenital glioblastoma multiforme is a rare primary brain tumor that has
Abstract,"""Congenital glioblastoma multiforme: case report and review of the literature.""",https://pubmed.ncbi.nlm.nih.gov/18504417,include,included,congenital glioblastoma should be included in the differential diagnosis of infants
Abstract,"""System-based approaches as prognostic tools for glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/31718568,diagnose,diagnosed,influence how glioblastoma is diagnosed and treated in the future.
Abstract,"""Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.""",https://pubmed.ncbi.nlm.nih.gov/27766560,report,reported,changes in glioblastomas has been previously reported to predict survival.
Abstract,"""Dynamics of FLAIR Volume Changes in Glioblastoma and Prediction of Survival.""",https://pubmed.ncbi.nlm.nih.gov/27766560,follow,followed,newly diagnosed glioblastoma followed by the stupp protocol between 2010 and 2013
Abstract,"""Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11701945,characterize,characterized,glioblastoma multiforme (gbm) is characterized by intratumoral heterogeneity
Abstract,"""Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11701945,characterize,characterized,conclude that glioblastoma cells in vivo are characterized by an extensive tendency
Abstract,"""Frequent mitotic errors in tumor cells of genetically micro-heterogeneous glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/11701945,preserve,preserve,ability of glioblastomas to preserve viable tumor cell clones under adaptive stress
Abstract,"""miR-143 inhibits glycolysis and depletes stemness of glioblastoma stem-like cells.""",https://pubmed.ncbi.nlm.nih.gov/23376635,rely,rely,glioblastomas rely mainly on aerobic glycolysis to sustain proliferation and
Abstract,"""Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.""",https://pubmed.ncbi.nlm.nih.gov/38631135,aim,aimed,124 sequential glioblastomas from a tertiary hospital and aimed to find correlations
Abstract,"""Molecular characterization and survival analysis of a cohort of glioblastoma, IDH-wildtype.""",https://pubmed.ncbi.nlm.nih.gov/38631135,prompt,prompting,"landscape of glioblastomas, prompting further investigations to examine these findings more"
Abstract,"""Glioblastoma multiforme with bone metastase and cauda equina syndrome.""",https://pubmed.ncbi.nlm.nih.gov/2162916,operate,operated,patient with glioblastoma multiforme who was operated and subsequently received radiation therapy
Abstract,"""Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.""",https://pubmed.ncbi.nlm.nih.gov/15857987,prove,proven,classified as glioblastomas have proven refractory to treatment and generally result in
Abstract,"""Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential.""",https://pubmed.ncbi.nlm.nih.gov/15857987,isolate,isolated,"passaged on glioblastoma cells; we isolated a variant, vsv-"
Abstract,"""[Genetic and molecular abnormalities of glioblastomas (GBM)].""",https://pubmed.ncbi.nlm.nih.gov/21084244,result,resulting,characterize primary glioblastomas and secondary glioblastomas resulting from the transformation of low
Abstract,"""[Genetic and molecular abnormalities of glioblastomas (GBM)].""",https://pubmed.ncbi.nlm.nih.gov/21084244,result,resulting,and secondary glioblastomas resulting from the transformation of low grade tumors (
Abstract,"""Glioblastoma in adults with neurofibromatosis type I: A report of two cases.""",https://pubmed.ncbi.nlm.nih.gov/31436000,occur,occurring,cases of glioblastomas occurring in adults with nf1 and briefly review the
Title,"""Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth.""",https://pubmed.ncbi.nlm.nih.gov/35478054,exhibit,exhibiting,the u87 glioblastoma cell line while exhibiting minor or moderate effects on
Abstract,"""Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth.""",https://pubmed.ncbi.nlm.nih.gov/35478054,exhibit,exhibited,"of u87 glioblastoma cells, in combinations they exhibited a synergistic effect"
Abstract,"""Unique combinations of epigenetic modifiers synergistically impair the viability of the U87 glioblastoma cell line while exhibiting minor or moderate effects on normal stem cell growth.""",https://pubmed.ncbi.nlm.nih.gov/35478054,exhibit,exhibiting,the u87 glioblastoma cells while exhibiting minor or moderate effects on normal
Abstract,"""Transcription factor NRF2 uses the Hippo pathway effector TAZ to induce tumorigenesis in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/31918259,induce,inducing,gliomas and glioblastomas by inducing the expression of the transcriptional co-
Title,"""Incorporating Supramaximal Resection into Survival Stratification of IDH-wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis.""",https://pubmed.ncbi.nlm.nih.gov/38829906,partition,partitioning,-wildtype glioblastoma: a refined multi-institutional recursive partitioning analysis
Abstract,"""Incorporating Supramaximal Resection into Survival Stratification of IDH-wildtype Glioblastoma: A Refined Multi-institutional Recursive Partitioning Analysis.""",https://pubmed.ncbi.nlm.nih.gov/38829906,incorporate,incorporates,-wildtype glioblastomas that incorporates the recently expanded conception of the extent
Abstract,"""Transtentorial dissemination of optic nerve glioblastoma: case report.""",https://pubmed.ncbi.nlm.nih.gov/28298017,present,presents,optic nerve glioblastoma is a rare entity that usually presents with rapidly
Abstract,"""Transtentorial dissemination of optic nerve glioblastoma: case report.""",https://pubmed.ncbi.nlm.nih.gov/28298017,render,render,"optic nerve glioblastoma may render diagnosis challenging and, thus, delay"
Abstract,"""Transtentorial dissemination of optic nerve glioblastoma: case report.""",https://pubmed.ncbi.nlm.nih.gov/28298017,treat,treated,optic nerve glioblastoma that was treated with subtotal resection followed by adjuvant
Title,"""Tumor associated seizures in glioblastomas are influenced by survival gene expression in a region-specific manner: a gene expression imaging study.""",https://pubmed.ncbi.nlm.nih.gov/24690158,influence,influenced,seizures in glioblastomas are influenced by survival gene expression in a region
Abstract,"""The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.""",https://pubmed.ncbi.nlm.nih.gov/26546995,analyze,analyzed,from 61 glioblastomas were analyzed using immunohistochemistry for dll4/jag1 expression
Abstract,"""NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/36333468,improve,improving,resistance in glioblastoma (gbm) is an essential strategy for improving
Title,"""[Glioblastoma revealed by strabismus].""",https://pubmed.ncbi.nlm.nih.gov/25478057,reveal,revealed,[glioblastoma revealed by strabismus].
Abstract,"""Sudden, unexpected death due to undiagnosed frontal glioblastoma in a schizophrenic patient.""",https://pubmed.ncbi.nlm.nih.gov/16191472,infiltrate,infiltrating,bilateral frontal glioblastoma infiltrating the genu of corpus callosum.
Abstract,"""Stereotactic radiosurgery for IDH wild type glioblastoma: an international, multicenter study.""",https://pubmed.ncbi.nlm.nih.gov/34797526,pool,pooled,-wt glioblastoma were pooled for this retrospective observational international multi-
Title,"""Treatment of novel IL17A inhibitor in glioblastoma implementing 3rd generation co-culture cell line and patient-derived tumor model.""",https://pubmed.ncbi.nlm.nih.gov/28322833,implement,implementing,inhibitor in glioblastoma implementing 3rd generation co-culture cell line and
Abstract,"""Transformation of low grade glioma and correlation with outcome: an NCCTG database analysis.""",https://pubmed.ncbi.nlm.nih.gov/21153680,originate,originate,glioblastomas (gbm) may originate de novo (primary
Title,"""Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10029095,pair,paired,de novo glioblastomas and paired astrocytic tumors.
Abstract,"""Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10029095,display,displays,glioblastoma multiforme (gbm) often displays morphological heterogeneity in
Abstract,"""Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10029095,exhibit,exhibited,"de novo glioblastomas exhibited numerous genetic aberrations, the proportion of which"
Abstract,"""Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10029095,compare,compared,de novo glioblastoma are genetically closer to each other compared with paired
Abstract,"""Molecular analysis of microdissected de novo glioblastomas and paired astrocytic tumors.""",https://pubmed.ncbi.nlm.nih.gov/10029095,exhibit,exhibited,de novo glioblastomas exhibited egfr amplification while a high proportion (62
Abstract,"""Identification of crucial parameters in a mathematical multiscale model of glioblastoma growth.""",https://pubmed.ncbi.nlm.nih.gov/24899919,cover,covers,model of glioblastoma progression that covers processes on the cellular and molecular
Title,"""Chemoresistance caused by the microenvironment of glioblastoma and the corresponding solutions.""",https://pubmed.ncbi.nlm.nih.gov/30391707,correspond,corresponding,microenvironment of glioblastoma and the corresponding solutions.
Abstract,"""A Novel Theranostic Strategy for MMP-14-Expressing Glioblastomas Impacts Survival.""",https://pubmed.ncbi.nlm.nih.gov/28659432,have,has,glioblastoma (gbm) has a dismal prognosis.
Abstract,"""Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9341929,develop,develop,primary glioblastomas develop rapidly de novo through a genetic pathway characterized
Abstract,"""Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9341929,develop,develop,secondary glioblastomas develop more slowly through progression from low grade or
Abstract,"""Alterations of cell cycle regulatory genes in primary (de novo) and secondary glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/9341929,analyze,analyzed,and secondary glioblastomas were analyzed for p16 deletions and cdk4 amplification by
Abstract,"""Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25215581,nf,nf,"observed in glioblastomas, while nf-Îºb inhibitor alpha (nfkbia"
Abstract,"""Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25215581,understand,understood,nfkbia to glioblastomas is poorly understood.
Abstract,"""Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25215581,find,found,nfkbia in glioblastoma and found that it was more frequently present in
Abstract,"""Identification of a NFKBIA polymorphism associated with lower NFKBIA protein levels and poor survival outcomes in patients with glioblastoma multiforme.""",https://pubmed.ncbi.nlm.nih.gov/25215581,provide,provide,"nfkbia in glioblastoma patients, we provide a new platform for further"
Abstract,"""A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27588397,have,has,glioblastoma is the most malignant tumor and has high mortality
Abstract,"""A three-gene signature for prognosis in patients with MGMT promoter-methylated glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/27588397,base,based,-methylated glioblastomas based on bioinformatics analysis.
Abstract,"""Effect of hyperthermia on intracellular pH in human U-87 MG glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/7478437,study,studied,"u-87 mg glioblastoma cells was studied by using the fluorescent probe 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein"
Abstract,"""Spectroscopic Characterization of Gliosarcomas-Do They Differ From Glioblastomas and Metastases?""",https://pubmed.ncbi.nlm.nih.gov/27560009,show,showed,glioblastomas showed higher creatine concentrations compared with metastases (p
Title,"""Gene expression profiles of human glioblastomas are associated with both tumor cytogenetics and histopathology.""",https://pubmed.ncbi.nlm.nih.gov/20484145,associate,associated,of human glioblastomas are associated with both tumor cytogenetics and histopathology.
Abstract,"""Expression of variant CD44 epitopes in human astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/8750182,grade,grade,"and 10 glioblastomas, who grade iv) and in cell lines"
Abstract,"""Expression of variant CD44 epitopes in human astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/8750182,express,expressed,", all glioblastomas expressed cd44 variants whereas expression in astrocytomas who grade"
Abstract,"""Expression of variant CD44 epitopes in human astrocytic brain tumors.""",https://pubmed.ncbi.nlm.nih.gov/8750182,analyze,analyzed,glioblastoma cells analyzed by flow cytometry showed the expected binding
Abstract,"""Stem cell-related 'self-renewal' signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/18565887,interrogate,interrogated,of 80 glioblastomas were interrogated for associations with resistance to therapy.
Abstract,"""Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30990881,assess,assessed,"glut1 in glioblastoma, we assessed the expression and localization of glut1"
Abstract,"""Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30990881,enhance,enhance,"expression in glioblastomas may enhance glycolysis, affecting patient prognosis."
Abstract,"""Expression of GLUT1 in Pseudopalisaded and Perivascular Tumor Cells Is an Independent Prognostic Factor for Patients With Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/30990881,provide,provide,patients with glioblastomas may provide a new prognostic tool to improve outcome
Title,"""Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.""",https://pubmed.ncbi.nlm.nih.gov/30176243,reveal,reveals,profiling of glioblastoma samples reveals a novel set of oncomir candidates and
Abstract,"""Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.""",https://pubmed.ncbi.nlm.nih.gov/30176243,remain,remains,"although glioblastomas are common, there remains a need to elucidate"
Abstract,"""Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.""",https://pubmed.ncbi.nlm.nih.gov/30176243,correlate,correlated,5p for glioblastoma negatively correlated with notable mrna targets both in tissues
Abstract,"""Simultaneous miRNA and mRNA transcriptome profiling of glioblastoma samples reveals a novel set of OncomiR candidates and their target genes.""",https://pubmed.ncbi.nlm.nih.gov/30176243,regard,regarding,analysis of glioblastoma samples regarding mirna and gene-expression levels.
Title,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,colocalize,colocalized,an epithelioid glioblastoma with the braf v600e mutation colocalized with braf intact
Abstract,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,recognize,recognized,"variants of glioblastomas, which are not formally recognized by the world"
Abstract,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,occur,occur,"epithelioid glioblastomas usually occur as primary lesions, but there have"
Abstract,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,exist,existing,secondary epithelioid glioblastomas or epithelioid glioblastomas with pre- or co-existing
Abstract,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,exist,existing,or epithelioid glioblastomas with pre- or co-existing lesions to date
Abstract,"""A case of an epithelioid glioblastoma with the BRAF V600E mutation colocalized with BRAF intact low-grade diffuse astrocytoma.""",https://pubmed.ncbi.nlm.nih.gov/26375727,colocalize,colocalized,between epithelioid glioblastoma and colocalized low-grade astrocytoma.
Title,"""Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.""",https://pubmed.ncbi.nlm.nih.gov/18951985,use,using,differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.
Abstract,"""Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.""",https://pubmed.ncbi.nlm.nih.gov/18951985,mean,mean,"diagnosis of glioblastomas (22 men, 16 women, mean age"
Abstract,"""Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.""",https://pubmed.ncbi.nlm.nih.gov/24292886,analyze,analyzed,"mutants in glioblastoma, we analyzed rna from a set of 192"
Abstract,"""Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.""",https://pubmed.ncbi.nlm.nih.gov/24292886,express,expressed,) of glioblastomas expressed at least one rtk intragenic deletion transcript in
Abstract,"""Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19224763,determine,determine,mgmt in glioblastomas and to determine the cpg region whose methylation best
Title,"""DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/33130898,relate,related,methylation based glioblastoma subclassification is related to tumoral t-cell infiltration
Abstract,"""DNA methylation based glioblastoma subclassification is related to tumoral T-cell infiltration and patient survival.""",https://pubmed.ncbi.nlm.nih.gov/33130898,have,have,histologically classified glioblastomas (gbm) can have different clinical behavior and
Abstract,"""Clinical utility of fluorescence in situ hybridization (FISH) in nonbrainstem glioblastomas of childhood.""",https://pubmed.ncbi.nlm.nih.gov/15832192,compare,compared,", nonbrainstem glioblastomas are extremely rare compared with their adult counterparts."
Title,"""Anti-tumour immune response in GL261 glioblastoma generated by Temozolomide Immune-Enhancing Metronomic Schedule monitored with MRSI-based nosological images.""",https://pubmed.ncbi.nlm.nih.gov/31926117,generate,generated,in gl261 glioblastoma generated by temozolomide immune-enhancing metronomic schedule monitored
Abstract,"""Dehydroeburicoic acid induces calcium- and calpain-dependent necrosis in human U87MG glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/19848398,induce,induces,"in human glioblastomas, deea induces necrotic cell death that involves ca(2"
Title,"""The PEA-15/PED protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the ERK/MAP kinase pathway.""",https://pubmed.ncbi.nlm.nih.gov/17700518,induce,induced,protein protects glioblastoma cells from glucose deprivation-induced apoptosis via the
Abstract,"""Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/21743969,elucidate,elucidated,signaling in glioblastomas have not yet been fully elucidated.
Abstract,"""Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/21743969,have,have,"t98g glioblastoma cells, which have low active notch-1 expression and"
Abstract,"""Notch-1 activation-dependent p53 restoration contributes to resveratrol-induced apoptosis in glioblastoma cells.""",https://pubmed.ncbi.nlm.nih.gov/21743969,reveal,revealed,resveratrol on glioblastoma cells and revealed notch-1 activation-dependent restoration of
Abstract,"""Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12060345,involve,involved,feature of glioblastomas but the mechanisms involved in the control of this
Abstract,"""Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12060345,surround,surrounding,"majority of glioblastomas and anaplastic astrocytomas, particularly surrounding areas of necrosis"
Abstract,"""Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12060345,compare,compared,increase in glioblastomas compared to lower grade tumours.
Abstract,"""Expression of hypoxia-inducible factor 1alpha in tumours of patients with glioblastoma.""",https://pubmed.ncbi.nlm.nih.gov/12060345,suggest,suggest,vascularization of glioblastomas and suggest that upregulation is at least partly at
Abstract,"""Investigating microglia-brain tumor cell interactions in vivo in the larval zebrafish brain.""",https://pubmed.ncbi.nlm.nih.gov/28129859,contain,contain,glioblastomas contain a high number of microglia and infiltrating macrophages
Abstract,"""Investigating microglia-brain tumor cell interactions in vivo in the larval zebrafish brain.""",https://pubmed.ncbi.nlm.nih.gov/28129859,promote,promote,colonized the glioblastoma display protumoral functions and promote tumor growth.
Title,"""Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation.""",https://pubmed.ncbi.nlm.nih.gov/35362874,harbor,harboring,findings of glioblastomas harboring a braf v600e mutation.
Abstract,"""Clinical and radiological findings of glioblastomas harboring a BRAF V600E mutation.""",https://pubmed.ncbi.nlm.nih.gov/35362874,harbor,harboring,characteristics of glioblastomas (gbms) harboring a braf mutation.
Abstract,"""Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32253265,remain,remains,"glioblastoma (gbm), an incurable tumor, remains"
Abstract,"""Tumor Microenvironment Is Critical for the Maintenance of Cellular States Found in Primary Glioblastomas.""",https://pubmed.ncbi.nlm.nih.gov/32253265,gsc)-derive,gsc)-derived,"-specific glioblastoma stem cell (gsc)-derived model types, including glioma"
